|
|
 |
|
| | |
| | | | | | | | | | | |
|
|
PR:000018264 |
proteolytic cleavage product
|
ClvPrd
|
"A protein that is produced as the result of proteolytic processing of a longer protein." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000001276 |
Muellerian-inhibiting factor proteolytic cleavage product
|
AMH/ClvPrd
|
"A Muellerian-inhibiting factor that has been processed by proteolytic cleavage." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000002146 |
CD14 molecule cleaved 1 soluble form
|
CD14/Clv:1/soluble
|
"A CD14 molecule, signal peptide removed form that lacks the GPI-anchor and has been processed by proteolytic cleavage to yield the N-terminal domain with extra C-terminal residues as compared to cleaved 2 form." [PMID:7519994]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000036615 |
CD14 molecule cleaved 1 soluble form (human)
|
hCD14/Clv:1/soluble
|
"A CD14 molecule cleaved 1 soluble form in human. UniProtKB:P08571, 20-367." [PMID:7519994, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000037469 |
CD14 molecule cleaved 1 soluble form (mouse)
|
mCD14/Clv:1/soluble
|
"A CD14 molecule cleaved 1 soluble form in mouse. UniProtKB:P10810, 16-358." [PMID:10601848, PMID:18606699, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000002148 |
CD14 molecule cleaved and GPI-anchored form
|
CD14/ClvPrd/anchored
|
"A CD14 molecule, signal peptide removed form that has been processed by proteolytic cleavage to yield the N-terminal domain that has been post-translationally modified to include a GPI-anchor." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018271 |
interferon gamma proteolytic cleavage product
|
IFNG/ClvPrd
|
"An interferon gamma that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018276 |
decorin proteolytic cleavage product
|
DCN/ClvPrd
|
"A decorin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000550 |
decorin isoform A cleaved 2
|
DCN/iso:A/Clv:2
|
"A decorin isoform A that has been cleaved after the Phe residue within the F[NS]GLN motif as a result of the catabolic processing of decorin. This form lacks most of the leucine-rich domains and is abundant in adult skin tissue." [PMID:12621051]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036460 |
decorin isoform A cleaved 2 (human)
|
hDCN/iso:A/Clv:2
|
"A decorin isoform A cleaved 2 in human. UniProtKB:P07585-1, 31-170." [PMID:12621051, PMID:20947661, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018277 |
tumor necrosis factor ligand superfamily member 6 proteolytic cleavage product
|
FASLG/ClvPrd
|
"A tumor necrosis factor ligand superfamily member 6 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000547 |
tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form
|
FASLG/iso:FasL/Clv:soluble
|
"A tumor necrosis factor ligand superfamily member 6 isoform FasL that is the soluble N-terminal portion after ADAM10 processing." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036459 |
tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form (human)
|
hFASLG/iso:FasL/Clv:soluble
|
"A tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form in human. UniProtKB:P48023-1, 130-281." [PMID:7536672, PMID:9228058, PMID:9396774, PMID:9405425, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018285 |
tumor necrosis factor proteolytic cleavage product
|
TNF/ClvPrd
|
"A tumor necrosis factor that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000604 |
tumor necrosis factor isoform 1 cleaved 1
|
TNF/iso:1/Clv:1
|
"A tumor necrosis factor isoform 1 that is the soluble C-terminal portion after processing by TNF alpha converting enzyme ADAM17." [PMID:12135369]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036504 |
tumor necrosis factor isoform 1 cleaved 1 (human)
|
hTNF/iso:1/Clv:1
|
"A tumor necrosis factor isoform 1 cleaved 1 in human. UniProtKB:P01375-1, 77-233." [PMID:14512626, PMID:3856324, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036505 |
tumor necrosis factor isoform 1 cleaved 1 (mouse)
|
mTNF/iso:1/Clv:1
|
"A tumor necrosis factor isoform 1 cleaved 1 in mouse. UniProtKB:P06804-1, 80-235." [PMID:10089307, PMID:9305915, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000605 |
tumor necrosis factor isoform 1 cleaved 2
|
TNF/iso:1/Clv:2
|
"A tumor necrosis factor isoform 1 that is the inactive soluble form after alternative protein processing. The resulting protein is 10 amino acids longer than the active form." [PMID:2777790, PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036506 |
tumor necrosis factor isoform 1 cleaved 2 (mouse)
|
mTNF/iso:1/Clv:2
|
"A tumor necrosis factor isoform 1 cleaved 2 in mouse. UniProtKB:P06804-1, 70-235." [PMID:2777790, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018286 |
bone morphogenetic protein 2 proteolytic cleavage product
|
BMP2/ClvPrd
|
"A bone morphogenetic protein 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018287 |
bone morphogenetic protein 4 proteolytic cleavage product
|
BMP4/ClvPrd
|
"A bone morphogenetic protein 4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018288 |
bone morphogenetic protein 7 proteolytic cleavage product
|
BMP7/ClvPrd
|
"A bone morphogenetic protein 7 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018289 |
GTP-binding protein RhoA proteolytic cleavage product
|
RHOA/ClvPrd
|
"A GTP-binding protein RhoA that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018292 |
TGF-beta 1 proteolytic cleavage product
|
TGFB1/ClvPrd
|
"A TGF-beta 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000616 |
TGF-beta 1 isoform 1 mature form
|
TGFB1/iso:1/mature
|
"A TGF-beta 1 isoform 1 that has been processed by proteolytic cleavage and released from the latent complex. This form is the active mature protein. Example: UniProtKB:P01137-1, 279-390." [PMID:3162913, PRO:CNA, PRO:DAN]
|
|
Yes |
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000025927 |
TGF-beta 1 isoform 1 mature form (human)
|
hTGFB1/iso:1/mature
|
"A TGF-beta 1 isoform 1 mature form in human. UniProtKB:P01137-1, 279-390." [PMID:3162913]
|
Yes |
Yes |
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000025928 |
TGF-beta 1 isoform 1 mature form (mouse)
|
mTGFB1/iso:1/mature
|
"A TGF-beta 1 isoform 1 mature form in mouse. UniProtKB:P04202-1, 279-390." [PMID:2209468]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000025929 |
TGF-beta 1 isoform 1 mature form (rat)
|
rTGFB1/iso:1/mature
|
"A TGF-beta 1 isoform 1 mature form in rat. UniProtKB:P17246-1, 279-390." [PMID:11453552]
|
Yes |
Yes |
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000025930 |
TGF-beta 1 isoform 1 mature form (green monkey)
|
GrMonkey-TGFB1/iso:1/mature
|
"A TGF-beta 1 isoform 1 mature form in green monkey. UniProtKB:P09533-1, 279-390." [PMID:3185545]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000617 |
TGF-beta 1 isoform 1 latency associated peptide
|
TGFB1/iso:1/LAP
|
"A TGF-beta 1 isoform 1, signal peptide removed form that has had the C-terminal mature peptide removed and has been N-glycosylated mainly at either one of the two first consensus N-glycosylation sites. Example: UniProtKB:P01137-1, 30-279, Asn-82, MOD:00160." [PMID:3162913, PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036526 |
TGF-beta 1 isoform 1 latency associated peptide (human)
|
hTGFB1/iso:1/LAP
|
"A TGF-beta 1 isoform 1 latency associated peptide in human. UniProtKB:P01137-1, 30-279, Asn-82, MOD:00160." [PMID:17015622, PMID:3162913, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000000619 |
TGF-beta 1 sequence variant T81H cleaved 1 (human)
|
hTGFB1/var:T81H/Clv:1
|
"A TGF-beta 1 sequence variant T81H, signal peptide removed form (human) that has been processed by subsequent removal of the latency associated peptide (LAP). UniProtKB:P01137, 279-390, Tyr-81, CHEBI:29979." [PMID:12493741, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000000620 |
TGF-beta 1 sequence variant T81H cleaved 2 (human)
|
hTGFB1/var:T81H/Clv:2
|
"A TGF-beta 1 sequence variant T81H, signal peptide removed form (human) that has been processed by subsequent removal of the C-terminal mature peptide. This chain is referred as to the latency associated peptide (LAP). UniProtKB:P01137, 30-278, Tyr-81, CHEBI:29979." [PMID:12493741, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000000621 |
TGF-beta 1 sequence variant R218C cleaved 1 (human)
|
hTGFB1/var:R218C/Clv:1
|
"A TGF-beta 1 sequence variant R218C, signal peptide removed form (human) that has been processed by subsequent removal of the latency associated peptide (LAP). UniProtKB:P01137, 279-390, Arg-218, CHEBI:29950." [PMID:11278244, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000000622 |
TGF-beta 1 sequence variant R218C cleaved 2 (human)
|
hTGFB1/var:R218C/Clv:2
|
"A TGF-beta 1 sequence variant R218C, signal peptide removed form (human) that has been processed by subsequent removal of the C-terminal mature peptide. This chain is referred as to the latency associated peptide (LAP). This form has decreased affinity for the mature peptide (PR:000000621). UniProtKB:P01137, 30-278, Arg-218, CHEBI:29950." [PMID:10973241, PMID:11062463, PMID:11278244, PMID:12493741, PMID:12843182, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000000623 |
TGF-beta 1 sequence variant H222D cleaved 1 (human)
|
hTGFB1/var:H222D/Clv:1
|
"A TGF-beta 1 sequence variant H222D, signal peptide removed form (human) that has been processed by subsequent removal of the latency associated peptide (LAP). UniProtKB:P01137, 279-390, His-222, CHEBI:29958." [PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000000624 |
TGF-beta 1 sequence variant H222D cleaved 2 (human)
|
hTGFB1/var:H222D/Clv:2
|
"A TGF-beta 1 sequence variant H222D, signal peptide removed form (human) that has been processed by subsequent removal of the C-terminal mature peptide. This chain is referred as to the latency associated peptide (LAP). UniProtKB:P01137, 30-278, His-222, CHEBI:29958." [PMID:11278244, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000000625 |
TGF-beta 1 sequence variant C225R cleaved 1 (human)
|
hTGFB1/var:C225R/Clv:1
|
"A TGF-beta 1 sequence variant C225R, signal peptide removed form (human) that has been processed by subsequent removal of the latency associated peptide (LAP). UniProtKB:P01137, 279-390, Cys-225, CHEBI:29952." [PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000000626 |
TGF-beta 1 sequence variant C225R cleaved 2 (human)
|
hTGFB1/var:C225R/Clv:2
|
"A TGF-beta 1 sequence variant C225R, signal peptide removed form (human) that has been processed by subsequent removal of the C-terminal mature peptide. This chain is referred as to the latency associated peptide (LAP). UniProtKB:P01137, 30-278, Cys-225, CHEBI:29952." [PMID:11278244, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000000627 |
TGF-beta 1 sequence variant R218H cleaved 1 (human)
|
hTGFB1/var:R218H/Clv:1
|
"A TGF-beta 1 sequence variant R218H, signal peptide removed form (human) that has been processed by subsequent removal of the latency associated peptide (LAP). UniProtKB:P01137, 279-390, Arg-218, CHEBI:29979." [PMID:11278244, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000000628 |
TGF-beta 1 sequence variant R218H cleaved 2 (human)
|
hTGFB1/var:R218H/Clv:2
|
"A TGF-beta 1 sequence variant R218H, signal peptide removed form (human) that has been processed by subsequent removal of the C-terminal mature peptide. This chain is referred as to the latency associated peptide (LAP). This form has decreased affinity for the mature peptide. UniProtKB:P01137, 30-278, Arg-218, CHEBI:29979." [PMID:11278244, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018293 |
TGF-beta 2 proteolytic cleavage product
|
TGFB2/ClvPrd
|
"A TGF-beta 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000629 |
TGF-beta 2 isoform A cleaved 1
|
TGFB2/iso:A/Clv:1
|
"A TGF-beta 2 isoform A that has been processed by proteolytic cleavage and released from the latent complex. This form, cross-linked to an identical chain, is the active mature protein." [PMID:3476488]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036530 |
TGF-beta 2 isoform A cleaved 1 (human)
|
hTGFB2/iso:A/Clv:1
|
"A TGF-beta 2 isoform A cleaved 1 in human. UniProtKB:P61812-1, 303-414." [PMID:15944186, PMID:16227582, PMID:2119582, PMID:3162913, PMID:3476488, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000630 |
TGF-beta 2 isoform A cleaved 2
|
TGFB2/iso:A/Clv:2
|
"A TGF-beta 2 isoform A, signal peptide removed form that has been processed by subsequent removal of the C-terminal mature protein. This chain is referred as to the latency associated peptide (LAP)." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036531 |
TGF-beta 2 isoform A cleaved 2 (mouse)
|
mTGFB2/iso:A/Clv:2
|
"A TGF-beta 2 isoform A cleaved 2 in mouse. UniProtKB:P27090-1, 20-302." [PMID:14985127, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036532 |
TGF-beta 2 isoform A cleaved 2 (human)
|
hTGFB2/iso:A/Clv:2
|
"A TGF-beta 2 isoform A cleaved 2 in human. UniProtKB:P61812-1, 20-302." [PMID:3162913, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000631 |
TGF-beta 2 isoform A cleaved 3
|
TGFB2/iso:A/Clv:3
|
"A TGF-beta 2 isoform A, signal peptide removed form that has been processed by subsequent cleavage at the dibasic cleavage site rendering the latency associated peptide (LAP) and the mature protein non-covalently bound." [PMID:10224129]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036533 |
TGF-beta 2 isoform A cleaved 3 (human)
|
hTGFB2/iso:A/Clv:3
|
"A TGF-beta 2 isoform A cleaved 3 in human, in which the cleaved parts remain joined by disulfide bonds. UniProtKB:P61812-1, 20-302, 303-414." [PMID:3162913, PMID:3476488, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000632 |
TGF-beta 2 isoform B cleaved 1
|
TGFB2/iso:B/Clv:1
|
"A TGF-beta 2 isoform B that has been processed by proteolytic cleavage and released from the latent complex. This form is the active mature peptide." [PMID:1777240]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036534 |
TGF-beta 2 isoform B cleaved 1 (human)
|
hTGFB2/iso:B/Clv:1
|
"A TGF-beta 2 isoform B cleaved 1 in human. UniProtKB:P61812-2, 331-442." [PMID:1777240, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000633 |
TGF-beta 2 isoform B cleaved 2
|
TGFB2/iso:B/Clv:2
|
"A TGF-beta 2 isoform B, signal peptide removed form that has been processed by subsequent cleavage at the dibasic cleavage site rendering the latency associated peptide (LAP) and the mature protein non-covalently bound." [PMID:1777240]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036535 |
TGF-beta 2 isoform B cleaved 2 (human)
|
hTGFB2/iso:B/Clv:2
|
"A TGF-beta 2 isoform B cleaved 2 in human, in which the cleaved parts remain joined by disulfide bonds. UniProtKB:P61812-2, 20-330, 331-442." [PMID:1777240, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018294 |
TGF-beta 3 proteolytic cleavage product
|
TGFB3/ClvPrd
|
"A TGF-beta 3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000634 |
TGF-beta 3 isoform 1 cleaved 1
|
TGFB3/iso:1/Clv:1
|
"A TGF-beta 3 isoform 1 that has been processed by proteolytic cleavage and released from the latent complex. This form is the active mature peptide." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036536 |
TGF-beta 3 isoform 1 cleaved 1 (human)
|
hTGFB3/iso:1/Clv:1
|
"A TGF-beta 3 isoform 1 cleaved 1 in human. UniProtKB:P10600-1, 301-412." [PMID:18243111, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036537 |
TGF-beta 3 isoform 1 cleaved 1 (mouse)
|
mTGFB3/iso:1/Clv:1
|
"A TGF-beta 3 isoform 1 cleaved 1 in mouse. UniProtKB:P17125-1, 299-410." [PMID:1821856, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000635 |
TGF-beta 3 isoform 1 cleaved 2
|
TGFB3/iso:1/Clv:2
|
"A TGF-beta 3 isoform 1, signal peptide removed form that has been processed by proteolytic cleavage to remove the C-terminal mature peptide. This chain is referred as to the latency associated peptide (LAP)." [PMID:11821050]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000636 |
TGF-beta 3 isoform 1 cleaved 3
|
TGFB3/iso:1/Clv:3
|
"A TGF-beta 3 isoform 1, signal peptide removed form that has been processed by subsequent cleavage at the dibasic cleavage site rendering the latency associated peptide (LAP) and the mature protein non-covalently bound." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036538 |
TGF-beta 3 isoform 1 cleaved 3 (mouse)
|
mTGFB3/iso:1/Clv:3
|
"A TGF-beta 3 isoform 1 cleaved 3 in mouse, in which the cleaved parts remain joined by disulfide bonds. UniProtKB:P17125-1, 30-298, 299-410." [PMID:1821856, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018295 |
activin/inhibin beta A chain proteolytic cleavage product
|
INHBA/ClvPrd
|
"An activin/inhibin beta A chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018298 |
platelet-derived growth factor C proteolytic cleavage product
|
PDGFC/ClvPrd
|
"A platelet-derived growth factor C that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000982 |
platelet-derived growth factor C isoform 1 cleaved 1
|
PDGFC/iso:1/Clv:1
|
"A platelet-derived growth factor C isoform 1, signal peptide removed form that has been processed by subsequent removal of the CUB domain." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036570 |
platelet-derived growth factor C isoform 1 cleaved 1 (human)
|
hPDGFC/iso:1/Clv:1
|
"A platelet-derived growth factor C isoform 1 cleaved 1 in human. UniProtKB:Q9NRA1-1, 226-345." [PMID:10806482, PMID:11297552, PMID:15911618, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036571 |
platelet-derived growth factor C isoform 1 cleaved 1 (mouse)
|
mPDGFC/iso:1/Clv:1
|
"A platelet-derived growth factor C isoform 1 cleaved 1 in mouse. UniProtKB:Q8CI19-1, 226-345." [PMID:11297552, PMID:15372073, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018311 |
integrin alpha-E proteolytic cleavage product
|
ITGAE/ClvPrd
|
"An integrin alpha-E that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018344 |
interleukin-1 alpha proteolytic cleavage product
|
IL1A/ClvPrd
|
"An interleukin-1 alpha that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018345 |
interleukin-1 beta proteolytic cleavage product
|
IL1B/ClvPrd
|
"An interleukin-1 beta that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018362 |
ADAM 17 endopeptidase proteolytic cleavage product
|
ADAM17/ClvPrd
|
"An ADAM 17 endopeptidase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018381 |
CD48 molecule proteolytic cleavage product
|
CD48/ClvPrd
|
"A CD48 molecule that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018390 |
L-selectin proteolytic cleavage product
|
SELL/ClvPrd
|
"An L-selectin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018395 |
angiotensin-converting enzyme proteolytic cleavage product
|
ACE/ClvPrd
|
"An angiotensin-converting enzyme that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018406 |
cell adhesion molecule CEACAM8 proteolytic cleavage product
|
CEACAM8/ClvPrd
|
"A cell adhesion molecule CEACAM8 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018411 |
complement decay-accelerating factor proteolytic cleavage product
|
CD55/ClvPrd
|
"A complement decay-accelerating factor that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018418 |
dipeptidyl peptidase 4 proteolytic cleavage product
|
DPP4/ClvPrd
|
"A dipeptidyl peptidase 4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018435 |
pro-interleukin-16 proteolytic cleavage product
|
IL16/ClvPrd
|
"A pro-interleukin-16 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000085740 |
interleukin-16 (mouse)
|
mIL16/mature
|
"A pro-interleukin-16 (mouse) that corresponds to the C-terminal portion after proteolytic cleavage by caspase-3. UniProtKB:O54824, 1205-1322." [PRO:DAN, UniProtKB:O54824]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018438 |
interleukin-18 proteolytic cleavage product
|
IL18/ClvPrd
|
"An interleukin-18 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018461 |
interleukin-8 proteolytic cleavage product
|
CXCL8/ClvPrd
|
"An interleukin-8 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018480 |
cadherin-2 proteolytic cleavage product
|
CDH2/ClvPrd
|
"A cadherin-2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018481 |
cadherin-1 proteolytic cleavage product
|
CDH1/ClvPrd
|
"A cadherin-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018490 |
gamma-glutamyltranspeptidase 1 proteolytic cleavage product
|
GGT1/ClvPrd
|
"A glutathione hydrolase 1 proenzyme that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018513 |
proteinase-activated receptor 1 proteolytic cleavage product
|
F2R/ClvPrd
|
"A proteinase-activated receptor 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018518 |
inhibin alpha chain proteolytic cleavage product
|
INHA/ClvPrd
|
"An inhibin alpha chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000001732 |
inhibin alpha chain isoform 1 cleaved and glycosylated form
|
INHA/iso:1/ClvGlyco+
|
"An inhibin alpha chain isoform 1, signal peptide removed form that has been processed by proteolytic cleavage and includes at least one glycosylated residue." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000001733 |
inhibin alpha chain isoform 1 cleaved and N-glycosylated 2
|
INHA/iso:1/ClvNGlyco:2
|
"An inhibin alpha chain isoform 1 cleaved and glycosylated form that has had release of the propeptide and has been glycosylated at Asn residues within the two consensus glycosylation sites. Glycosylation favors formation of the inhibin A complex. Example: UniProtKB:P05111-1, 233-366, Asn-268/Asn-302, MOD:00160." [PMID:17456790, PMID:8885240]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000036608 |
inhibin alpha chain isoform 1 cleaved and N-glycosylated 2 (human)
|
hINHA/iso:1/ClvNGlyco:2
|
"An inhibin alpha chain isoform 1 cleaved and N-glycosylated 2 in human. UniProtKB:P05111-1, 233-366, Asn-268/Asn-302, MOD:00160." [PMID:17456790, PMID:8885240, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000001736 |
inhibin alpha chain isoform 1 cleaved and N-glycosylated 1
|
INHA/iso:1/ClvNGlyco:1
|
"An inhibin alpha chain isoform 1 cleaved and glycosylated form that has had release of the propeptide and has been N-glycosylated at an Asn residue within the first (or unique) consensus glycosylation site. Glycosylation favors formation of the inhibin A complex." [PMID:17456790]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018519 |
nuclear factor NF-kappa-B p105 subunit proteolytic cleavage product
|
NFKB1/ClvPrd
|
"A nuclear factor NF-kappa-B p105 subunit that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000001757 |
nuclear factor NF-kappa-B p50 subunit
|
NFKBp50
|
"A nuclear factor NF-kappa-B p105 subunit isoform 1 that has been processed by proteolytic cleavage to remove the C-terminal domain of p105 downstream from the 23-residue glycine rich region (GRR). Example: UniProtKB:P19838-1, 1-433." [PMID:2203532, PMID:8628291, PRO:DAN, PRO:JAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000028540 |
nuclear factor NF-kappa-B p50 subunit (mouse)
|
mNFKBp50
|
"A nuclear factor NF-kappa-B p50 subunit in mouse. Example: UniProtKB:P25799-1, 1-431." [PMID:2203532, PRO:CNA]
|
|
Yes |
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000035834 |
nuclear factor NF-kappa-B p50 subunit (human)
|
hNFKBp50
|
"A nuclear factor NF-kappa-B p50 subunit in human. Example: UniProtKB:P19838-1, 1-433." [PRO:DNx, UniProtKB:P19838]
|
Yes |
Yes |
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018524 |
5'-nucleotidase proteolytic cleavage product
|
NT5E/ClvPrd
|
"A 5'-nucleotidase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018533 |
P-selectin glycoprotein ligand 1 proteolytic cleavage product
|
SELPLG/ClvPrd
|
"A P-selectin glycoprotein ligand 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018546 |
Thy-1 membrane glycoprotein proteolytic cleavage product
|
THY1/ClvPrd
|
"A Thy-1 membrane glycoprotein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018547 |
cathepsin K proteolytic cleavage product
|
CTSK/ClvPrd
|
"A cathepsin K that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018550 |
fractalkine proteolytic cleavage product
|
CX3CL1/ClvPrd
|
"A fractalkine that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018553 |
interleukin-4 receptor subunit alpha proteolytic cleavage product
|
IL4R/ClvPrd
|
"An interleukin-4 receptor subunit alpha that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018568 |
low affinity immunoglobulin epsilon Fc receptor proteolytic cleavage product
|
FCER2/ClvPrd
|
"A low affinity immunoglobulin epsilon Fc receptor that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018578 |
mucin-1 proteolytic cleavage product
|
MUC1/ClvPrd
|
"A mucin-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018591 |
platelet glycoprotein Ib alpha chain proteolytic cleavage product
|
GP1BA/ClvPrd
|
"A platelet glycoprotein Ib alpha chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018594 |
scavenger receptor cysteine-rich type 1 protein M130 proteolytic cleavage product
|
CD163/ClvPrd
|
"A scavenger receptor cysteine-rich type 1 protein M130 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018603 |
transferrin receptor protein 1 proteolytic cleavage product
|
TFRC/ClvPrd
|
"A transferrin receptor protein 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018604 |
tumor necrosis factor ligand superfamily member 13 proteolytic cleavage product
|
TNFSF13/ClvPrd
|
"A tumor necrosis factor ligand superfamily member 13 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018605 |
tumor necrosis factor ligand superfamily member 13B proteolytic cleavage product
|
TNFSF13B/ClvPrd
|
"A tumor necrosis factor ligand superfamily member 13B that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018606 |
tumor necrosis factor ligand superfamily member 5 proteolytic cleavage product
|
CD40LG/ClvPrd
|
"A tumor necrosis factor ligand superfamily member 5 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018613 |
tumor necrosis factor receptor superfamily member 1A proteolytic cleavage product
|
TNFRSF1A/ClvPrd
|
"A tumor necrosis factor receptor superfamily member 1A that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018616 |
tumor necrosis factor receptor superfamily member 1B proteolytic cleavage product
|
TNFRSF1B/ClvPrd
|
"A tumor necrosis factor receptor superfamily member 1B that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018635 |
C-C motif chemokine 14 proteolytic cleavage product
|
CCL14/ClvPrd
|
"A C-C motif chemokine 14 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018638 |
C-C motif chemokine 15 proteolytic cleavage product
|
CCL15/ClvPrd
|
"A C-C motif chemokine 15 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018645 |
C-C motif chemokine 18 proteolytic cleavage product
|
CCL18/ClvPrd
|
"A C-C motif chemokine 18 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018650 |
C-C motif chemokine 20 proteolytic cleavage product
|
CCL20/ClvPrd
|
"A C-C motif chemokine 20 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018655 |
C-C motif chemokine 22 proteolytic cleavage product
|
CCL22/ClvPrd
|
"A C-C motif chemokine 22 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018658 |
C-C motif chemokine 23 proteolytic cleavage product
|
CCL23/ClvPrd
|
"A C-C motif chemokine 23 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018695 |
T-cell surface glycoprotein CD1e proteolytic cleavage product
|
CD1E/ClvPrd
|
"A T-cell surface glycoprotein CD1e that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018709 |
low-density lipoprotein receptor-related protein 1 proteolytic cleavage product
|
LRP1/ClvPrd
|
"A low-density lipoprotein receptor-related protein 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018718 |
C-C motif chemokine 5 proteolytic cleavage product
|
CCL5/ClvPrd
|
"A C-C motif chemokine 5 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018721 |
tumor necrosis factor ligand superfamily member 11 proteolytic cleavage product
|
TNFSF11/ClvPrd
|
"A tumor necrosis factor ligand superfamily member 11 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000002437 |
tumor necrosis factor ligand superfamily member 11 isoform 1 soluble form
|
TNFSF11/iso:1/Clv:soluble
|
"A tumor necrosis factor ligand superfamily member 11 isoform 1 that has been processed by a metalloprotease-disintegrin TNF-alpha convertase (TACE) to yield the tumor necrosis factor ligand superfamily member 11 soluble form." [PMID:10196481]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018727 |
C-C motif chemokine 13 proteolytic cleavage product
|
CCL13/ClvPrd
|
"A C-C motif chemokine 13 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018732 |
C-C motif chemokine 3 proteolytic cleavage product
|
CCL3/ClvPrd
|
"A C-C motif chemokine 3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018735 |
C-C motif chemokine 4 proteolytic cleavage product
|
CCL4/ClvPrd
|
"A C-C motif chemokine 4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018738 |
C-C motif chemokine 8 proteolytic cleavage product
|
CCL8/ClvPrd
|
"A C-C motif chemokine 8 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018744 |
14-3-3 protein beta/alpha proteolytic cleavage product
|
YWHAB/ClvPrd
|
"A 14-3-3 protein beta/alpha that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018749 |
BH3-interacting domain death agonist proteolytic cleavage product
|
BID/ClvPrd
|
"A BH3-interacting domain death agonist that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000002439 |
BH3-interacting domain death agonist isoform 1 cleaved 1
|
BID/iso:1/Clv:1
|
"A BH3-interacting domain death agonist isoform 1 that has been processed by proteolytic cleavage mediated by a caspase to yield the matured peptide BH3-interacting domain death agonist p15." [PMID:9873064]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000026785 |
BH3-interacting domain death agonist isoform 1 cleaved 1 (mouse)
|
mBID/iso:1/Clv:1
|
"A BH3-interacting domain death agonist isoform 1 cleaved 1 in mouse. UniProtKB:P70444-1, 61-195." [PMID:9727492, PRO:HJD]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000028379 |
BH3-interacting domain death agonist isoform 1 cleaved 1 (human)
|
hBID/iso:1/Clv:1
|
"A BH3-interacting domain death agonist isoform 1 cleaved 1 in human. UniProtKB:P55957-1, 62-195." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000002440 |
BH3-interacting domain death agonist isoform 1 cleaved 2
|
BID/iso:1/Clv:2
|
"A BH3-interacting domain death agonist isoform 1 that has been processed by proteolytic cleavage mediated by a caspase to yield the matured peptide BH3-interacting domain death agonist p13." [PMID:9873064]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000026786 |
BH3-interacting domain death agonist isoform 1 cleaved 2 (mouse)
|
mBID/iso:1/Clv:2
|
"A BH3-interacting domain death agonist isoform 1 cleaved 2 in mouse. This cleaved form is generated via granzyme B cleavage. UniProtKB:P70444-1, 76-195." [PMID:9727492, PRO:HJD]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000002441 |
BH3-interacting domain death agonist isoform 1 cleaved 3
|
BID/iso:1/Clv:3
|
"A BH3-interacting domain death agonist isoform 1 that has been processed by proteolytic cleavage mediated by a caspase to yield the matured peptide BH3-interacting domain death agonist p11." [PMID:9873064]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018754 |
proteasome subunit beta type-4 proteolytic cleavage product
|
PSMB4/ClvPrd
|
"A proteasome subunit beta type-4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018755 |
tumor necrosis factor ligand superfamily member 14 proteolytic cleavage product
|
TNFSF14/ClvPrd
|
"A tumor necrosis factor ligand superfamily member 14 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018756 |
tumor necrosis factor ligand superfamily member 15 proteolytic cleavage product
|
TNFSF15/ClvPrd
|
"A tumor necrosis factor ligand superfamily member 15 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018758 |
caspase-1 proteolytic cleavage product
|
CASP1/ClvPrd
|
"A caspase-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000002449 |
caspase-1 isoform 1 cleaved 1
|
CASP1/iso:1/Clv:1
|
"A caspase-1 isoform 1 that has been processed by proteolytic cleavage to yield the mature caspase-1 subunit p20." [PMID:8044845, PRO:JAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000002450 |
caspase-1 isoform 1 cleaved 2
|
CASP1/iso:1/Clv:2
|
"A caspase-1 isoform 1 that has been processed by proteolytic cleavage to yield the mature caspase-1 subunit p10." [PMID:8044845, PRO:JAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018759 |
caspase-10 proteolytic cleavage product
|
CASP10/ClvPrd
|
"A caspase-10 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018761 |
caspase-2 proteolytic cleavage product
|
CASP2/ClvPrd
|
"A caspase-2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000002451 |
caspase-2 subunit p18
|
CASP2/p18
|
"A caspase-2 isoform 1 that corresponds to the N-terminal portion after removal of the propeptides. Example: UniProtKB:P42575-1, 170-325." [PMID:8654923, PRO:DAN, PRO:JAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000050110 |
caspase-2 subunit p18 (human)
|
hCASP2/p18
|
"A caspase-2 subunit p18 in human. Example: UniProtKB:P42575-1, 170-325." [PRO:DNx, UniProtKB:P42575]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000002452 |
caspase-2 subunit p13
|
CASP2/p13
|
"A caspase-2 isoform 1 that corresponds to the C-terminal portion after removal of the propeptides. UniProtKB:P42575-1, 334-452." [PMID:8654923, PRO:DAN, PRO:JAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000050111 |
caspase-2 subunit p13 (human)
|
hCASP2/p13
|
"A caspase-2 subunit p13 in human. Example: UniProtKB:P42575-1, 334-452." [PRO:DNx, UniProtKB:P42575]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000002453 |
caspase-2 subunit p12
|
CASP2/p12
|
"A caspase-2 isoform 1 that corresponds to the C-terminal portion after removal of the propeptides and a short intersubunit linker (in humans, the N-terminal-most 14 amino acids of the p13 form). UniProtKB:P42575-1, 348-452." [PMID:8654923, PRO:DAN, PRO:JAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000050112 |
caspase-2 subunit p12 (human)
|
hCASP2/p12
|
"A caspase-2 subunit p12 in human. Example: UniProtKB:P42575-1, 348-452." [PRO:DAN, UniProtKB:P42575]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018762 |
caspase-3 proteolytic cleavage product
|
CASP3/ClvPrd
|
"A caspase-3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000002454 |
caspase-3 isoform 1 cleaved 1
|
CASP3/iso:1/Clv:1
|
"A caspase-3 isoform 1 that has been processed by proteolytic cleavage to yield the mature caspase-3 subunit p12." [PRO:CNA]
|
|
Yes |
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000026876 |
caspase-3 isoform 1 cleaved 1 (human)
|
hCASP3/iso:1/Clv:1
|
"A caspase-3 isoform 1 cleaved 1 in human. UniProtKB:P42574-1, 176-277." [PMID:11931755, PRO:CNA]
|
|
Yes |
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000002455 |
caspase-3 isoform 1 cleaved 2
|
CASP3/iso:1/Clv:2
|
"A caspase-3 isoform 1 that has been processed by proteolytic cleavage to yield the mature caspase-3 subunit p17." [PRO:CNA]
|
|
Yes |
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000026877 |
caspase-3 isoform 1 cleaved 2 (human)
|
hCASP3/iso:1/Clv:2
|
"A caspase-3 isoform 1 cleaved 2 in human. UniProtKB:P42574-1, 29-175." [PRO:CNA]
|
|
Yes |
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018763 |
caspase-4 proteolytic cleavage product
|
CASP4/ClvPrd
|
"A caspase-4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018764 |
caspase-5 proteolytic cleavage product
|
CASP5/ClvPrd
|
"A caspase-5 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018765 |
caspase-6 proteolytic cleavage product
|
CASP6/ClvPrd
|
"A caspase-6 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000002456 |
caspase-6 subunit p11
|
CASP6/p11
|
"A caspase-6 isoform 1 that corresponds to the C-terminal portion after removal of the propeptides. UniProtKB:P55212-1, 194-293." [PMID:8900201, PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000050094 |
caspase-6 subunit p11 (human)
|
hCASP6/p11
|
"A caspase-6 subunit p11 in human. Example: UniProtKB:P55212-1, 194-293." [PRO:DNx, UniProtKB:P55212]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000002457 |
caspase-6 subunit p18
|
CASP6/p18
|
"A caspase-6 isoform 1 that corresponds to the N-terminal portion after removal of the propeptides. Example: UniProtKB:P55212-1, 24-179." [PMID:8900201, PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000050093 |
caspase-6 subunit p18 (human)
|
hCASP6/p18
|
"A caspase-6 subunit p18 in human. Example: UniProtKB:P55212-1, 24-179." [PRO:DNx, UniProtKB:P55212]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018767 |
caspase-7 proteolytic cleavage product
|
CASP7/ClvPrd
|
"A caspase-7 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000002458 |
caspase-7 subunit p11
|
CASP7/p11
|
"A caspase-7 isoform 1 that corresponds to the C-terminal portion after removal of the propeptides. Example: UniProtKB:P55210-1, 207-303." [PMID:8755496, PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000050106 |
caspase-7 subunit p11 (human)
|
hCASP7/p11
|
"A caspase-7 subunit p11 in human. Example: UniProtKB:P55210-1, 207-303." [PRO:DNx, UniProtKB:P55210]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000002459 |
caspase-7 subunit p20
|
CASP7/p20
|
"A caspase-7 isoform 1 that corresponds to the N-terminal portion after removal of the propeptides. Example: UniProtKB:P55210-1, 24-198." [PMID:8755496, PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000050105 |
caspase-7 subunit p20 (human)
|
hCASP7/p20
|
"A caspase-7 subunit p20 in human. Example: UniProtKB:P55210-1, 24-198." [PRO:DNx, UniProtKB:P55210]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018768 |
caspase-8 proteolytic cleavage product
|
CASP8/ClvPrd
|
"A caspase-8 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036062 |
caspase-8 isoform 1 cleaved 1
|
CASP8/iso:1/Clv:1
|
"A caspase-8 isoform 1 that has been processed by proteolytic cleavage to yield the mature caspase-8 subunit p18." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036063 |
caspase-8 isoform 1 cleaved 1 (human)
|
hCASP8/iso:1/Clv:1
|
"A caspase-8 isoform 1 cleaved 1 in human. UniProtKB:Q14790-1, 217-374." [PMID:9184224, PRO:CNA]
|
|
Yes |
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036064 |
caspase-8 isoform 1 cleaved 2
|
CASP8/iso:1/Clv:2
|
"A caspase-8 isoform 1 that has been processed by proteolytic cleavage to yield the mature caspase-8 subunit p10." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036065 |
caspase-8 isoform 1 cleaved 2 (human)
|
hCASP8/iso:1/Clv:2
|
"A caspase-8 isoform 1 cleaved 2 in human. UniProtKB:Q14790-1, 385-479." [PMID:9184224, PRO:CNA]
|
|
Yes |
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018769 |
caspase-9 proteolytic cleavage product
|
CASP9/ClvPrd
|
"A caspase-9 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000002460 |
caspase-9 isoform 1 subunit p35
|
CASP9/iso:1/p35
|
"A caspase-9 isoform 1 that corresponds to the N-terminal portion after removal of the propeptides. Example: UniProtKB:P55211-1, ?-315." [PMID:8900201, PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000002461 |
caspase-9 isoform 1 subunit p10
|
CASP9/iso:1/p10
|
"A caspase-9 isoform 1 that corresponds to the C-terminal portion after removal of the propeptides. Example: UniProtKB:P55211-1, 331-416." [PMID:8900201, PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000050089 |
caspase-9 subunit p35
|
CASP9/p35
|
"A caspase-9 that corresponds to the N-terminal portion after removal of the propeptides. Example: UniProtKB:P55211-1, ?-315." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000050095 |
caspase-9 subunit p35 (human)
|
hCASP9/p35
|
"A caspase-9 subunit p35 in human. Example: UniProtKB:P55211-1, ?-315." [PRO:DNx, UniProtKB:P55211]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000050090 |
caspase-9 subunit p10
|
CASP9/p10
|
"A caspase-9 that corresponds to the C-terminal portion after removal of the propeptides. Example: UniProtKB:P55211-1, 331-416." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000050096 |
caspase-9 subunit p10 (human)
|
hCASP9/p10
|
"A caspase-9 subunit p10 in human. Example: UniProtKB:P55211-1, 331-416." [PRO:DNx, UniProtKB:P55211]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018780 |
prostate-specific antigen proteolytic cleavage product
|
KLK3/ClvPrd
|
"A prostate-specific antigen that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018787 |
furin proteolytic cleavage product
|
FURIN/ClvPrd
|
"A furin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018798 |
collagen alpha-1(I) chain proteolytic cleavage product
|
COL1A1/ClvPrd
|
"A collagen alpha-1(I) chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000003372 |
collagen alpha-1(I) chain isoform 1 mature form
|
COL1A1/iso:1/mature
|
"A collagen alpha-1(I) chain isoform 1, signal peptide removed form that has been processed by subsequent removal of all propeptides. Example: UniProtKB:P02452-1, 162-1218." [PRO:CNA]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018799 |
collagen alpha-2(I) chain proteolytic cleavage product
|
COL1A2/ClvPrd
|
"A collagen alpha-2(I) chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018800 |
collagen type II alpha chain proteolytic cleavage product
|
COL2A1/ClvPrd
|
"A collagen type II alpha chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000003367 |
chondrocalcin
|
COL2A1/iso:2/Clv:2
|
"A collagen type II alpha chain isoform 2 that is the C-terminal region after proteolytic cleavage. Example: UniProtKB:P02458-2, 1242-1487." [PMID:3800925, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000003368 |
collagen type II alpha chain isoform 2 cleaved 1
|
COL2A1/iso:2/Clv:1
|
"A collagen type II alpha chain isoform 2, signal peptide removed form that has been processed by subsequent removal of the N-terminal propeptide and the C-terminal chondrocalcin sequence, yielding the mature protein. Example: UniProtKB:P02458-2, 182-1241." [PRO:CNA]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018803 |
insulin-like growth factor 1 receptor proteolytic cleavage product
|
IGF1R/ClvPrd
|
"An insulin-like growth factor 1 receptor that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000003276 |
insulin-like growth factor 1 receptor isoform 1 cleaved 1
|
IGF1R/iso:1/Clv:1
|
"An insulin-like growth factor 1 receptor isoform 1, signal peptide removed form that has been subsequently processed to yield the N-terminal mature chain." [PMID:8257688, PRO:JAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000003277 |
insulin-like growth factor 1 receptor isoform 1 cleaved 2
|
IGF1R/iso:1/Clv:2
|
"An insulin-like growth factor 1 receptor isoform 1, signal peptide removed form that has been subsequently processed to yield the C-terminal mature chain." [PRO:JAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018809 |
collagen alpha-1(III) chain proteolytic cleavage product
|
COL3A1/ClvPrd
|
"A collagen alpha-1(III) chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018812 |
collagen alpha-2(V) chain proteolytic cleavage product
|
COL5A2/ClvPrd
|
"A collagen alpha-2(V) chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018813 |
collagen alpha-1(V) chain proteolytic cleavage product
|
COL5A1/ClvPrd
|
"A collagen alpha-1(V) chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018820 |
granzyme K proteolytic cleavage product
|
GZMK/ClvPrd
|
"A granzyme K that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018823 |
granzyme D proteolytic cleavage product
|
Gzmd/ClvPrd
|
"A granzyme D that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018826 |
granzyme G proteolytic cleavage product
|
Gzmg/ClvPrd
|
"A granzyme G that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018829 |
granzyme E proteolytic cleavage product
|
Gzme/ClvPrd
|
"A granzyme E that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018832 |
granzyme C proteolytic cleavage product
|
Gzmc/ClvPrd
|
"A granzyme C that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018835 |
granzyme H proteolytic cleavage product
|
GZMH/ClvPrd
|
"A granzyme H that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018838 |
granzyme F proteolytic cleavage product
|
Gzmf/ClvPrd
|
"A granzyme F that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018849 |
histo-blood group ABO system transferase proteolytic cleavage product
|
ABO/ClvPrd
|
"A histo-blood group ABO system transferase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018864 |
aggrecan core protein proteolytic cleavage product
|
ACAN/ClvPrd
|
"An aggrecan core protein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018866 |
angiotensin-converting enzyme 2 proteolytic cleavage product
|
ACE2/ClvPrd
|
"An angiotensin-converting enzyme 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018880 |
acrosin proteolytic cleavage product
|
ACR/ClvPrd
|
"An acrosin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018883 |
actin, aortic smooth muscle proteolytic cleavage product
|
ACTA2/ClvPrd
|
"An actin, aortic smooth muscle that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018885 |
actin, cytoplasmic 1 proteolytic cleavage product
|
ACTB/ClvPrd
|
"An actin, cytoplasmic 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018887 |
actin, cytoplasmic 2 proteolytic cleavage product
|
ACTG1/ClvPrd
|
"An actin, cytoplasmic 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018892 |
disintegrin and metalloproteinase domain-containing protein 2 proteolytic cleavage product
|
ADAM2/ClvPrd
|
"A disintegrin and metalloproteinase domain-containing protein 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018895 |
a disintegrin and metalloproteinase with thrombospondin motifs 1 proteolytic cleavage product
|
ADAMTS1/ClvPrd
|
"An a disintegrin and metalloproteinase with thrombospondin motifs 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018896 |
a disintegrin and metalloproteinase with thrombospondin motifs 13 proteolytic cleavage product
|
ADAMTS13/ClvPrd
|
"An a disintegrin and metalloproteinase with thrombospondin motifs 13 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018897 |
a disintegrin and metalloproteinase with thrombospondin motifs 4 proteolytic cleavage product
|
ADAMTS4/ClvPrd
|
"An a disintegrin and metalloproteinase with thrombospondin motifs 4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018898 |
a disintegrin and metalloproteinase with thrombospondin motifs 7 proteolytic cleavage product
|
ADAMTS7/ClvPrd
|
"An a disintegrin and metalloproteinase with thrombospondin motifs 7 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018899 |
a disintegrin and metalloproteinase with thrombospondin motifs 9 proteolytic cleavage product
|
ADAMTS9/ClvPrd
|
"An a disintegrin and metalloproteinase with thrombospondin motifs 9 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018902 |
pituitary adenylate cyclase-activating polypeptide proteolytic cleavage product
|
ADCYAP1/ClvPrd
|
"A pituitary adenylate cyclase-activating polypeptide that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018914 |
pro-adrenomedullin proteolytic cleavage product
|
ADM/ClvPrd
|
"A pro-adrenomedullin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018924 |
N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase proteolytic cleavage product
|
AGA/ClvPrd
|
"An N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018932 |
angiotensinogen proteolytic cleavage product
|
AGT/ClvPrd
|
"An angiotensinogen, signal peptide removed form that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036008 |
angiotensin I
|
ang I
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of renin on angiotensinogen, signal peptide removed form." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036009 |
angiotensin II
|
ang II
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme on angiotensin I." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000036010 |
angiotensin III
|
ang III
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase A on angiotensin II." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
| |
modification
|
|
PR:000036011 |
angiotensin IV
|
ang IV
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase M on angiotensin III." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000036013 |
angiotensin 1-7
|
ang 1-7
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme 2 on angiotensin II." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036012 |
angiotensin 1-9
|
ang 1-9
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme 2 on angiotensin I." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036009 |
angiotensin II
|
ang II
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme on angiotensin I." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036010 |
angiotensin III
|
ang III
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase A on angiotensin II." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000036011 |
angiotensin IV
|
ang IV
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase M on angiotensin III." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036013 |
angiotensin 1-7
|
ang 1-7
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme 2 on angiotensin II." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036010 |
angiotensin III
|
ang III
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase A on angiotensin II." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036011 |
angiotensin IV
|
ang IV
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase M on angiotensin III." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036011 |
angiotensin IV
|
ang IV
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase M on angiotensin III." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036012 |
angiotensin 1-9
|
ang 1-9
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme 2 on angiotensin I." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036013 |
angiotensin 1-7
|
ang 1-7
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme 2 on angiotensin II." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018934 |
aryl hydrocarbon receptor proteolytic cleavage product
|
AHR/ClvPrd
|
"An aryl hydrocarbon receptor that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018937 |
alpha-2-HS-glycoprotein proteolytic cleavage product
|
AHSG/ClvPrd
|
"An alpha-2-HS-glycoprotein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018950 |
albumin proteolytic cleavage product
|
ALB/ClvPrd
|
"An albumin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018969 |
alkaline phosphatase, placental type proteolytic cleavage product
|
ALPP/ClvPrd
|
"An alkaline phosphatase, placental type that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018973 |
protein AMBP proteolytic cleavage product
|
AMBP/ClvPrd
|
"A protein AMBP that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000018999 |
acyloxyacyl hydrolase proteolytic cleavage product
|
AOAH/ClvPrd
|
"An acyloxyacyl hydrolase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019005 |
serum amyloid P-component proteolytic cleavage product
|
APCS/ClvPrd
|
"A serum amyloid P-component that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019010 |
apolipoprotein A-I proteolytic cleavage product
|
APOA1/ClvPrd
|
"An apolipoprotein A-I that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019013 |
apolipoprotein A-II proteolytic cleavage product
|
APOA2/ClvPrd
|
"An apolipoprotein A-II that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019018 |
apolipoprotein B-100 proteolytic cleavage product
|
APOB/ClvPrd
|
"An apolipoprotein B-100 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019029 |
apolipoprotein F proteolytic cleavage product
|
APOF/ClvPrd
|
"An apolipoprotein F that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019036 |
amyloid-beta precursor protein proteolytic cleavage product
|
APP/ClvPrd
|
"An amyloid-beta precursor protein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000025577 |
soluble APP-alpha
|
S-APP-alpha
|
"An amyloid-beta precursor protein proteolytic cleavage product that is the N-terminal product of cleavage by alpha-secretase of amyloid-beta precursor protein, signal peptide removed form. Example: UniProtKB:P05067-1, 18-687." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000025578 |
soluble APP-beta
|
S-APP-beta
|
"An amyloid-beta precursor protein proteolytic cleavage product that is the N-terminal product of cleavage by beta-secretase of amyloid-beta precursor protein, signal peptide removed form. Example: UniProtKB:P05067-1, 18-671." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000025579 |
soluble APP-theta
|
S-APP-theta
|
"An amyloid-beta precursor protein proteolytic cleavage product that is the N-terminal product of cleavage by theta-secretase of amyloid-beta precursor protein, signal peptide removed form." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000025580 |
C99
|
APP-C99
|
"An amyloid-beta precursor protein proteolytic cleavage product that is the C-terminal product of cleavage by beta-secretase of certain amyloid-beta precursor protein isoforms, signal peptide removed form. Example: UniProtKB:P05067-1, 672-770." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036193 |
amyloid beta peptide
|
Abeta
|
"An amyloid-beta precursor protein proteolytic cleavage product that is the N-terminal chain produced by gamma-secretase cleavage of C99." [PMID:19828817, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000025583 |
beta-amyloid protein 42
|
Abeta(1-42)
|
"An amyloid beta peptide that corresponds residues 1-42 of C99. Example: UniProtKB:P05067-1, 672-713." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
| |
organism-modification
|
|
PR:000050063 |
beta-amyloid protein 42 (human)
|
hAbeta(1-42)
|
"A beta-amyloid protein 42 in human. Example: UniProtKB:P05067-1, 672-713." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000025584 |
beta-amyloid protein 40
|
Abeta(1-40)
|
"An amyloid beta peptide that corresponds to residues 1-40 of C99. Example: UniProtKB:P05067-1, 672-711." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
| |
organism-modification
|
|
PR:000050064 |
beta-amyloid protein 40 (human)
|
hAbeta(1-40)
|
"A beta-amyloid protein 40 in human. Example: UniProtKB:P05067-1, 672-711." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
| |
organism-modification
|
|
PR:000085741 |
beta-amyloid protein 40 (mouse)
|
mAbeta(1-40)
|
"A beta-amyloid protein 40 in mouse. Example: UniProtKB:P12023-1, 672-711." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000025581 |
C83
|
APP-C83
|
"An amyloid-beta precursor protein proteolytic cleavage product that is the C-terminal product of cleavage by alpha-secretase of certain amyloid-beta precursor protein isoforms, signal peptide removed form. Example: UniProtKB:P05067-1, 688-770." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000025587 |
P3(42)
|
APP-P3(42)
|
"An amyloid-beta precursor protein proteolytic cleavage product that is the N-terminal chain of 26 amino acid residues produced by gamma-secretase cleavage of C83." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000025588 |
P3(40)
|
APP-P3(40)
|
"An amyloid-beta precursor protein proteolytic cleavage product that is the N-terminal chain of 24 amino acid residues produced by gamma-secretase cleavage of C83." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000025582 |
C80
|
APP-C80
|
"An amyloid-beta precursor protein proteolytic cleavage product that is the C-terminal product of cleavage by theta-secretase of certain amyloid-beta precursor protein isoforms, signal peptide removed form. Example: UniProtKB:P05067-1, 691-770." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000025585 |
gamma-secretase C-terminal fragment 57
|
APP-CTF(57)
|
"An amyloid-beta precursor protein proteolytic cleavage product that is the C-terminal chain of 57 amino acid residues produced by gamma-secretase cleavage of certain amyloid-beta A4 proteolytic cleavage products. Example: UniProtKB:P05067-1, 714-770." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000025586 |
gamma-secretase C-terminal fragment 59
|
APP-CTF(59)
|
"An amyloid-beta precursor protein proteolytic cleavage product that is the C-terminal chain of 59 amino acid residues produced by gamma-secretase cleavage of certain amyloid-beta A4 proteolytic cleavage products. Example: UniProtKB:P05067-1, 712-770." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000025587 |
P3(42)
|
APP-P3(42)
|
"An amyloid-beta precursor protein proteolytic cleavage product that is the N-terminal chain of 26 amino acid residues produced by gamma-secretase cleavage of C83." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000025588 |
P3(40)
|
APP-P3(40)
|
"An amyloid-beta precursor protein proteolytic cleavage product that is the N-terminal chain of 24 amino acid residues produced by gamma-secretase cleavage of C83." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000025589 |
gamma-secretase C-terminal fragment 50
|
APP-CTF(50)
|
"An amyloid-beta precursor protein proteolytic cleavage product that is the C-terminal chain of 50 amino acid residues produced by gamma-secretase cleavage of certain amyloid-beta A4 proteolytic cleavage products. Example: UniProtKB:P05067-1, 721-770." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000025744 |
precursor of amyloid-beta precursor protein gamma-secretase C-terminal fragment
|
APP-preCTF
|
"An amyloid-beta precursor protein proteolytic cleavage product that gives rise to gamma secretase C-terminal fragments 50, 57, and 59." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000025580 |
C99
|
APP-C99
|
"An amyloid-beta precursor protein proteolytic cleavage product that is the C-terminal product of cleavage by beta-secretase of certain amyloid-beta precursor protein isoforms, signal peptide removed form. Example: UniProtKB:P05067-1, 672-770." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000036193 |
amyloid beta peptide
|
Abeta
|
"An amyloid-beta precursor protein proteolytic cleavage product that is the N-terminal chain produced by gamma-secretase cleavage of C99." [PMID:19828817, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
| |
modification
|
|
PR:000025583 |
beta-amyloid protein 42
|
Abeta(1-42)
|
"An amyloid beta peptide that corresponds residues 1-42 of C99. Example: UniProtKB:P05067-1, 672-713." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | | | |
organism-modification
|
|
PR:000050063 |
beta-amyloid protein 42 (human)
|
hAbeta(1-42)
|
"A beta-amyloid protein 42 in human. Example: UniProtKB:P05067-1, 672-713." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
| |
modification
|
|
PR:000025584 |
beta-amyloid protein 40
|
Abeta(1-40)
|
"An amyloid beta peptide that corresponds to residues 1-40 of C99. Example: UniProtKB:P05067-1, 672-711." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | | | |
organism-modification
|
|
PR:000050064 |
beta-amyloid protein 40 (human)
|
hAbeta(1-40)
|
"A beta-amyloid protein 40 in human. Example: UniProtKB:P05067-1, 672-711." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | | | |
organism-modification
|
|
PR:000085741 |
beta-amyloid protein 40 (mouse)
|
mAbeta(1-40)
|
"A beta-amyloid protein 40 in mouse. Example: UniProtKB:P12023-1, 672-711." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000025581 |
C83
|
APP-C83
|
"An amyloid-beta precursor protein proteolytic cleavage product that is the C-terminal product of cleavage by alpha-secretase of certain amyloid-beta precursor protein isoforms, signal peptide removed form. Example: UniProtKB:P05067-1, 688-770." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000025587 |
P3(42)
|
APP-P3(42)
|
"An amyloid-beta precursor protein proteolytic cleavage product that is the N-terminal chain of 26 amino acid residues produced by gamma-secretase cleavage of C83." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000025588 |
P3(40)
|
APP-P3(40)
|
"An amyloid-beta precursor protein proteolytic cleavage product that is the N-terminal chain of 24 amino acid residues produced by gamma-secretase cleavage of C83." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000025585 |
gamma-secretase C-terminal fragment 57
|
APP-CTF(57)
|
"An amyloid-beta precursor protein proteolytic cleavage product that is the C-terminal chain of 57 amino acid residues produced by gamma-secretase cleavage of certain amyloid-beta A4 proteolytic cleavage products. Example: UniProtKB:P05067-1, 714-770." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000025586 |
gamma-secretase C-terminal fragment 59
|
APP-CTF(59)
|
"An amyloid-beta precursor protein proteolytic cleavage product that is the C-terminal chain of 59 amino acid residues produced by gamma-secretase cleavage of certain amyloid-beta A4 proteolytic cleavage products. Example: UniProtKB:P05067-1, 712-770." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000025589 |
gamma-secretase C-terminal fragment 50
|
APP-CTF(50)
|
"An amyloid-beta precursor protein proteolytic cleavage product that is the C-terminal chain of 50 amino acid residues produced by gamma-secretase cleavage of certain amyloid-beta A4 proteolytic cleavage products. Example: UniProtKB:P05067-1, 721-770." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036193 |
amyloid beta peptide
|
Abeta
|
"An amyloid-beta precursor protein proteolytic cleavage product that is the N-terminal chain produced by gamma-secretase cleavage of C99." [PMID:19828817, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000025583 |
beta-amyloid protein 42
|
Abeta(1-42)
|
"An amyloid beta peptide that corresponds residues 1-42 of C99. Example: UniProtKB:P05067-1, 672-713." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000050063 |
beta-amyloid protein 42 (human)
|
hAbeta(1-42)
|
"A beta-amyloid protein 42 in human. Example: UniProtKB:P05067-1, 672-713." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000025584 |
beta-amyloid protein 40
|
Abeta(1-40)
|
"An amyloid beta peptide that corresponds to residues 1-40 of C99. Example: UniProtKB:P05067-1, 672-711." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000050064 |
beta-amyloid protein 40 (human)
|
hAbeta(1-40)
|
"A beta-amyloid protein 40 in human. Example: UniProtKB:P05067-1, 672-711." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000085741 |
beta-amyloid protein 40 (mouse)
|
mAbeta(1-40)
|
"A beta-amyloid protein 40 in mouse. Example: UniProtKB:P12023-1, 672-711." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019041 |
amphiregulin proteolytic cleavage product
|
AREG/ClvPrd
|
"An amphiregulin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019058 |
arylsulfatase A proteolytic cleavage product
|
ARSA/ClvPrd
|
"An arylsulfatase A that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019059 |
acid ceramidase proteolytic cleavage product
|
ASAH1/ClvPrd
|
"An acid ceramidase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019064 |
retroviral-like aspartic protease 1 proteolytic cleavage product
|
ASPRV1/ClvPrd
|
"A retroviral-like aspartic protease 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019066 |
cyclic AMP-dependent transcription factor ATF-6 alpha proteolytic cleavage product
|
ATF6/ClvPrd
|
"A cyclic AMP-dependent transcription factor ATF-6 alpha that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019067 |
cyclic AMP-dependent transcription factor ATF-6 beta proteolytic cleavage product
|
ATF6B/ClvPrd
|
"A cyclic AMP-dependent transcription factor ATF-6 beta that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019069 |
sodium/potassium-transporting ATPase subunit alpha-1 proteolytic cleavage product
|
ATP1A1/ClvPrd
|
"A sodium/potassium-transporting ATPase subunit alpha-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019087 |
copper-transporting ATPase 2 proteolytic cleavage product
|
ATP7B/ClvPrd
|
"A copper-transporting ATPase 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019093 |
vasopressin-neurophysin 2-copeptin proteolytic cleavage product
|
AVP/ClvPrd
|
"A vasopressin-neurophysin 2-copeptin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019098 |
azurocidin proteolytic cleavage product
|
AZU1/ClvPrd
|
"An azurocidin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019101 |
S-adenosylmethionine decarboxylase proenzyme 2 proteolytic cleavage product
|
Amd2/ClvPrd
|
"An S-adenosylmethionine decarboxylase proenzyme 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019110 |
beta-2-microglobulin proteolytic cleavage product
|
B2M/ClvPrd
|
"A beta-2-microglobulin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019111 |
beta-1,4-galactosyltransferase 1 proteolytic cleavage product
|
B4GALT1/ClvPrd
|
"A beta-1,4-galactosyltransferase 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019112 |
beta-secretase 1 proteolytic cleavage product
|
BACE1/ClvPrd
|
"A beta-secretase 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019113 |
beta-secretase 2 proteolytic cleavage product
|
BACE2/ClvPrd
|
"A beta-secretase 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019130 |
neurotrophic factor BDNF precursor form proteolytic cleavage product
|
BDNF/ClvPrd
|
"A neurotrophic factor BDNF precursor form that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019131 |
biglycan proteolytic cleavage product
|
BGN/ClvPrd
|
"A biglycan that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019133 |
biliverdin reductase A proteolytic cleavage product
|
BLVRA/ClvPrd
|
"A biliverdin reductase A that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019135 |
bone morphogenetic protein 15 proteolytic cleavage product
|
BMP15/ClvPrd
|
"A bone morphogenetic protein 15 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019150 |
probetacellulin proteolytic cleavage product
|
BTC/ClvPrd
|
"A probetacellulin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019169 |
complement C1r subcomponent proteolytic cleavage product
|
C1R/ClvPrd
|
"A complement C1r subcomponent that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019172 |
complement C1s subcomponent proteolytic cleavage product
|
C1S/ClvPrd
|
"A complement C1s subcomponent that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019175 |
complement C2 proteolytic cleavage product
|
C2/ClvPrd
|
"A complement C2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019178 |
complement C3 proteolytic cleavage product
|
C3/ClvPrd
|
"A complement C3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000050119 |
complement C3 beta chain
|
C3/beta
|
"A complement C3, signal peptide removed form that corresponds to the N-terminal portion after proteolytic cleavage that removes the intersubunit linker (four arginine residues in human, mouse, and rat). Example: UniProtKB:P01024, 23-667." [PMID:2579379, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000050121 |
C3-beta-c
|
C3/beta-c
|
"A complement C3 beta chain that corresponds to the C-terminal portion after proteolytic cleavage. Example: UniProtKB:P01024, 569-667." [PMID:8352775, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000050134 |
C3-beta-c (human)
|
hC3/beta-c
|
"A C3-beta-c in human. UniProtKB:P01024, 569-667." [PRO:DNx, UniProtKB:P01024]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000050133 |
complement C3 beta chain (human)
|
hC3/beta
|
"A complement C3 beta chain in human. UniProtKB:P01024, 23-667." [PRO:DNx, UniProtKB:P01024]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000050134 |
C3-beta-c (human)
|
hC3/beta-c
|
"A C3-beta-c in human. UniProtKB:P01024, 569-667." [PRO:DNx, UniProtKB:P01024]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019181 |
complement C4-A proteolytic cleavage product
|
C4A/ClvPrd
|
"A complement C4-A that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019184 |
complement C4-B proteolytic cleavage product
|
C4B/ClvPrd
|
"A complement C4-B that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019189 |
complement C5 proteolytic cleavage product
|
C5/ClvPrd
|
"A complement C5 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019194 |
complement component C8 beta chain proteolytic cleavage product
|
C8B/ClvPrd
|
"A complement component C8 beta chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019199 |
complement component C9 proteolytic cleavage product
|
C9/ClvPrd
|
"A complement component C9 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019204 |
carbonic anhydrase 4 proteolytic cleavage product
|
CA4/ClvPrd
|
"A carbonic anhydrase 4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019215 |
voltage-dependent calcium channel subunit alpha-2/delta-1 proteolytic cleavage product
|
CACNA2D1/ClvPrd
|
"A voltage-dependent calcium channel subunit alpha-2/delta-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000050068 |
voltage-dependent calcium channel subunit alpha-2-1
|
CACNA2D1/Clv:1
|
"A voltage-dependent calcium channel subunit alpha-2/delta-1, signal peptide removed form that corresponds to the N-terminal portion after proteolytic cleavage. Example: UniProtKB:P54289-1, 25-956." [PMID:30519455, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000050070 |
voltage-dependent calcium channel subunit alpha-2-1 (human)
|
hCACNA2D1/Clv:1
|
"A voltage-dependent calcium channel subunit alpha-2-1 in human. Example: UniProtKB:P54289-1, 25-956." [PRO:DNx, UniProtKB:P54289]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000050069 |
voltage-dependent calcium channel subunit delta-1
|
CACNA2D1/Clv:2
|
"A voltage-dependent calcium channel subunit alpha-2/delta-1, signal peptide removed form that corresponds to the C-terminal portion after proteolytic cleavage. Example: UniProtKB:P54289-1, 957-1103." [PMID:30519455, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000050071 |
voltage-dependent calcium channel subunit delta-1 (human)
|
hCACNA2D1/Clv:2
|
"A voltage-dependent calcium channel subunit delta-1 in human. Example: UniProtKB:P54289-1, 957-1103." [PRO:DNx, UniProtKB:P54289]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019220 |
calcitonin gene-related peptide 2 proteolytic cleavage product
|
CALCB/ClvPrd
|
"A calcitonin gene-related peptide 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019241 |
cocaine- and amphetamine-regulated transcript protein proteolytic cleavage product
|
CARTPT/ClvPrd
|
"A cocaine- and amphetamine-regulated transcript protein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019242 |
caspase-14 proteolytic cleavage product
|
CASP14/ClvPrd
|
"A caspase-14 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019244 |
cerebellin-1 proteolytic cleavage product
|
CBLN1/ClvPrd
|
"A cerebellin-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019255 |
cholecystokinin proteolytic cleavage product
|
CCK/ClvPrd
|
"A cholecystokinin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019258 |
C-C motif chemokine 3-like 1 proteolytic cleavage product
|
CCL3L/ClvPrd
|
"A C-C motif chemokine 3-like 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019275 |
CD59 glycoprotein proteolytic cleavage product
|
CD59/ClvPrd
|
"A CD59 glycoprotein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019280 |
cell division control protein 42 proteolytic cleavage product
|
CDC42/ClvPrd
|
"A cell division control protein 42 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019284 |
cadherin-13 proteolytic cleavage product
|
CDH13/ClvPrd
|
"A cadherin-13 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019287 |
cadherin-3 proteolytic cleavage product
|
CDH3/ClvPrd
|
"A cadherin-3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019289 |
cyclin-dependent kinase 5 activator 1 proteolytic cleavage product
|
CDK5R1/ClvPrd
|
"A cyclin-dependent kinase 5 activator 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000050087 |
cyclin-dependent kinase 5 activator 1 cleaved 1
|
CDK5R1/Clv:1
|
"A cyclin-dependent kinase 5 activator 1 that corresponds to the C-terminal portion after proteolytic cleavage by calpain. Example: UniProtKB:Q15078, 99-307." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000050088 |
cyclin-dependent kinase 5 activator 1 cleaved 1 (human)
|
hCDK5R1/Clv:1
|
"A cyclin-dependent kinase 5 activator 1 cleaved 1 in human. UniProtKB:Q15078, 99-307." [PRO:DNx, UniProtKB:Q15078]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000085739 |
cyclin-dependent kinase 5 activator 1 cleaved 1 (mouse)
|
mCDK5R1/Clv:1
|
"A cyclin-dependent kinase 5 activator 1 cleaved 1 in mouse. UniProtKB:P61809, 99-307." [PRO:DNx, UniProtKB:P61809]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019308 |
complement factor B proteolytic cleavage product
|
CFB/ClvPrd
|
"A complement factor B that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019315 |
complement factor I proteolytic cleavage product
|
CFI/ClvPrd
|
"A complement factor I that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019326 |
chromogranin-A proteolytic cleavage product
|
CHGA/ClvPrd
|
"A chromogranin-A that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019329 |
secretogranin-1 proteolytic cleavage product
|
CHGB/ClvPrd
|
"A secretogranin-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019355 |
cartilage intermediate layer protein 1 proteolytic cleavage product
|
CILP/ClvPrd
|
"A cartilage intermediate layer protein 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019362 |
calcium-activated chloride channel regulator 2 proteolytic cleavage product
|
CLCA2/ClvPrd
|
"A calcium-activated chloride channel regulator 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019363 |
calcium-activated chloride channel regulator 4 proteolytic cleavage product
|
CLCA4/ClvPrd
|
"A calcium-activated chloride channel regulator 4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019376 |
calsyntenin-1 proteolytic cleavage product
|
CLSTN1/ClvPrd
|
"A calsyntenin-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019379 |
clusterin proteolytic cleavage product
|
CLU/ClvPrd
|
"A clusterin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019382 |
chymase proteolytic cleavage product
|
CMA1/ClvPrd
|
"A chymase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019390 |
contactin-1 proteolytic cleavage product
|
CNTN1/ClvPrd
|
"A contactin-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019396 |
collagen alpha-1(XI) chain proteolytic cleavage product
|
COL11A1/ClvPrd
|
"A collagen alpha-1(XI) chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019397 |
collagen alpha-2(XI) chain proteolytic cleavage product
|
COL11A2/ClvPrd
|
"A collagen alpha-2(XI) chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019398 |
collagen alpha-1(XV) chain proteolytic cleavage product
|
COL15A1/ClvPrd
|
"A collagen alpha-1(XV) chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019401 |
collagen alpha-1(XVII) chain proteolytic cleavage product
|
COL17A1/ClvPrd
|
"A collagen alpha-1(XVII) chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019402 |
collagen alpha-1(XVIII) chain proteolytic cleavage product
|
COL18A1/ClvPrd
|
"A collagen alpha-1(XVIII) chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019403 |
collagen alpha-1(XXV) chain proteolytic cleavage product
|
COL25A1/ClvPrd
|
"A collagen alpha-1(XXV) chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019404 |
collagen alpha-1(XXVII) chain proteolytic cleavage product
|
COL27A1/ClvPrd
|
"A collagen alpha-1(XXVII) chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019407 |
collagen alpha-1(IV) chain proteolytic cleavage product
|
COL4A1/ClvPrd
|
"A collagen alpha-1(IV) chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019410 |
collagen alpha-2(IV) chain proteolytic cleavage product
|
COL4A2/ClvPrd
|
"A collagen alpha-2(IV) chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019411 |
collagen alpha-3(IV) chain proteolytic cleavage product
|
COL4A3/ClvPrd
|
"A collagen alpha-3(IV) chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019412 |
collagen alpha-1(VIII) chain proteolytic cleavage product
|
COL8A1/ClvPrd
|
"A collagen alpha-1(VIII) chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019416 |
coatomer subunit alpha proteolytic cleavage product
|
COPA/ClvPrd
|
"A coatomer subunit alpha that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019451 |
carboxypeptidase A1 proteolytic cleavage product
|
CPA1/ClvPrd
|
"A carboxypeptidase A1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019452 |
carboxypeptidase A2 proteolytic cleavage product
|
CPA2/ClvPrd
|
"A carboxypeptidase A2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019455 |
mast cell carboxypeptidase A proteolytic cleavage product
|
CPA3/ClvPrd
|
"A mast cell carboxypeptidase A that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019458 |
carboxypeptidase B proteolytic cleavage product
|
CPB1/ClvPrd
|
"A carboxypeptidase B that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019459 |
carboxypeptidase B2 proteolytic cleavage product
|
CPB2/ClvPrd
|
"A carboxypeptidase B2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019460 |
carboxypeptidase E proteolytic cleavage product
|
CPE/ClvPrd
|
"A carboxypeptidase E that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019461 |
complexin-3 proteolytic cleavage product
|
CPLX3/ClvPrd
|
"A complexin-3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019462 |
complexin-4 proteolytic cleavage product
|
CPLX4/ClvPrd
|
"A complexin-4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019474 |
cyclic AMP-responsive element-binding protein 3 proteolytic cleavage product
|
CREB3/ClvPrd
|
"A cyclic AMP-responsive element-binding protein 3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019475 |
cyclic AMP-responsive element-binding protein 3-like protein 1 proteolytic cleavage product
|
CREB3L1/ClvPrd
|
"A cyclic AMP-responsive element-binding protein 3-like protein 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019476 |
cyclic AMP-responsive element-binding protein 3-like protein 2 proteolytic cleavage product
|
CREB3L2/ClvPrd
|
"A cyclic AMP-responsive element-binding protein 3-like protein 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019477 |
cyclic AMP-responsive element-binding protein 3-like protein 3 proteolytic cleavage product
|
CREB3L3/ClvPrd
|
"A cyclic AMP-responsive element-binding protein 3-like protein 3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019478 |
cyclic AMP-responsive element-binding protein 3-like protein 4 proteolytic cleavage product
|
CREB3L4/ClvPrd
|
"A cyclic AMP-responsive element-binding protein 3-like protein 4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019483 |
corticoliberin proteolytic cleavage product
|
CRH/ClvPrd
|
"A corticoliberin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019490 |
cysteine-rich motor neuron 1 protein proteolytic cleavage product
|
CRIM1/ClvPrd
|
"A cysteine-rich motor neuron 1 protein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019500 |
C-reactive protein proteolytic cleavage product
|
CRP/ClvPrd
|
"A C-reactive protein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019502 |
alpha-crystallin A chain proteolytic cleavage product
|
CRYAA/ClvPrd
|
"An alpha-crystallin A chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019505 |
beta-crystallin B1 proteolytic cleavage product
|
CRYBB1/ClvPrd
|
"A beta-crystallin B1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019515 |
macrophage colony-stimulating factor 1 proteolytic cleavage product
|
CSF1/ClvPrd
|
"A macrophage colony-stimulating factor 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019524 |
alpha-S1-casein proteolytic cleavage product
|
CSN1S1/ClvPrd
|
"An alpha-S1-casein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019549 |
chymotrypsinogen B proteolytic cleavage product
|
CTRB1/ClvPrd
|
"A chymotrypsinogen B that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019550 |
chymotrypsinogen B2 proteolytic cleavage product
|
CTRB2/ClvPrd
|
"A chymotrypsinogen B2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019551 |
chymotrypsin-C proteolytic cleavage product
|
CTRC/ClvPrd
|
"A chymotrypsin-C that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019554 |
lysosomal protective protein proteolytic cleavage product
|
CTSA/ClvPrd
|
"A lysosomal protective protein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019555 |
cathepsin B proteolytic cleavage product
|
CTSB/ClvPrd
|
"A cathepsin B that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019558 |
dipeptidyl peptidase 1 proteolytic cleavage product
|
CTSC/ClvPrd
|
"A dipeptidyl peptidase 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019561 |
cathepsin D proteolytic cleavage product
|
CTSD/ClvPrd
|
"A cathepsin D that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019564 |
cathepsin E proteolytic cleavage product
|
CTSE/ClvPrd
|
"A cathepsin E that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019565 |
cathepsin F proteolytic cleavage product
|
CTSF/ClvPrd
|
"A cathepsin F that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019568 |
cathepsin G proteolytic cleavage product
|
CTSG/ClvPrd
|
"A cathepsin G that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019571 |
cathepsin H proteolytic cleavage product
|
CTSH/ClvPrd
|
"A cathepsin H that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019574 |
procathepsin L proteolytic cleavage product
|
CTSL/ClvPrd
|
"A procathepsin L that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019575 |
cathepsin L2 proteolytic cleavage product
|
CTSL2/ClvPrd
|
"A cathepsin L2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019576 |
cathepsin O proteolytic cleavage product
|
CTSO/ClvPrd
|
"A cathepsin O that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019577 |
cathepsin S proteolytic cleavage product
|
CTSS/ClvPrd
|
"A cathepsin S that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019580 |
cathepsin Z proteolytic cleavage product
|
CTSZ/ClvPrd
|
"A cathepsin Z that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019581 |
cubilin proteolytic cleavage product
|
CUBN/ClvPrd
|
"A cubilin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019585 |
growth-regulated alpha protein proteolytic cleavage product
|
CXCL1/ClvPrd
|
"A growth-regulated alpha protein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019588 |
C-X-C motif chemokine 10 proteolytic cleavage product
|
CXCL10/ClvPrd
|
"A C-X-C motif chemokine 10 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019591 |
stromal cell-derived factor 1 proteolytic cleavage product
|
CXCL12/ClvPrd
|
"A stromal cell-derived factor 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019596 |
C-X-C motif chemokine 2 proteolytic cleavage product
|
CXCL2/ClvPrd
|
"A C-X-C motif chemokine 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019599 |
C-X-C motif chemokine 3 proteolytic cleavage product
|
CXCL3/ClvPrd
|
"A C-X-C motif chemokine 3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019602 |
C-X-C motif chemokine 5 proteolytic cleavage product
|
CXCL5/ClvPrd
|
"A C-X-C motif chemokine 5 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019605 |
C-X-C motif chemokine 6 proteolytic cleavage product
|
CXCL6/ClvPrd
|
"A C-X-C motif chemokine 6 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019609 |
NADH-cytochrome b5 reductase 3 proteolytic cleavage product
|
CYB5R3/ClvPrd
|
"An NADH-cytochrome b5 reductase 3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019624 |
cytochrome P450 4A11 proteolytic cleavage product
|
CYP4A11/ClvPrd
|
"A cytochrome P450 4A11 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019627 |
C-C motif chemokine 6 proteolytic cleavage product
|
Ccl6/ClvPrd
|
"A C-C motif chemokine 6 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019628 |
C-C motif chemokine 9 proteolytic cleavage product
|
Ccl9/ClvPrd
|
"A C-C motif chemokine 9 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019639 |
cathepsin J proteolytic cleavage product
|
Ctsj/ClvPrd
|
"A cathepsin J that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019640 |
cathepsin M proteolytic cleavage product
|
Ctsm/ClvPrd
|
"A cathepsin M that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019642 |
dystroglycan 1 proteolytic cleavage product
|
DAG1/ClvPrd
|
"A dystroglycan 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000037405 |
dystroglycan 1 alpha chain (mouse)
|
mDAG1/Clv:alpha
|
"A dystroglycan 1 precursor (mouse) that is the N-terminal product of autolytic cleavage. UniProtKB:Q62165, 28-651." [PMID:9057818, PRO:KRC, UniProtKB:Q62165]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000037406 |
dystroglycan 1 beta chain (mouse)
|
mDAG1/Clv:beta
|
"A dystroglycan 1 precursor (mouse) that is the C-terminal product of autolytic cleavage. UniProtKB:Q62165, 652-893." [PMID:8872465, PRO:KRC, UniProtKB:Q62165]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019644 |
dopamine beta-hydroxylase proteolytic cleavage product
|
DBH/ClvPrd
|
"A dopamine beta-hydroxylase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019649 |
dermcidin proteolytic cleavage product
|
DCD/ClvPrd
|
"A dermcidin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019661 |
beta-defensin 1 proteolytic cleavage product
|
DEFB1/ClvPrd
|
"A beta-defensin 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019670 |
desert hedgehog protein proteolytic cleavage product
|
DHH/ClvPrd
|
"A desert hedgehog protein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019681 |
dickkopf-related protein 4 proteolytic cleavage product
|
DKK4/ClvPrd
|
"A dickkopf-related protein 4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019688 |
protein delta homolog 1 proteolytic cleavage product
|
DLK1/ClvPrd
|
"A protein delta homolog 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019700 |
dipeptidase 1 proteolytic cleavage product
|
DPEP1/ClvPrd
|
"A dipeptidase 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019705 |
dihydropyrimidine dehydrogenase [NADP(+)] proteolytic cleavage product
|
DPYD/ClvPrd
|
"A dihydropyrimidine dehydrogenase [NADP(+)] that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019708 |
dentin sialophosphoprotein proteolytic cleavage product
|
DSPP/ClvPrd
|
"A dentin sialophosphoprotein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019717 |
beta-defensin 8 proteolytic cleavage product
|
Defb8/ClvPrd
|
"A beta-defensin 8 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019718 |
defensin-related cryptdin-2 proteolytic cleavage product
|
Defcr2/ClvPrd
|
"A defensin-related cryptdin-2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019727 |
ectodysplasin-A proteolytic cleavage product
|
EDA/ClvPrd
|
"An ectodysplasin-A that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019734 |
endothelin-1 proteolytic cleavage product
|
EDN1/ClvPrd
|
"An endothelin-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019735 |
endothelin-2 proteolytic cleavage product
|
EDN2/ClvPrd
|
"An endothelin-2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019736 |
endothelin-3 proteolytic cleavage product
|
EDN3/ClvPrd
|
"An endothelin-3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019744 |
ephrin-A1 proteolytic cleavage product
|
EFNA1/ClvPrd
|
"An ephrin-A1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019772 |
chymotrypsin-like elastase family member 1 proteolytic cleavage product
|
ELA1/ClvPrd
|
"A chymotrypsin-like elastase family member 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019773 |
neutrophil elastase proteolytic cleavage product
|
ELANE/ClvPrd
|
"A neutrophil elastase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019776 |
chymotrypsin-like elastase family member 2A proteolytic cleavage product
|
ELA2A/ClvPrd
|
"A chymotrypsin-like elastase family member 2A that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019779 |
chymotrypsin-like elastase family member 2B proteolytic cleavage product
|
ELA2B/ClvPrd
|
"A chymotrypsin-like elastase family member 2B that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019782 |
autotaxin proteolytic cleavage product
|
ENPP2/ClvPrd
|
"An autotaxin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019783 |
glycerophosphocholine cholinephosphodiesterase ENPP6 proteolytic cleavage product
|
ENPP6/ClvPrd
|
"A glycerophosphocholine cholinephosphodiesterase ENPP6 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019798 |
erythropoietin proteolytic cleavage product
|
EPO/ClvPrd
|
"An erythropoietin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019802 |
eosinophil peroxidase proteolytic cleavage product
|
EPX/ClvPrd
|
"An eosinophil peroxidase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019803 |
proepiregulin proteolytic cleavage product
|
EREG/ClvPrd
|
"A proepiregulin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019809 |
syncytin-1 proteolytic cleavage product
|
ERVWE1/ClvPrd
|
"A syncytin-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019812 |
homeobox protein ESX1 proteolytic cleavage product
|
ESX1/ClvPrd
|
"A homeobox protein ESX1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019820 |
exostosin-like 2 proteolytic cleavage product
|
EXTL2/ClvPrd
|
"An exostosin-like 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019822 |
epidermal growth factor-binding protein type B proteolytic cleavage product
|
Egfbp2/ClvPrd
|
"An epidermal growth factor-binding protein type B that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019823 |
coagulation factor X proteolytic cleavage product
|
F10/ClvPrd
|
"A coagulation factor X that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000035936 |
activated factor Xa heavy chain
|
F10/Clv:aH
|
"A coagulation factor X heavy chain that has had the activation peptide removed, and that corresponds to the C-terminal region containing the Trypsin (Pfam:PF00089) domain. Example: UniProtKB:P00742-1, 235-488." [PMID:6587384, PMID:921929, Reactome:R-HSA-140642, Reactome:R-HSA-140688]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000035937 |
activated factor Xa heavy chain (human)
|
hF10/Clv:aH
|
"An activated factor Xa heavy chain in human. UniProtKB:P00742, 235-488." [PMID:6587384, PMID:921929, Reactome:R-HSA-140642, Reactome:R-HSA-140688]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019826 |
coagulation factor XI proteolytic cleavage product
|
F11/ClvPrd
|
"A coagulation factor XI that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019829 |
coagulation factor XII proteolytic cleavage product
|
F12/ClvPrd
|
"A coagulation factor XII that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019831 |
coagulation factor XIII A chain proteolytic cleavage product
|
F13A1/ClvPrd
|
"A coagulation factor XIII A chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019834 |
prothrombin proteolytic cleavage product
|
F2/ClvPrd
|
"A prothrombin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019837 |
coagulation factor V proteolytic cleavage product
|
F5/ClvPrd
|
"A coagulation factor V that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000035910 |
coagulation factor V light chain
|
F5/Clv:L
|
"A coagulation factor V that is the C-terminal-most portion after proteolytic cleavage by thrombin. Example: UniProtKB:P12259, 1574-2224." [PMID:12393635, PMID:86313665, PMID:88107560, Reactome:R-HSA-140660, Reactome:R-HSA-140690]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000035911 |
coagulation factor V light chain (human)
|
hF5/Clv:L
|
"A coagulation factor V light chain in human. UniProtKB:P12259, 1574-2224." [PMID:12393635, PMID:86313665, PMID:88107560, Reactome:R-HSA-140660, Reactome:R-HSA-140690]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019838 |
coagulation factor VII proteolytic cleavage product
|
F7/ClvPrd
|
"A coagulation factor VII that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000050102 |
coagulation factor VII zymogen
|
F7/zymogen
|
"A coagulation factor VII that has had the signal peptide and propeptide removed. Example: UniProtKB:P08709-1, 61-466." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000035926 |
coagulation factor VIIa heavy chain
|
F7/Clv:aH
|
"A coagulation factor VII zymogen that corresponds to the C-terminal region after proteolytic cleavage by factor Xa, factor XIIa, factor IXa, or thrombin, containing the Trypsin (Pfam:PF00089) domain. Example: UniProtKB:P08709, 213-466." [PMID:3264725, PMID:3486420, PRO:DAN, Reactome:R-HSA-140724, Reactome:R-HSA-140750]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000035927 |
coagulation factor VIIa heavy chain (human)
|
hF7/Clv:aH
|
"A coagulation factor VIIa heavy chain in human. Example: UniProtKB:P08709-1, 213-466." [PMID:3264725, PMID:3486420, Reactome:R-HSA-140724, Reactome:R-HSA-140750]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000050103 |
coagulation factor VIIa light chain
|
F7/Clv:aL
|
"A coagulation factor VII zymogen that corresponds to the N-terminal portion after proteolytic cleavage by factor Xa, factor XIIa, factor IXa, or thrombin. Example: UniProtKB:P08709-1, 61-212." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000050108 |
coagulation factor VIIa light chain (human)
|
hF7/Clv:aL
|
"A coagulation factor VIIa light chain in human. Example: UniProtKB:P08709-1, 61-212." [PRO:DNx, UniProtKB:P08709]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000050107 |
coagulation factor VII zymogen (human)
|
hF7/zymogen
|
"A coagulation factor VII zymogen in human. Example: UniProtKB:P08709-1, 61-466." [PRO:DNx, UniProtKB:P08709]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000035927 |
coagulation factor VIIa heavy chain (human)
|
hF7/Clv:aH
|
"A coagulation factor VIIa heavy chain in human. Example: UniProtKB:P08709-1, 213-466." [PMID:3264725, PMID:3486420, Reactome:R-HSA-140724, Reactome:R-HSA-140750]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000050108 |
coagulation factor VIIa light chain (human)
|
hF7/Clv:aL
|
"A coagulation factor VIIa light chain in human. Example: UniProtKB:P08709-1, 61-212." [PRO:DNx, UniProtKB:P08709]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019841 |
coagulation factor VIII proteolytic cleavage product
|
F8/ClvPrd
|
"A coagulation factor VIII that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019842 |
coagulation factor IX proteolytic cleavage product
|
F9/ClvPrd
|
"A coagulation factor IX that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000035934 |
coagulation factor IXa heavy chain
|
F9/Clv:aH
|
"A coagulation factor IX that corresponds to the C-terminal region containing the Trypsin (Pfam:PF00089) domain after proteolytic processing by factor XIa. Example: UniProtKB:P00740, 227-461." [PMID:2994716, Reactome:R-HSA-140895, Reactome:R-HSA-158225]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000035935 |
coagulation factor IXa heavy chain (human)
|
hF9/Clv:aH
|
"A coagulation factor IXa heavy chain in human. UniProtKB:P00740, 227-461." [PMID:2994716, Reactome:R-HSA-140895, Reactome:R-HSA-158225]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019875 |
fibrinogen alpha chain proteolytic cleavage product
|
FGA/ClvPrd
|
"A fibrinogen alpha chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019878 |
fibrinogen beta chain proteolytic cleavage product
|
FGB/ClvPrd
|
"A fibrinogen beta chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019879 |
fibroblast growth factor 1 proteolytic cleavage product
|
FGF1/ClvPrd
|
"A fibroblast growth factor 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019882 |
fibroblast growth factor 2 proteolytic cleavage product
|
FGF2/ClvPrd
|
"A fibroblast growth factor 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019887 |
fibroblast growth factor 23 proteolytic cleavage product
|
FGF23/ClvPrd
|
"A fibroblast growth factor 23 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019890 |
fibroblast growth factor 9 proteolytic cleavage product
|
FGF9/ClvPrd
|
"A fibroblast growth factor 9 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019901 |
vascular endothelial growth factor D proteolytic cleavage product
|
VEGFD/ClvPrd
|
"A vascular endothelial growth factor D that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019919 |
fibronectin proteolytic cleavage product
|
FN1/ClvPrd
|
"A fibronectin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019921 |
folate receptor alpha proteolytic cleavage product
|
FOLR1/ClvPrd
|
"A folate receptor alpha that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019924 |
folate receptor beta proteolytic cleavage product
|
FOLR2/ClvPrd
|
"A folate receptor beta that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019948 |
frataxin, mitochondrial proteolytic cleavage product
|
FXN/ClvPrd
|
"A frataxin, mitochondrial that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019956 |
lysosomal alpha-glucosidase proteolytic cleavage product
|
GAA/ClvPrd
|
"A lysosomal alpha-glucosidase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019959 |
galanin proteolytic cleavage product
|
GAL/ClvPrd
|
"A galanin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019965 |
polypeptide N-acetylgalactosaminyltransferase 1 proteolytic cleavage product
|
GALNT1/ClvPrd
|
"A polypeptide N-acetylgalactosaminyltransferase 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019966 |
polypeptide N-acetylgalactosaminyltransferase 2 proteolytic cleavage product
|
GALNT2/ClvPrd
|
"A polypeptide N-acetylgalactosaminyltransferase 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019973 |
gastrin proteolytic cleavage product
|
GAST/ClvPrd
|
"A gastrin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019980 |
pro-glucagon proteolytic cleavage product
|
GCG/ClvPrd
|
"A pro-glucagon that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019988 |
gamma-glutamyltransferase 6 proteolytic cleavage product
|
GGT6/ClvPrd
|
"A glutathione hydrolase 6 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019995 |
growth hormone receptor proteolytic cleavage product
|
GHR/ClvPrd
|
"A growth hormone receptor that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019996 |
somatoliberin proteolytic cleavage product
|
GHRH/ClvPrd
|
"A somatoliberin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000019999 |
appetite-regulating hormone proteolytic cleavage product
|
GHRL/ClvPrd
|
"An appetite-regulating hormone that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020000 |
gastric inhibitory polypeptide proteolytic cleavage product
|
GIP/ClvPrd
|
"A gastric inhibitory polypeptide that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020005 |
eukaryotic-type beta-galactosidase proteolytic cleavage product
|
GLB1/ClvPrd
|
"A eukaryotic-type beta-galactosidase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020016 |
ganglioside GM2 activator proteolytic cleavage product
|
GM2A/ClvPrd
|
"A ganglioside GM2 activator that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020024 |
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 proteolytic cleavage product
|
GNG11/ClvPrd
|
"A guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020026 |
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 proteolytic cleavage product
|
GNG2/ClvPrd
|
"A guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020027 |
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 proteolytic cleavage product
|
GNG4/ClvPrd
|
"A guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020029 |
N-acetylglucosamine-1-phosphotransferase subunits alpha/beta proteolytic cleavage product
|
GNPTAB/ClvPrd
|
"An N-acetylglucosamine-1-phosphotransferase subunits alpha/beta that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020032 |
progonadoliberin-1 proteolytic cleavage product
|
GNRH1/ClvPrd
|
"A progonadoliberin-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020033 |
progonadoliberin-2 proteolytic cleavage product
|
GNRH2/ClvPrd
|
"A progonadoliberin-2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020044 |
glypican-1 proteolytic cleavage product
|
GPC1/ClvPrd
|
"A glypican-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020045 |
glypican-2 proteolytic cleavage product
|
GPC2/ClvPrd
|
"A glypican-2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020046 |
glypican-3 proteolytic cleavage product
|
GPC3/ClvPrd
|
"A glypican-3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020047 |
glypican-4 proteolytic cleavage product
|
GPC4/ClvPrd
|
"A glypican-4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020048 |
glypican-5 proteolytic cleavage product
|
GPC5/ClvPrd
|
"A glypican-5 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020049 |
glypican-6 proteolytic cleavage product
|
GPC6/ClvPrd
|
"A glypican-6 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020062 |
progranulin proteolytic cleavage product
|
GRN/ClvPrd
|
"A progranulin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020072 |
transcription initiation factor IIA subunit 1 proteolytic cleavage product
|
GTF2A1/ClvPrd
|
"A transcription initiation factor IIA subunit 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020083 |
guanylin proteolytic cleavage product
|
GUCA2A/ClvPrd
|
"A guanylin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020084 |
guanylate cyclase activator 2B proteolytic cleavage product
|
GUCA2B/ClvPrd
|
"A guanylate cyclase activator 2B that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020093 |
gastrin-releasing peptide proteolytic cleavage product
|
GRP/ClvPrd
|
"A gastrin-releasing peptide that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020103 |
factor VII-activating protease proteolytic cleavage product
|
HABP2/ClvPrd
|
"A factor VII-activating protease that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020108 |
hepcidin proteolytic cleavage product
|
HAMP/ClvPrd
|
"A hepcidin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020109 |
hyaluronan and proteoglycan link protein 1 proteolytic cleavage product
|
HAPLN1/ClvPrd
|
"A hyaluronan and proteoglycan link protein 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020115 |
hemoglobin subunit beta proteolytic cleavage product
|
HBB/ClvPrd
|
"A hemoglobin subunit beta that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020117 |
proheparin-binding EGF-like growth factor proteolytic cleavage product
|
HBEGF/ClvPrd
|
"A proheparin-binding EGF-like growth factor that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020123 |
host cell factor 1 proteolytic cleavage product
|
HCFC1/ClvPrd
|
"A host cell factor 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020124 |
hypocretin neuropeptide precursor proteolytic cleavage product
|
HCRT/ClvPrd
|
"A hypocretin neuropeptide precursor that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020129 |
beta-hexosaminidase subunit alpha proteolytic cleavage product
|
HEXA/ClvPrd
|
"A beta-hexosaminidase subunit alpha that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020130 |
beta-hexosaminidase subunit beta proteolytic cleavage product
|
HEXB/ClvPrd
|
"A beta-hexosaminidase subunit beta that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020135 |
hepatocyte growth factor proteolytic cleavage product
|
HGF/ClvPrd
|
"A hepatocyte growth factor that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020138 |
hepatocyte growth factor activator serine protease proteolytic cleavage product
|
HGFAC/ClvPrd
|
"A hepatocyte growth factor activator serine protease that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020165 |
Rho GTPase-activating protein 45 proteolytic cleavage product
|
ARHGAP45/ClvPrd
|
"A Rho GTPase-activating protein 45 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020166 |
minor histocompatibility protein HB-1 proteolytic cleavage product
|
HMHB1/ClvPrd
|
"A minor histocompatibility protein HB-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020172 |
heterogeneous nuclear ribonucleoprotein F proteolytic cleavage product
|
HNRNPF/ClvPrd
|
"A heterogeneous nuclear ribonucleoprotein F that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020174 |
heterogeneous nuclear ribonucleoprotein H proteolytic cleavage product
|
HNRNPH1/ClvPrd
|
"A heterogeneous nuclear ribonucleoprotein H that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020180 |
haptoglobin proteolytic cleavage product
|
HP/ClvPrd
|
"A haptoglobin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020186 |
heparanase proteolytic cleavage product
|
HPSE/ClvPrd
|
"A heparanase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000050114 |
heparanase 8 kDa subunit
|
HPSE/p8
|
"A heparanase, signal peptide removed form that corresponds to the N-terminal portion after removal of the linker peptide. Example: UniProtKB:Q9Y251-1, 36-109." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000050117 |
heparanase 8 kDa subunit (human)
|
hHPSE/p8
|
"A heparanase 8 kDa subunit in human. Example: UniProtKB:Q9Y251-1, 36-109." [PRO:DNx, UniProtKB:Q9Y251]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000050115 |
heparanase 50 kDa subunit
|
HPSE/p50
|
"A heparanase, signal peptide removed form that corresponds to the C-terminal portion after removal of the linker peptide. Example: UniProtKB:Q9Y251-1, 158-543." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000050118 |
heparanase 50 kDa subunit (human)
|
hHPSE/p50
|
"A heparanase 50 kDa subunit in human. Example: UniProtKB:Q9Y251-1, 158-543." [PRO:DNx, UniProtKB:Q9Y251]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020214 |
histatin-1 proteolytic cleavage product
|
HTN1/ClvPrd
|
"A histatin-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020217 |
histatin-3 proteolytic cleavage product
|
HTN3/ClvPrd
|
"A histatin-3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020220 |
serine protease HTRA2, mitochondrial proteolytic cleavage product
|
HTRA2/ClvPrd
|
"A serine protease HTRA2, mitochondrial that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020226 |
islet amyloid polypeptide proteolytic cleavage product
|
IAPP/ClvPrd
|
"An islet amyloid polypeptide that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020230 |
iduronate 2-sulfatase proteolytic cleavage product
|
IDS/ClvPrd
|
"An iduronate 2-sulfatase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020231 |
gamma-interferon-inducible lysosomal thiol reductase proteolytic cleavage product
|
IFI30/ClvPrd
|
"A gamma-interferon-inducible lysosomal thiol reductase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020233 |
interferon-induced protein 44-like proteolytic cleavage product
|
IFI44L/ClvPrd
|
"An interferon-induced protein 44-like that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020267 |
insulin-like growth factor 2 proteolytic cleavage product
|
IGF2/ClvPrd
|
"An insulin-like growth factor 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020283 |
Indian hedgehog protein proteolytic cleavage product
|
IHH/ClvPrd
|
"An Indian hedgehog protein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020286 |
interleukin-15 receptor subunit alpha proteolytic cleavage product
|
IL15RA/ClvPrd
|
"An interleukin-15 receptor subunit alpha that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020293 |
interleukin-37 proteolytic cleavage product
|
IL1F7/ClvPrd
|
"An interleukin-37 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020308 |
type II inositol 1,4,5-trisphosphate 5-phosphatase proteolytic cleavage product
|
INPP5B/ClvPrd
|
"A type II inositol 1,4,5-trisphosphate 5-phosphatase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020314 |
insulin-like 3 proteolytic cleavage product
|
INSL3/ClvPrd
|
"An insulin-like 3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020317 |
early placenta insulin-like peptide proteolytic cleavage product
|
INSL4/ClvPrd
|
"An early placenta insulin-like peptide that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020320 |
insulin receptor proteolytic cleavage product
|
INSR/ClvPrd
|
"An insulin receptor that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020329 |
integrin alpha-IIb proteolytic cleavage product
|
ITGA2B/ClvPrd
|
"An integrin alpha-IIb that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020336 |
integrin alpha-5 proteolytic cleavage product
|
ITGA5/ClvPrd
|
"An integrin alpha-5 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020343 |
integrin alpha-V proteolytic cleavage product
|
ITGAV/ClvPrd
|
"An integrin alpha-V that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020348 |
inter-alpha-trypsin inhibitor heavy chain H1 proteolytic cleavage product
|
ITIH1/ClvPrd
|
"An inter-alpha-trypsin inhibitor heavy chain H1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020349 |
inter-alpha-trypsin inhibitor heavy chain H2 proteolytic cleavage product
|
ITIH2/ClvPrd
|
"An inter-alpha-trypsin inhibitor heavy chain H2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020350 |
inter-alpha-trypsin inhibitor heavy chain H3 proteolytic cleavage product
|
ITIH3/ClvPrd
|
"An inter-alpha-trypsin inhibitor heavy chain H3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020353 |
inter-alpha-trypsin inhibitor heavy chain H4 proteolytic cleavage product
|
ITIH4/ClvPrd
|
"An inter-alpha-trypsin inhibitor heavy chain H4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020357 |
insulin-like growth factor 1 proteolytic cleavage product
|
IGF1/ClvPrd
|
"An insulin-like growth factor 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020360 |
insulin-1 proteolytic cleavage product
|
Ins1/ClvPrd
|
"An insulin-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020363 |
insulin-2 proteolytic cleavage product
|
Ins2/ClvPrd
|
"An insulin-2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020375 |
kin of IRRE-like protein 3 proteolytic cleavage product
|
KIRREL3/ClvPrd
|
"A kin of IRRE-like protein 3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020376 |
metastasis-suppressor KiSS-1 proteolytic cleavage product
|
KISS1/ClvPrd
|
"A metastasis-suppressor KiSS-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020379 |
klotho proteolytic cleavage product
|
KL/ClvPrd
|
"A klotho that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020382 |
kallikrein-1 proteolytic cleavage product
|
KLK1/ClvPrd
|
"A kallikrein-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020383 |
kallikrein-11 proteolytic cleavage product
|
KLK11/ClvPrd
|
"A kallikrein-11 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020386 |
kallikrein-14 proteolytic cleavage product
|
KLK14/ClvPrd
|
"A kallikrein-14 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020389 |
kallikrein-7 proteolytic cleavage product
|
KLK7/ClvPrd
|
"A kallikrein-7 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020390 |
kallikrein-8 proteolytic cleavage product
|
KLK8/ClvPrd
|
"A kallikrein-8 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020393 |
plasma kallikrein proteolytic cleavage product
|
KLKB1/ClvPrd
|
"A plasma kallikrein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020396 |
kininogen-1 proteolytic cleavage product
|
KNG1/ClvPrd
|
"A kininogen-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020402 |
GTPase KRas proteolytic cleavage product
|
KRAS/ClvPrd
|
"A GTPase KRas that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020414 |
kallikrein 1-related peptidase b16 proteolytic cleavage product
|
Klk1b16/ClvPrd
|
"A kallikrein 1-related peptidase b16 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020417 |
kallikrein 1-related peptidase b22 proteolytic cleavage product
|
Klk1b22/ClvPrd
|
"A kallikrein 1-related peptidase b22 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020418 |
kallikrein 1-related peptidase b26 proteolytic cleavage product
|
Klk1b26/ClvPrd
|
"A kallikrein 1-related peptidase b26 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020419 |
kallikrein 1-related peptidase b3 proteolytic cleavage product
|
Klk1b3/ClvPrd
|
"A kallikrein 1-related peptidase b3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020422 |
kallikrein 1-related peptidase b9 proteolytic cleavage product
|
Klk1b9/ClvPrd
|
"A kallikrein 1-related peptidase b9 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020448 |
lactase/phlorizin hydrolase proteolytic cleavage product
|
LCT/ClvPrd
|
"A lactase/phlorizin hydrolase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020456 |
liver-expressed antimicrobial peptide 2 proteolytic cleavage product
|
LEAP2/ClvPrd
|
"A liver-expressed antimicrobial peptide 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020463 |
legumain proteolytic cleavage product
|
LGMN/ClvPrd
|
"A legumain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020480 |
leucyl-cystinyl aminopeptidase proteolytic cleavage product
|
LNPEP/ClvPrd
|
"A leucyl-cystinyl aminopeptidase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020489 |
inositol 1,4,5-triphosphate receptor associated 2 proteolytic cleavage product
|
LRMP/ClvPrd
|
"An inositol 1,4,5-triphosphate receptor associated 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020497 |
lactotransferrin proteolytic cleavage product
|
LTF/ClvPrd
|
"A lactotransferrin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020513 |
epididymal-specific lipocalin-5 proteolytic cleavage product
|
Lcn5/ClvPrd
|
"An epididymal-specific lipocalin-5 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020525 |
lysosomal alpha-mannosidase proteolytic cleavage product
|
MAN2B1/ClvPrd
|
"A lysosomal alpha-mannosidase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020527 |
microtubule-associated protein 1A proteolytic cleavage product
|
MAP1A/ClvPrd
|
"A microtubule-associated protein 1A that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020529 |
microtubule-associated protein 1B proteolytic cleavage product
|
MAP1B/ClvPrd
|
"A microtubule-associated protein 1B that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020530 |
microtubule-associated protein 1 light chain 3 alpha proteolytic cleavage product
|
MAP1LC3A/ClvPrd
|
"A microtubule-associated protein 1 light chain 3 alpha that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020531 |
microtubule-associated protein 1 light chain 3 beta proteolytic cleavage product
|
MAP1LC3B/ClvPrd
|
"A microtubule-associated protein 1 light chain 3 beta that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020532 |
microtubule-associated protein 1 light chain 3 gamma proteolytic cleavage product
|
MAP1LC3C/ClvPrd
|
"A microtubule-associated protein 1 light chain 3 gamma that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020533 |
microtubule-associated protein 1S proteolytic cleavage product
|
MAP1S/ClvPrd
|
"A microtubule-associated protein 1S that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020543 |
mannan-binding lectin serine protease 1 proteolytic cleavage product
|
MASP1/ClvPrd
|
"A mannan-binding lectin serine protease 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020544 |
mannan-binding lectin serine protease 2 proteolytic cleavage product
|
MASP2/ClvPrd
|
"A mannan-binding lectin serine protease 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020556 |
membrane-bound transcription factor site-1 protease proteolytic cleavage product
|
MBTPS1/ClvPrd
|
"A membrane-bound transcription factor site-1 protease that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020557 |
proto-oncogene DBL proteolytic cleavage product
|
MCF2/ClvPrd
|
"A proto-oncogene DBL that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020561 |
MAM domain-containing glycosylphosphatidylinositol anchor protein 1 proteolytic cleavage product
|
MDGA1/ClvPrd
|
"A MAM domain-containing glycosylphosphatidylinositol anchor protein 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020573 |
meprin A subunit alpha proteolytic cleavage product
|
MEP1A/ClvPrd
|
"A meprin A subunit alpha that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020574 |
meprin A subunit beta proteolytic cleavage product
|
MEP1B/ClvPrd
|
"A meprin A subunit beta that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020586 |
lactadherin proteolytic cleavage product
|
MFGE8/ClvPrd
|
"A lactadherin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020590 |
matrix Gla protein proteolytic cleavage product
|
MGP/ClvPrd
|
"A matrix Gla protein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020602 |
promotilin proteolytic cleavage product
|
MLN/ClvPrd
|
"A promotilin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020605 |
interstitial collagenase proteolytic cleavage product
|
MMP1/ClvPrd
|
"An interstitial collagenase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020606 |
stromelysin-2 proteolytic cleavage product
|
MMP10/ClvPrd
|
"A stromelysin-2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020607 |
macrophage metalloelastase proteolytic cleavage product
|
MMP12/ClvPrd
|
"A macrophage metalloelastase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020608 |
matrix metalloproteinase-14 proteolytic cleavage product
|
MMP14/ClvPrd
|
"A matrix metalloproteinase-14 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020609 |
matrix metalloproteinase-19 proteolytic cleavage product
|
MMP19/ClvPrd
|
"A matrix metalloproteinase-19 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020610 |
72 kDa type IV collagenase proteolytic cleavage product
|
MMP2/ClvPrd
|
"A 72 kDa type IV collagenase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020611 |
matrix metalloproteinase-23 proteolytic cleavage product
|
MMP23/ClvPrd
|
"A matrix metalloproteinase-23 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020612 |
matrix metalloproteinase-24 proteolytic cleavage product
|
MMP24/ClvPrd
|
"A matrix metalloproteinase-24 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020613 |
stromelysin-1 proteolytic cleavage product
|
MMP3/ClvPrd
|
"A stromelysin-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020616 |
matrilysin proteolytic cleavage product
|
MMP7/ClvPrd
|
"A matrilysin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020619 |
neutrophil collagenase proteolytic cleavage product
|
MMP8/ClvPrd
|
"A neutrophil collagenase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020622 |
matrix metalloproteinase-9 proteolytic cleavage product
|
MMP9/ClvPrd
|
"A matrix metalloproteinase-9 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020623 |
multimerin-1 proteolytic cleavage product
|
MMRN1/ClvPrd
|
"A multimerin-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000050083 |
platelet glycoprotein Ia* (human)
|
hMMRN1/Clv:1
|
"A multimerin-1 (human) that corresponds to the portion, after proteolytic cleavage, that contains the EMI domain. Example: UniProtKB:Q13201-1, 184-1228." [PMID:9798985, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000050084 |
155 kDa platelet multimerin (human)
|
hMMRN1/Clv:2
|
"A multimerin-1 (human) that corresponds to the portion, after proteolytic cleavage, that lacks the EMI domain. Example: UniProtKB:Q13201-1, 318-1228." [PMID:9798985, PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020631 |
myeloperoxidase proteolytic cleavage product
|
MPO/ClvPrd
|
"A myeloperoxidase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020639 |
mesothelin proteolytic cleavage product
|
MSLN/ClvPrd
|
"A mesothelin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020654 |
mucin-4 proteolytic cleavage product
|
MUC4/ClvPrd
|
"A mucin-4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020662 |
interferon-induced GTP-binding protein Mx1 proteolytic cleavage product
|
MX1/ClvPrd
|
"An interferon-induced GTP-binding protein Mx1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020671 |
myosin-Ig proteolytic cleavage product
|
MYO1G/ClvPrd
|
"A myosin-Ig that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020675 |
mast cell protease 1 proteolytic cleavage product
|
Mcpt1/ClvPrd
|
"A mast cell protease 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020678 |
mast cell protease 2 proteolytic cleavage product
|
Mcpt2/ClvPrd
|
"A mast cell protease 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020681 |
mast cell protease 4 proteolytic cleavage product
|
Mcpt4/ClvPrd
|
"A mast cell protease 4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020682 |
mast cell protease 8 proteolytic cleavage product
|
Mcpt8/ClvPrd
|
"A mast cell protease 8 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020703 |
alpha-N-acetylglucosaminidase proteolytic cleavage product
|
NAGLU/ClvPrd
|
"An alpha-N-acetylglucosaminidase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020704 |
N-acetylglutamate synthase, mitochondrial proteolytic cleavage product
|
NAGS/ClvPrd
|
"An N-acetylglutamate synthase, mitochondrial that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020707 |
napsin-A proteolytic cleavage product
|
NAPSA/ClvPrd
|
"A napsin-A that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020722 |
ubiquitin-like protein NEDD8 proteolytic cleavage product
|
NEDD8/ClvPrd
|
"A ubiquitin-like protein NEDD8 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020723 |
enhancer of filamentation 1 proteolytic cleavage product
|
NEDD9/ClvPrd
|
"An enhancer of filamentation 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020733 |
neurofibromin proteolytic cleavage product
|
NF1/ClvPrd
|
"A neurofibromin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020735 |
nuclear factor NF-kappa-B p100 subunit proteolytic cleavage product
|
NFKB2/ClvPrd
|
"A nuclear factor NF-kappa-B p100 subunit that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020737 |
beta-nerve growth factor proteolytic cleavage product
|
NGF/ClvPrd
|
"A beta-nerve growth factor that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020755 |
neuromedin-B proteolytic cleavage product
|
NMB/ClvPrd
|
"A neuromedin-B that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020758 |
neuromedin-S proteolytic cleavage product
|
NMS/ClvPrd
|
"A neuromedin-S that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020759 |
neuromedin-U proteolytic cleavage product
|
NMU/ClvPrd
|
"A neuromedin-U that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020763 |
neurogenic locus notch homolog protein 1 proteolytic cleavage product
|
NOTCH1/ClvPrd
|
"A neurogenic locus notch homolog protein 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000085743 |
notch 1 intracellular domain (mouse)
|
mNOTCH1/NICD
|
"A neurogenic locus notch homolog protein 1 (mouse) that corresponds to the C-terminal portion after proteolytic cleavage by PSEN1 or PSEN2. UniProtKB:Q01705, 1744-2531." [PMID:10882062, PMID:11459941, PMID:11518718, PRO:DAN, UniProtKB:Q01705]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020764 |
neurogenic locus notch homolog protein 2 proteolytic cleavage product
|
NOTCH2/ClvPrd
|
"A neurogenic locus notch homolog protein 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020765 |
neurogenic locus notch homolog protein 3 proteolytic cleavage product
|
NOTCH3/ClvPrd
|
"A neurogenic locus notch homolog protein 3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000085750 |
notch 3 intracellular domain (mouse)
|
mNOTCH3/NICD
|
"A neurogenic locus notch homolog protein 3 (mouse) that corresponds to the C-terminal portion after proteolytic cleavage by PSEN1 or PSEN2. UniProtKB:Q61982, 1663-2318." [PRO:DAN, UniProtKB:Q61982]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020766 |
neurogenic locus notch homolog protein 4 proteolytic cleavage product
|
NOTCH4/ClvPrd
|
"A neurogenic locus notch homolog protein 4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020769 |
neuropeptide B proteolytic cleavage product
|
NPB/ClvPrd
|
"A neuropeptide B that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020770 |
FMRFamide-related neuropeptide FF proteolytic cleavage product
|
NPFF/ClvPrd
|
"An FMRFamide-related neuropeptide FF that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020775 |
atrial natriuretic factor proteolytic cleavage product
|
NPPA/ClvPrd
|
"An atrial natriuretic factor that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020778 |
natriuretic peptides B proteolytic cleavage product
|
NPPB/ClvPrd
|
"A natriuretic peptides B that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020779 |
C-type natriuretic peptide proteolytic cleavage product
|
NPPC/ClvPrd
|
"A C-type natriuretic peptide that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020782 |
neuropeptide S proteolytic cleavage product
|
NPS/ClvPrd
|
"A neuropeptide S that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020785 |
FMRFamide-related neuropeptide VF proteolytic cleavage product
|
NPVF/ClvPrd
|
"An FMRFamide-related neuropeptide VF that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020786 |
neuropeptide W proteolytic cleavage product
|
NPW/ClvPrd
|
"A neuropeptide W that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020789 |
neuropeptide Y proteolytic cleavage product
|
NPY/ClvPrd
|
"A neuropeptide Y that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020792 |
pro-neuregulin-2, membrane-bound isoform proteolytic cleavage product
|
NRG2/ClvPrd
|
"A pro-neuregulin-2, membrane-bound isoform that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020793 |
pro-neuregulin-3, membrane-bound isoform proteolytic cleavage product
|
NRG3/ClvPrd
|
"A pro-neuregulin-3, membrane-bound isoform that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020794 |
pro-neuregulin-4, membrane-bound isoform proteolytic cleavage product
|
NRG4/ClvPrd
|
"A pro-neuregulin-4, membrane-bound isoform that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020795 |
neurotrophin-3 proteolytic cleavage product
|
NTF3/ClvPrd
|
"A neurotrophin-3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020796 |
neurotrophin-4 proteolytic cleavage product
|
NTF4/ClvPrd
|
"A neurotrophin-4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020805 |
neurotensin/neuromedin N proteolytic cleavage product
|
NTS/ClvPrd
|
"A neurotensin/neuromedin N that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020811 |
nuclear pore complex protein Nup98-Nup96 proteolytic cleavage product
|
NUP98/ClvPrd
|
"A nuclear pore complex protein Nup98-Nup96 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020817 |
ornithine aminotransferase, mitochondrial proteolytic cleavage product
|
OAT/ClvPrd
|
"An ornithine aminotransferase, mitochondrial that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020831 |
oxidized low-density lipoprotein receptor 1 proteolytic cleavage product
|
OLR1/ClvPrd
|
"An oxidized low-density lipoprotein receptor 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020841 |
oncostatin-M proteolytic cleavage product
|
OSM/ClvPrd
|
"An oncostatin-M that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020842 |
osteocrin proteolytic cleavage product
|
OSTN/ClvPrd
|
"An osteocrin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020852 |
oxytocin-neurophysin 1 proteolytic cleavage product
|
OXT/ClvPrd
|
"An oxytocin-neurophysin 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020865 |
serine/threonine-protein kinase PAK 2 proteolytic cleavage product
|
PAK2/ClvPrd
|
"A serine/threonine-protein kinase PAK 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020867 |
pappalysin-1 proteolytic cleavage product
|
PAPPA/ClvPrd
|
"A pappalysin-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020868 |
pappalysin-2 proteolytic cleavage product
|
PAPPA2/ClvPrd
|
"A pappalysin-2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020871 |
presenilin-associated rhomboid-like protein, mitochondrial proteolytic cleavage product
|
PARL/ClvPrd
|
"A presenilin-associated rhomboid-like protein, mitochondrial that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020885 |
ProSAAS proteolytic cleavage product
|
PCSK1N/ClvPrd
|
"A ProSAAS that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020888 |
proprotein convertase subtilisin/kexin type 5 proteolytic cleavage product
|
PCSK5/ClvPrd
|
"A proprotein convertase subtilisin/kexin type 5 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020889 |
proprotein convertase subtilisin/kexin type 6 proteolytic cleavage product
|
PCSK6/ClvPrd
|
"A proprotein convertase subtilisin/kexin type 6 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020892 |
proprotein convertase subtilisin/kexin type 9 proteolytic cleavage product
|
PCSK9/ClvPrd
|
"A proprotein convertase subtilisin/kexin type 9 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020902 |
platelet-derived growth factor subunit A proteolytic cleavage product
|
PDGFA/ClvPrd
|
"A platelet-derived growth factor subunit A that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020905 |
platelet-derived growth factor subunit B proteolytic cleavage product
|
PDGFB/ClvPrd
|
"A platelet-derived growth factor subunit B that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020916 |
proenkephalin-B proteolytic cleavage product
|
PDYN/ClvPrd
|
"A proenkephalin-B that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020918 |
phosphatidylethanolamine-binding protein 1 proteolytic cleavage product
|
PEBP1/ClvPrd
|
"A phosphatidylethanolamine-binding protein 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020924 |
proenkephalin-A proteolytic cleavage product
|
PENK/ClvPrd
|
"A proenkephalin-A that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000085760 |
Met-enkephalin
|
PENK/M-enk
|
"A proenkephalin-A that has been proteolytically cleaved by cathepsin L to yield a peptide with the sequence YGGFM. Example: UniProtKB:P01210, 100-104." [PMID:12869695, PRO:DAN, UniProtKB:P01210]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000085761 |
Met-enkephalin (human)
|
hPENK/M-enk
|
"A Met-enkephalin in human. Example: UniProtKB:P01210, 100-104." [PRO:DAN, UniProtKB:P01210]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000085762 |
Met-enkephalin (mouse)
|
mPENK/M-enk
|
"A Met-enkephalin in mouse. Example: UniProtKB:P22005, 100-104." [PRO:DAN, UniProtKB:P22005]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000085774 |
Met-enkephalin (cow)
|
cow-PENK/M-enk
|
"A Met-enkephalin in cow. Example: UniProtKB:P01211, 97-101." [PRO:DAN, UniProtKB:P01211]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000085763 |
Leu-enkephalin
|
PENK/L-enk
|
"A proenkephalin-A that has been proteolytically cleaved by cathepsin L to yield a peptide with the sequence YGGFL. Example: UniProtKB:P01210, 230-234." [PRO:DAN, UniProtKB:P01210]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000085764 |
Leu-enkephalin (human)
|
hPENK/L-enk
|
"A Leu-enkephalin in human. UniProtKB:P01210, 230-234." [PRO:DAN, UniProtKB:P01210]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000085765 |
Leu-enkephalin (mouse)
|
mPENK/L-enk
|
"A Leu-enkephalin in mouse. UniProtKB:P22005, 231-235." [PRO:DAN, UniProtKB:P22005]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000085775 |
Leu-enkephalin (cow)
|
cow-PENK/L-enk
|
"A Leu-enkephalin in cow. UniProtKB:P01211, 226-230." [PRO:DAN, UniProtKB:P01211]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000085766 |
Met-enkephalin-Arg-Gly-Leu (human)
|
hPENK/M-enk-RGL
|
"A proenkephalin-A (human) that has been proteolytically cleaved by cathepsin L to yield a peptide with the sequence YGGFMRGL. UniProtKB:P01210, 186-193." [PRO:DAN, UniProtKB:P01210]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000085768 |
Met-enkephalin-Arg-Phe
|
PENK/M-enk-RF
|
"A proenkephalin-A that has been proteolytically cleaved by cathepsin L to yield a peptide with the sequence YGGFMRF. Example: UniProtKB:P01210, 261-267." [PRO:DAN, UniProtKB:P01210]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000085769 |
Met-enkephalin-Arg-Phe (human)
|
hPENK/M-enk-RF
|
"A Met-enkephalin-Arg-Phe in human. UniProtKB:P01210, 261-267." [PRO:DAN, UniProtKB:P01210]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000085770 |
Met-enkephalin-Arg-Phe (mouse)
|
mPENK/M-enk-RF
|
"A Met-enkephalin-Arg-Phe in mouse. UniProtKB:P22005, 262-268." [PRO:DAN, UniProtKB:P22005]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000085777 |
Met-enkephalin-Arg-Phe (cow)
|
cow-PENK/M-enk-RF
|
"A Met-enkephalin-Arg-Phe in cow. UniProtKB:P01211, 257-263." [PRO:DAN, UniProtKB:P01211]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000085767 |
Met-enkephalin-Arg-Ser-Leu (mouse)
|
mPENK/M-enk-RSL
|
"A proenkephalin-A (mouse) that has been proteolytically cleaved by cathepsin L to yield a peptide with the sequence YGGFMRSL. UniProtKB:P22005, 187-194." [PRO:DAN, UniProtKB:P22005]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000085776 |
Met-enkephalin-Arg-Gly-Leu (cow)
|
cow-PENK/M-enk-RGL
|
"A proenkephalin-A (cow) that has been proteolytically cleaved by cathepsin L to yield a peptide with the sequence YGGFMRGL. UniProtKB:P01211, 182-189." [PRO:DAN, UniProtKB:P01211]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020929 |
platelet factor 4 proteolytic cleavage product
|
PF4/ClvPrd
|
"A platelet factor 4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020932 |
platelet factor 4 variant proteolytic cleavage product
|
PF4V1/ClvPrd
|
"A platelet factor 4 variant that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020941 |
pepsin A-5 proteolytic cleavage product
|
PGA5/ClvPrd
|
"A pepsin A-5 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020944 |
gastricsin proteolytic cleavage product
|
PGC/ClvPrd
|
"A gastricsin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020945 |
carboxypeptidase Q proteolytic cleavage product
|
PGCP/ClvPrd
|
"A carboxypeptidase Q that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020960 |
elafin proteolytic cleavage product
|
PI3/ClvPrd
|
"An elafin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020966 |
polymeric immunoglobulin receptor proteolytic cleavage product
|
PIGR/ClvPrd
|
"A polymeric immunoglobulin receptor that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000050188 |
polymeric immunoglobulin receptor secretory component
|
PIGR/SC
|
"A polymeric immunoglobulin receptor, signal peptide removed form that has been processed by proteolytic cleavage to separate the extracellular domain (represented here) from the transmembrane domain. Example: UniProtKB:P01833, 19-603." [GOC:add, ISBN:0781765196, PMID:16362985, PRO:ADD, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000050169 |
polymeric immunoglobulin receptor secretory component (human)
|
hPIGR/SC
|
"A polymeric immunoglobulin receptor secretory component in human. UniProtKB:P01833, 19-603." [GOC:add, ISBN:0781765196, PMID:16362985, PRO:ADD, UniProtKB:P01833]
|
|
Yes |
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020980 |
phosphatidylserine decarboxylase proenzyme proteolytic cleavage product
|
PISD/ClvPrd
|
"A phosphatidylserine decarboxylase proenzyme that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020987 |
group 10 secretory phospholipase A2 proteolytic cleavage product
|
PLA2G10/ClvPrd
|
"A group 10 secretory phospholipase A2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020992 |
phospholipase A2 proteolytic cleavage product
|
PLA2G1B/ClvPrd
|
"A phospholipase A2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000020995 |
cytosolic phospholipase A2 gamma proteolytic cleavage product
|
PLA2G4C/ClvPrd
|
"A cytosolic phospholipase A2 gamma that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021000 |
tissue-type plasminogen activator proteolytic cleavage product
|
PLAT/ClvPrd
|
"A tissue-type plasminogen activator that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021003 |
urokinase-type plasminogen activator proteolytic cleavage product
|
PLAU/ClvPrd
|
"A urokinase-type plasminogen activator that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021010 |
plasminogen proteolytic cleavage product
|
PLG/ClvPrd
|
"A plasminogen that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021016 |
pro-MCH proteolytic cleavage product
|
PMCH/ClvPrd
|
"A pro-MCH that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021025 |
nociceptin proteolytic cleavage product
|
PNOC/ClvPrd
|
"A nociceptin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021036 |
pro-opiomelanocortin proteolytic cleavage product
|
POMC/ClvPrd
|
"A pro-opiomelanocortin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000044793 |
melanotropin
|
POMC/Clv:MSH
|
"A pro-opiomelanocortin proteolytic cleavage product that represents a mature hormone peptide that stimulates pigment dispersion, such as alpha-MSH in mammalian melanocytes." [PMID:24146662, PRO:CNA]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021044 |
platelet basic protein proteolytic cleavage product
|
PPBP/ClvPrd
|
"A platelet basic protein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021066 |
pancreatic polypeptide prohormone proteolytic cleavage product
|
PPY/ClvPrd
|
"A pancreatic polypeptide prohormone that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021070 |
basic salivary proline-rich protein 1 proteolytic cleavage product
|
PRB1/ClvPrd
|
"A basic salivary proline-rich protein 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021071 |
basic salivary proline-rich protein 2 proteolytic cleavage product
|
PRB2/ClvPrd
|
"A basic salivary proline-rich protein 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021074 |
basic salivary proline-rich protein 4 proteolytic cleavage product
|
PRB4/ClvPrd
|
"A basic salivary proline-rich protein 4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021075 |
lysosomal Pro-X carboxypeptidase proteolytic cleavage product
|
PRCP/ClvPrd
|
"A lysosomal Pro-X carboxypeptidase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021082 |
bone marrow proteoglycan proteolytic cleavage product
|
PRG2/ClvPrd
|
"A bone marrow proteoglycan that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021083 |
proteoglycan 4 proteolytic cleavage product
|
PRG4/ClvPrd
|
"A proteoglycan 4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021086 |
salivary acidic proline-rich phosphoprotein proteolytic cleavage product
|
PRH/ClvPrd
|
"A salivary acidic proline-rich phosphoprotein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021096 |
prolactin-releasing peptide proteolytic cleavage product
|
PRLH/ClvPrd
|
"A prolactin-releasing peptide that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021100 |
protamine-2 proteolytic cleavage product
|
PRM2/ClvPrd
|
"A protamine-2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021105 |
vitamin K-dependent protein C proteolytic cleavage product
|
PROC/ClvPrd
|
"A vitamin K-dependent protein C that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000026177 |
pro-protein C light chain
|
PROC/Clv:proL
|
"A vitamin K-dependent protein C, signal peptide removed form that contains the N-terminal propeptide and the most N-terminal active polypeptide, and that is post-translationally modified to include multiple gamma-carboxyglutamic acid residues and one beta-hydroxyaspartic acid residue. Example: UniProtKB:P04070-1, 19-197, Glu-48/Glu-49/Glu-56/Glu-58/Glu-61/Glu-62/Glu-67/Glu-68/Glu-71, MOD:00041|Asp-113, MOD:00036." [PMID:2991887, PRO:CNx, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000026178 |
pro-protein C light chain (human)
|
hPROC/Clv:proL
|
"A pro-protein C light chain in human. UniProtKB:P04070, 19-197, Glu-48/Glu-49/Glu-56/Glu-58/Glu-61/Glu-62/Glu-67/Glu-68/Glu-71, MOD:00041|Asp-113, MOD:00036." [PMID:2991887, PRO:CNx, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000035918 |
vitamin K-dependent protein C activation peptide
|
PROC/Clv:act_pep
|
"A vitamin K-dependent protein C proteolytic cleavage product that corresponds to the dodecapeptide from the amino end of the heavy chain. Example: UniProtKB:P04070, 200-211." [PMID:2405901, PMID:468991, PMID:6589623, Reactome:R-HSA-141051]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000035919 |
vitamin K-dependent protein C activation peptide (human)
|
hPROC/Clv:act_pep
|
"A vitamin K-dependent protein C activation peptide in human. UniProtKB:P04070, 200-211." [PMID:2405901, PMID:468991, PMID:6589623, Reactome:R-HSA-141051]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000035920 |
vitamin K-dependent protein C heavy chain
|
PROC/Clv:H
|
"A vitamin K-dependent protein C proteolytic cleavage product that is the C-terminal region encompassing the activation peptide and the Trypsin (Pfam:PF00089) domain. Example: UniProtKB:P04070, 200-461." [PMID:2405901, PMID:6589623, Reactome:R-HSA-141042, Reactome:R-HSA-159780, Reactome:R-HSA-159827]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000035918 |
vitamin K-dependent protein C activation peptide
|
PROC/Clv:act_pep
|
"A vitamin K-dependent protein C proteolytic cleavage product that corresponds to the dodecapeptide from the amino end of the heavy chain. Example: UniProtKB:P04070, 200-211." [PMID:2405901, PMID:468991, PMID:6589623, Reactome:R-HSA-141051]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000035919 |
vitamin K-dependent protein C activation peptide (human)
|
hPROC/Clv:act_pep
|
"A vitamin K-dependent protein C activation peptide in human. UniProtKB:P04070, 200-211." [PMID:2405901, PMID:468991, PMID:6589623, Reactome:R-HSA-141051]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000035921 |
vitamin K-dependent protein C heavy chain (human)
|
hPROC/Clv:H
|
"A vitamin K-dependent protein C heavy chain in human. UniProtKB:P04070, 200-461." [PMID:2405901, PMID:6589623, Reactome:R-HSA-141042, Reactome:R-HSA-159780, Reactome:R-HSA-159827]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021112 |
vitamin K-dependent protein S proteolytic cleavage product
|
PROS1/ClvPrd
|
"A vitamin K-dependent protein S that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021115 |
vitamin K-dependent protein Z proteolytic cleavage product
|
PROZ/ClvPrd
|
"A vitamin K-dependent protein Z that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021123 |
transmembrane gamma-carboxyglutamic acid protein 2 proteolytic cleavage product
|
PRRG2/ClvPrd
|
"A transmembrane gamma-carboxyglutamic acid protein 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021126 |
serine protease 1 proteolytic cleavage product
|
PRSS1/ClvPrd
|
"A serine protease 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021127 |
trypsin-3 proteolytic cleavage product
|
PRSS3/ClvPrd
|
"A trypsin-3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021128 |
enteropeptidase proteolytic cleavage product
|
PRSS7/ClvPrd
|
"An enteropeptidase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021129 |
prostasin proteolytic cleavage product
|
PRSS8/ClvPrd
|
"A prostasin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021132 |
myeloblastin proteolytic cleavage product
|
PRTN3/ClvPrd
|
"A myeloblastin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021135 |
presenilin-1 proteolytic cleavage product
|
PSEN1/ClvPrd
|
"A presenilin-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021143 |
proteasome subunit beta type-1 proteolytic cleavage product
|
PSMB1/ClvPrd
|
"A proteasome subunit beta type-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021145 |
proteasome subunit beta type-5 proteolytic cleavage product
|
PSMB5/ClvPrd
|
"A proteasome subunit beta type-5 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021147 |
proteasome subunit beta type-6 proteolytic cleavage product
|
PSMB6/ClvPrd
|
"A proteasome subunit beta type-6 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021148 |
proteasome subunit beta type-7 proteolytic cleavage product
|
PSMB7/ClvPrd
|
"A proteasome subunit beta type-7 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021149 |
proteasome subunit beta type-9 proteolytic cleavage product
|
PSMB9/ClvPrd
|
"A proteasome subunit beta type-9 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021170 |
parathyroid hormone proteolytic cleavage product
|
PTH/ClvPrd
|
"A parathyroid hormone that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021171 |
tuberoinfundibular peptide of 39 residues proteolytic cleavage product
|
PTH2/ClvPrd
|
"A tuberoinfundibular peptide of 39 residues that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021172 |
parathyroid hormone-related protein proteolytic cleavage product
|
PTHLH/ClvPrd
|
"A parathyroid hormone-related protein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021174 |
prothymosin alpha proteolytic cleavage product
|
PTMA/ClvPrd
|
"A prothymosin alpha that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021185 |
nectin-4 proteolytic cleavage product
|
NECTIN4/ClvPrd
|
"A nectin-4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021195 |
peptide YY proteolytic cleavage product
|
PYY/ClvPrd
|
"A peptide YY that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021202 |
orexigenic neuropeptide QRFP proteolytic cleavage product
|
QRFP/ClvPrd
|
"An orexigenic neuropeptide QRFP that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021225 |
Ras-related protein Rap-1A proteolytic cleavage product
|
RAP1A/ClvPrd
|
"A Ras-related protein Rap-1A that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021226 |
Ras-related protein Rap-1b proteolytic cleavage product
|
RAP1B/ClvPrd
|
"A Ras-related protein Rap-1b that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021227 |
Ras-related protein Rap-2b proteolytic cleavage product
|
RAP2B/ClvPrd
|
"A Ras-related protein Rap-2b that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021239 |
RNA-binding motif protein, X chromosome proteolytic cleavage product
|
RBMX/ClvPrd
|
"An RNA-binding motif protein, X chromosome that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021245 |
retinol-binding protein 4 proteolytic cleavage product
|
RBP4/ClvPrd
|
"A retinol-binding protein 4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021263 |
GTP-binding protein Rheb proteolytic cleavage product
|
RHEB/ClvPrd
|
"A GTP-binding protein Rheb that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021264 |
Rho-related GTP-binding protein RhoB proteolytic cleavage product
|
RHOB/ClvPrd
|
"A Rho-related GTP-binding protein RhoB that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021267 |
prorelaxin H2 proteolytic cleavage product
|
RLN2/ClvPrd
|
"A prorelaxin H2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021334 |
eukaryotic-type small ribosomal subunit protein uS7 proteolytic cleavage product
|
RPS5/ClvPrd
|
"A eukaryotic-type small ribosomal subunit protein uS7 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021349 |
renin-2 proteolytic cleavage product
|
Ren2/ClvPrd
|
"A renin-2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021352 |
protein S100-A12 proteolytic cleavage product
|
S100A12/ClvPrd
|
"A protein S100-A12 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021368 |
secretogranin-2 proteolytic cleavage product
|
SCG2/ClvPrd
|
"A secretogranin-2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021385 |
secretin proteolytic cleavage product
|
SCT/ClvPrd
|
"A secretin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021386 |
aminoacyl tRNA synthase complex-interacting multifunctional protein 1 proteolytic cleavage product
|
SCYE1/ClvPrd
|
"An aminoacyl tRNA synthase complex-interacting multifunctional protein 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021404 |
semenogelin-1 proteolytic cleavage product
|
SEMG1/ClvPrd
|
"A semenogelin-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021416 |
alpha-1-antitrypsin proteolytic cleavage product
|
SERPINA1/ClvPrd
|
"An alpha-1-antitrypsin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021423 |
alpha-1-antichymotrypsin proteolytic cleavage product
|
SERPINA3/ClvPrd
|
"An alpha-1-antichymotrypsin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021440 |
alpha-2-antiplasmin proteolytic cleavage product
|
SERPINF2/ClvPrd
|
"An alpha-2-antiplasmin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021459 |
pulmonary surfactant-associated protein B proteolytic cleavage product
|
SFTPB/ClvPrd
|
"A pulmonary surfactant-associated protein B that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021460 |
surfactant protein C proteolytic cleavage product
|
SFTPC/ClvPrd
|
"A surfactant protein C that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021468 |
sonic hedgehog protein proteolytic cleavage product
|
SHH/ClvPrd
|
"A sonic hedgehog protein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000037273 |
sonic hedgehog protein N-product
|
SHH/Clv:Nter
|
"A sonic hedgehog protein, signal peptide removed form that is the N-terminal product after autolysis. The N-product is the active species in signal transduction." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000037269 |
sonic hedgehog protein N-product dually lipidated 1 (mouse)
|
mSHH/Clv:Nter/2*Lipid:1
|
"A sonic hedgehog protein N-product in mouse that has been further modified on the N-terminal Cys residue by palmitoylation and the C-terminal Gly residue by cholesterylation. UniProtKB:Q62226, 25-198, Cys-25, MOD:00069|Gly-198, MOD:00314." [PMID:15075292, PMID:8824192, PRO:KRC]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000037274 |
sonic hedgehog protein N-product dually lipidated 1 (human)
|
hSHH/Clv:Nter/2*Lipid:1
|
"A sonic hedgehog protein N-product in human that has been further modified on the N-terminal Cys residue by palmitoylation and the C-terminal Gly residue by cholesterylation. UniProtKB:Q15465, 24-197, Cys-24, MOD:00069|Gly-197, MOD:00314." [PMID:9593755, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000037275 |
sonic hedgehog protein C-product
|
SHH/Clv:Cter
|
"A sonic hedgehog protein, signal peptide removed form that is the C-terminal product after autolysis. The C-product has autoproteolysis activity but does not participate in signal transduction." [PMID:24342078, PRO:CNA]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021475 |
sucrase-isomaltase, intestinal proteolytic cleavage product
|
SI/ClvPrd
|
"A sucrase-isomaltase, intestinal that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021476 |
sialate O-acetylesterase proteolytic cleavage product
|
SIAE/ClvPrd
|
"A sialate O-acetylesterase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021479 |
melanocyte protein Pmel 17 proteolytic cleavage product
|
SILV/ClvPrd
|
"A melanocyte protein Pmel 17 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021503 |
slit homolog 2 protein proteolytic cleavage product
|
SLIT2/ClvPrd
|
"A slit homolog 2 protein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021514 |
submaxillary gland androgen-regulated protein 3B proteolytic cleavage product
|
SMR3B/ClvPrd
|
"A submaxillary gland androgen-regulated protein 3B that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021531 |
extracellular superoxide dismutase [Cu-Zn] proteolytic cleavage product
|
SOD3/ClvPrd
|
"An extracellular superoxide dismutase [Cu-Zn] that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021534 |
sortilin-related receptor proteolytic cleavage product
|
SORL1/ClvPrd
|
"A sortilin-related receptor that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021535 |
sortilin proteolytic cleavage product
|
SORT1/ClvPrd
|
"A sortilin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021540 |
sperm acrosome membrane-associated protein 3 proteolytic cleavage product
|
SPACA3/ClvPrd
|
"A sperm acrosome membrane-associated protein 3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021550 |
serine protease inhibitor Kazal-type 5 proteolytic cleavage product
|
SPINK5/ClvPrd
|
"A serine protease inhibitor Kazal-type 5 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021563 |
sterol regulatory element-binding protein 1 proteolytic cleavage product
|
SREBF1/ClvPrd
|
"A sterol regulatory element-binding protein 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021564 |
sterol regulatory element-binding protein 2 proteolytic cleavage product
|
SREBF2/ClvPrd
|
"A sterol regulatory element-binding protein 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000085746 |
processed sterol regulatory element-binding protein 2 (mouse)
|
mSREBF2/processed
|
"A sterol regulatory element-binding protein 2 (mouse) that corresponds to the N-terminal portion after proteolytic cleavage by site 2 protease (aka MBTPS2 and S2P). UniProtKB:Q3U1N2, 1-473." [PRO:DAN, UniProtKB:Q3U1N2]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021578 |
somatostatin proteolytic cleavage product
|
SST/ClvPrd
|
"A somatostatin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021579 |
stabilin-2 proteolytic cleavage product
|
STAB2/ClvPrd
|
"A stabilin-2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021601 |
small ubiquitin-related modifier 1 proteolytic cleavage product
|
SUMO1/ClvPrd
|
"A small ubiquitin-related modifier 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021602 |
small ubiquitin-related modifier 2 proteolytic cleavage product
|
SUMO2/ClvPrd
|
"A small ubiquitin-related modifier 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021603 |
small ubiquitin-related modifier 3 proteolytic cleavage product
|
SUMO3/ClvPrd
|
"A small ubiquitin-related modifier 3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021619 |
protachykinin-1 proteolytic cleavage product
|
TAC1/ClvPrd
|
"A protachykinin-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021620 |
tachykinin-3 proteolytic cleavage product
|
TAC3/ClvPrd
|
"A tachykinin-3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021621 |
tachykinin-4 proteolytic cleavage product
|
TAC4/ClvPrd
|
"A tachykinin-4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021629 |
threonine aspartase 1 proteolytic cleavage product
|
TASP1/ClvPrd
|
"A threonine aspartase 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021657 |
protransforming growth factor alpha proteolytic cleavage product
|
TGFA/ClvPrd
|
"A protransforming growth factor alpha that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021660 |
protein-glutamine gamma-glutamyltransferase E proteolytic cleavage product
|
TGM3/ClvPrd
|
"A protein-glutamine gamma-glutamyltransferase E that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021680 |
tolloid-like protein 2 proteolytic cleavage product
|
TLL2/ClvPrd
|
"A tolloid-like protein 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021689 |
transmembrane protease serine 11D proteolytic cleavage product
|
TMPRSS11D/ClvPrd
|
"A transmembrane protease serine 11D that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021690 |
transmembrane protease serine 2 proteolytic cleavage product
|
TMPRSS2/ClvPrd
|
"A transmembrane protease serine 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021708 |
tumor necrosis factor ligand superfamily member 12 proteolytic cleavage product
|
TNFSF12/ClvPrd
|
"A tumor necrosis factor ligand superfamily member 12 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021725 |
tripeptidyl-peptidase 1 proteolytic cleavage product
|
TPP1/ClvPrd
|
"A tripeptidyl-peptidase 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021730 |
tryptase beta-2 proteolytic cleavage product
|
TPSB2/ClvPrd
|
"A tryptase beta-2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021731 |
tryptase gamma proteolytic cleavage product
|
TPSG1/ClvPrd
|
"A tryptase gamma that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021735 |
pro-thyrotropin-releasing hormone proteolytic cleavage product
|
TRH/ClvPrd
|
"A pro-thyrotropin-releasing hormone that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021742 |
thyrotropin subunit beta proteolytic cleavage product
|
TSHB/ClvPrd
|
"A thyrotropin subunit beta that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021759 |
thioredoxin reductase 1, cytoplasmic proteolytic cleavage product
|
TXNRD1/ClvPrd
|
"A thioredoxin reductase 1, cytoplasmic that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021762 |
thymidine phosphorylase proteolytic cleavage product
|
TYMP/ClvPrd
|
"A thymidine phosphorylase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021766 |
peroxisomal leader peptide-processing protease proteolytic cleavage product
|
TYSND1/ClvPrd
|
"A peroxisomal leader peptide-processing protease that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021782 |
unique cartilage matrix-associated protein proteolytic cleavage product
|
UCMA/ClvPrd
|
"A unique cartilage matrix-associated protein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021783 |
urocortin proteolytic cleavage product
|
UCN/ClvPrd
|
"A urocortin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021784 |
urocortin-3 proteolytic cleavage product
|
UCN3/ClvPrd
|
"A urocortin-3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021785 |
ubiquitin-fold modifier 1 proteolytic cleavage product
|
UFM1/ClvPrd
|
"A ubiquitin-fold modifier 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021806 |
urotensin-2 proteolytic cleavage product
|
UTS2/ClvPrd
|
"A urotensin-2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021823 |
vascular endothelial growth factor C proteolytic cleavage product
|
VEGFC/ClvPrd
|
"A vascular endothelial growth factor C that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021826 |
vasoactive intestinal polypeptides proteolytic cleavage product
|
VIP/ClvPrd
|
"A VIP peptides that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021838 |
vitronectin proteolytic cleavage product
|
VTN/ClvPrd
|
"A vitronectin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021841 |
von Willebrand factor proteolytic cleavage product
|
VWF/ClvPrd
|
"A von Willebrand factor that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000043586 |
von Willebrand factor isoform 1 cleaved 1 (human)
|
hVWF/iso:1/Clv:1
|
"A von Willebrand factor isoform 1 (human) that is the N-terminal part after signal peptide removal and cleavage between residues Arg-763 and Ser-764. UniProtKB:P04275-1, 23-763." [PRO:DAN]
|
|
Yes |
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000043993 |
von Willebrand factor isoform 1 cleaved 2 (human)
|
hVWF/iso:1/Clv:2
|
"A von Willebrand factor isoform 1 (human) that is the C-terminal part after cleavage between residues Arg-763 and Ser-764. UniProtKB:P04275-1, 764-2813." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021843 |
tryptophan--tRNA ligase, cytoplasmic proteolytic cleavage product
|
WARS/ClvPrd
|
"A tryptophan--tRNA ligase, cytoplasmic that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021856 |
protein Wnt-5a proteolytic cleavage product
|
WNT5A/ClvPrd
|
"A protein Wnt-5a that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021868 |
14-3-3 protein gamma proteolytic cleavage product
|
YWHAG/ClvPrd
|
"A 14-3-3 protein gamma that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021885 |
zona pellucida sperm-binding protein 1 proteolytic cleavage product
|
ZP1/ClvPrd
|
"A zona pellucida sperm-binding protein 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021888 |
zona pellucida sperm-binding protein 2 proteolytic cleavage product
|
ZP2/ClvPrd
|
"A zona pellucida sperm-binding protein 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021891 |
zona pellucida sperm-binding protein 3 proteolytic cleavage product
|
ZP3/ClvPrd
|
"A zona pellucida sperm-binding protein 3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021892 |
zona pellucida sperm-binding protein 4 proteolytic cleavage product
|
ZP4/ClvPrd
|
"A zona pellucida sperm-binding protein 4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021927 |
activin/inhibin beta B chain proteolytic cleavage product
|
INHBB/ClvPrd
|
"An activin/inhibin beta B chain that has been processed by proteolytic cleavage." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021928 |
activin/inhibin beta E chain proteolytic cleavage product
|
INHBE/ClvPrd
|
"An activin/inhibin beta E chain that has been processed by proteolytic cleavage." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021929 |
growth/differentiation factor 5 proteolytic cleavage product
|
GDF5/ClvPrd
|
"A growth/differentiation factor 5 that has been processed by proteolytic cleavage." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021930 |
growth/differentiation factor 7 proteolytic cleavage product
|
GDF7/ClvPrd
|
"A growth/differentiation factor 7 that has been processed by proteolytic cleavage." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021931 |
bone morphogenetic protein 5 proteolytic cleavage product
|
BMP5/ClvPrd
|
"A bone morphogenetic protein 5 that has been processed by proteolytic cleavage." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021932 |
bone morphogenetic protein 6 proteolytic cleavage product
|
BMP6/ClvPrd
|
"A bone morphogenetic protein 6 that has been processed by proteolytic cleavage." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021933 |
activin/inhibin beta C chain proteolytic cleavage product
|
INHBC/ClvPrd
|
"An activin/inhibin beta C chain that has been processed by proteolytic cleavage." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000021934 |
adhesion G protein-coupled receptor L1 proteolytic cleavage product
|
ADGRL1/ClvPrd
|
"An adhesion G protein-coupled receptor L1 that has been processed by proteolytic cleavage." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000001274 |
adhesion G protein-coupled receptor L1 isoform 4 cleaved 1
|
ADGRL1/iso:4/Clv:1
|
"An adhesion G protein-coupled receptor L1 isoform 4, signal peptide removed form that is the N-terminal product of the cleavage upstream of a Thr residue within the GPS domain, corresponding to Thr-838 in the rat sequence UniProtKB:O88917-4. This form remains non-covalently bound to the C-terminal product. Example: UniProtKB:O88917-4, 25-837." [PMID:12270923]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036603 |
adhesion G protein-coupled receptor L1 isoform 4 cleaved 1 (rat)
|
rADGRL1/iso:4/Clv:1
|
"An adhesion G protein-coupled receptor L1 isoform 4 cleaved 1 in rat. UniProtKB:O88917-4, 25-837." [PMID:12270923, PMID:12270924, PMID:9208860, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000001275 |
adhesion G protein-coupled receptor L1 isoform 4 cleaved 2
|
ADGRL1/iso:4/Clv:2
|
"An adhesion G protein-coupled receptor L1 isoform 4, signal peptide removed form that is the C-terminal product of the cleavage upstream of a Thr residue within the GPS domain, corresponding to Thr-838 in the rat sequence UniProtKB:O88917-4. Example: UniProtKB:O88917-4, 838-1471." [PMID:12270923]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036604 |
adhesion G protein-coupled receptor L1 isoform 4 cleaved 2 (rat)
|
rADGRL1/iso:4/Clv:2
|
"An adhesion G protein-coupled receptor L1 isoform 4 cleaved 2 in rat. UniProtKB:O88917-4, 838-1471." [PMID:12270923, PMID:12270924, PMID:9208860, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000024268 |
bifunctional transcriptional activator/DNA repair enzyme Ada proteolytic cleavage product
|
ada/ClvPrd
|
"A bifunctional transcriptional activator/DNA repair enzyme Ada that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000024304 |
acid shock protein proteolytic cleavage product
|
asr/ClvPrd
|
"An acid shock protein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000024323 |
ATP-dependent Clp protease proteolytic subunit proteolytic cleavage product
|
clpP/ClvPrd
|
"An ATP-dependent Clp protease proteolytic subunit that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000024373 |
DNA polymerase III subunit tau proteolytic cleavage product
|
dnaX/ClvPrd
|
"A DNA polymerase III subunit tau that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000024433 |
antigen 43 proteolytic cleavage product
|
flu/ClvPrd
|
"An antigen 43 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000024442 |
peptidoglycan D,D-transpeptidase FtsI proteolytic cleavage product
|
ftsI/ClvPrd
|
"A peptidoglycan D,D-transpeptidase FtsI that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000024458 |
glutamate synthase [NADPH] large chain proteolytic cleavage product
|
gltB/ClvPrd
|
"A glutamate synthase [NADPH] large chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000024485 |
hydrogenase-2 large chain proteolytic cleavage product
|
hybC/ClvPrd
|
"A hydrogenase-2 large chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000024488 |
formate hydrogenlyase subunit 5 proteolytic cleavage product
|
hycE/ClvPrd
|
"A formate hydrogenlyase subunit 5 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000024491 |
isoaspartyl peptidase proteolytic cleavage product
|
iaaA/ClvPrd
|
"An isoaspartyl peptidase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000024498 |
translation initiation factor IF-3 proteolytic cleavage product
|
infC/ClvPrd
|
"A translation initiation factor IF-3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000024637 |
aspartate 1-decarboxylase proteolytic cleavage product
|
panD/ClvPrd
|
"An aspartate 1-decarboxylase that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000024659 |
pyruvate dehydrogenase [ubiquinone] proteolytic cleavage product
|
poxB/ClvPrd
|
"A pyruvate dehydrogenase [ubiquinone] that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000024730 |
small ribosomal subunit protein bS6 proteolytic cleavage product
|
rpsF/ClvPrd
|
"A small ribosomal subunit protein bS6 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000024760 |
S-adenosylmethionine decarboxylase proenzyme proteolytic cleavage product
|
speD/ClvPrd
|
"An S-adenosylmethionine decarboxylase proenzyme that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000024798 |
pilin proteolytic cleavage product
|
traA/ClvPrd
|
"A pilin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000024819 |
protein UmuD proteolytic cleavage product
|
umuD/ClvPrd
|
"A protein UmuD that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000024855 |
P-factor
|
map2/Clv:P-factor
|
"A proteolytic cleavage product that is derived from P-factor precursor. In Schizosaccharomyces pombe 972h- the sequence is TYADFLRAYQSWNTFVNPDRPNL, corresponding to residues 66-88 or 134-156 of the amino acid sequence represented by UniProtKB:Q09180-1." [PRO:MSY]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000024858 |
inactivated P-factor
|
map2/Clv:P-factor/inactive
|
"A proteolytic cleavage product that is derived from P-factor by removal of the C-terminal leucine residue." [PMID:10792724, PRO:MSY]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000024856 |
P-factor-like 1
|
map2/Clv:P-factor-like1
|
"A proteolytic cleavage product that is derived from P-factor precursor. In Schizosaccharomyces pombe 972h- the sequence is SYADFLRVYQSWNTFANPDRPNL, corresponding to residues 32-54 of the amino acid sequence represented by UniProtKB:Q09180-1." [PRO:MSY]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000024857 |
P-factor-like 2
|
map2/Clv:P-factor-like2
|
"A proteolytic cleavage product that is derived from P-factor precursor. In Schizosaccharomyces pombe 972h- the sequence is SYADFLRAYHSWNTFVNPDRPNL, corresponding to residues 100-122 of the amino acid sequence represented by UniProtKB:Q09180-1." [PRO:MSY]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000024858 |
inactivated P-factor
|
map2/Clv:P-factor/inactive
|
"A proteolytic cleavage product that is derived from P-factor by removal of the C-terminal leucine residue." [PMID:10792724, PRO:MSY]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025001 |
M-factor
|
M-factor/mature
|
"A proteolytic cleavage product that is derived from propeptide removal from M-factor precursor, farnesylated 1. In Schizosaccharomyces pombe 972h- the sequence is YTPKVPYMC, with a farnesylated C-terminal residue." [PMID:1547790, PMID:8196631, PRO:MSY]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025410 |
PC4 and SFRS1-interacting protein proteolytic cleavage product
|
PSIP1/ClvPrd
|
"A PC4 and SFRS1-interacting protein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000003424 |
PC4 and SFRS1-interacting protein p38
|
PSIP1/iso:2/Clv:p38
|
"A PC4 and SFRS1-interacting protein isoform 2 that is the C-terminal proteolytic product generated by caspase 7 and caspase 3 cleavage during apoptosis. Example: UniProtKB:O75475-2, 86-333." [PMID:18708362, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036645 |
PC4 and SFRS1-interacting protein p38 (human)
|
hPSIP1/iso:2/Clv:p38
|
"A PC4 and SFRS1-interacting protein p38 in human. UniProtKB:O75475-2, 86-333." [PMID:18708362, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025411 |
TGF-beta receptor type-1 proteolytic cleavage product
|
TGFBR1/ClvPrd
|
"A TGF-beta receptor type-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025412 |
TGF-beta receptor type-2 proteolytic cleavage product
|
TGFBR2/ClvPrd
|
"A TGF-beta receptor type-2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025413 |
alpha-latrotoxin proteolytic cleavage product
|
alpha-LTX/ClvPrd
|
"An alpha-latrotoxin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025414 |
basigin proteolytic cleavage product
|
BSG/ClvPrd
|
"A basigin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025415 |
beta-type platelet-derived growth factor receptor proteolytic cleavage product
|
PDGFRB/ClvPrd
|
"A beta-type platelet-derived growth factor receptor that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025416 |
cartilage oligomeric matrix protein proteolytic cleavage product
|
COMP/ClvPrd
|
"A cartilage oligomeric matrix protein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025417 |
cholera enterotoxin subunit A proteolytic cleavage product
|
ctxA/ClvPrd
|
"A cholera enterotoxin subunit A that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000021965 |
cholera enterotoxin subunit A1
|
ctxA/Clv:A1
|
"A cholera enterotoxin subunit A isoform 1 that has been processed by proteolytic cleavage to yield the catalytic subunit of subunit A. The cholera holotoxin consists of a pentameric ring of B subunits whose central pore is occupied by the A subunit. The A subunit contains two chains, A1 and A2, linked by a disulfide bridge." [PMID:955672, UniProtKB:P01555]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036647 |
cholera enterotoxin subunit A1 (Vibrio cholerae O1 biovar El Tor str. N16961)
|
ctxA/Clv:A1 (VIBCH)
|
"A cholera enterotoxin subunit A1 in Vibrio cholerae O1 biovar El Tor str. N16961. UniProtKB:P01555, 19-212." [PMID:13679513, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000021966 |
cholera enterotoxin subunit A2
|
ctxA/Clv:A2
|
"A cholera enterotoxin subunit A isoform 1 that has been processed by proteolytic cleavage to yield the tethering subunit of subunit A. The cholera holotoxin consists of a pentameric ring of B subunits whose central pore is occupied by the A subunit. The A subunit contains two chains, A1 and A2, linked by a disulfide bridge." [PMID:7028752, UniProtKB:P01555]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036648 |
cholera enterotoxin subunit A2 (Vibrio cholerae O1 biovar El Tor str. N16961)
|
ctxA/Clv:A2 (VIBCH)
|
"A cholera enterotoxin subunit A2 in Vibrio cholerae O1 biovar El Tor str. N16961. UniProtKB:P01555, 213-258." [PMID:13679513, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025418 |
cholera enterotoxin subunit B proteolytic cleavage product
|
ctxB/ClvPrd
|
"A cholera enterotoxin subunit B that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025419 |
chordin proteolytic cleavage product
|
CHRD/ClvPrd
|
"A chordin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000425 |
chordin isoform 1 cleaved 2
|
CHRD/iso:1/Clv:2
|
"A chordin isoform 1 that has been cleaved by BMP1 at two sites upstream of Asp residues. One site is within the motif Y[SN]DR, whereas the other is within the motif MQ[AS]DG. This form activates BMP signaling pathway. Example: UniProtKB:Q9Z0E2-1, 154-861." [PMID:10479448, UniProtKB:Q9Z0E2]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036411 |
chordin isoform 1 cleaved 2 (mouse)
|
mCHRD/iso:1/Clv:2
|
"A chordin isoform 1 cleaved 2 in mouse. UniProtKB:Q9Z0E2-1, 154-861." [PMID:10479448, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025420 |
collagen alpha-1(VI) chain proteolytic cleavage product
|
COL6A1/ClvPrd
|
"A collagen alpha-1(VI) chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025421 |
collagen alpha-1(VII) chain proteolytic cleavage product
|
COL7A1/ClvPrd
|
"A collagen alpha-1(VII) chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025422 |
collagen alpha-2(VI) chain proteolytic cleavage product
|
COL6A2/ClvPrd
|
"A collagen alpha-2(VI) chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025423 |
collagen alpha-3(VI) chain proteolytic cleavage product
|
COL6A3/ClvPrd
|
"A collagen alpha-3(VI) chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025424 |
collagen alpha-4(IV) chain proteolytic cleavage product
|
COL4A4/ClvPrd
|
"A collagen alpha-4(IV) chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025425 |
collagen alpha-5(IV) chain proteolytic cleavage product
|
COL4A5/ClvPrd
|
"A collagen alpha-5(IV) chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025426 |
diablo IAP-binding mitochondrial protein proteolytic cleavage product
|
DIABLO/ClvPrd
|
"A diablo IAP-binding mitochondrial protein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025427 |
interleukin-1 receptor antagonist protein proteolytic cleavage product
|
IL1RN/ClvPrd
|
"An interleukin-1 receptor antagonist protein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025428 |
interleukin-17A proteolytic cleavage product
|
IL17A/ClvPrd
|
"An interleukin-17A that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025429 |
interleukin-6 receptor subunit alpha proteolytic cleavage product
|
IL6R/ClvPrd
|
"An interleukin-6 receptor subunit alpha that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000001798 |
interleukin-6 receptor subunit alpha isoform 1 soluble form
|
IL6R/iso:1/Clv:soluble
|
"An interleukin-6 receptor subunit alpha isoform 1 that has been post-translationally cleaved to release the extracellular domain into the extracellular space." [PMID:8477802, PRO:HJD]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044514 |
interleukin-6 receptor subunit alpha isoform 1 soluble form (mouse)
|
mIL6R/iso:1/Clv:soluble
|
"An interleukin-6 receptor subunit alpha isoform 1 soluble form in mouse." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025430 |
latent TGF-beta-binding protein 1 proteolytic cleavage product
|
LTBP1/ClvPrd
|
"A latent TGF-beta-binding protein 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025431 |
lefty 1 proteolytic cleavage product
|
LEFTY1/ClvPrd
|
"A lefty 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000643 |
lefty 1 isoform 1 cleaved 1
|
LEFTY1/iso:1/Clv:1
|
"A lefty 1 isoform 1 that is the C-terminal part after processing by proteolytic cleavage at the first dibasic RxxR cleavage site within the propeptide region." [PMID:11278322, PMID:18039650]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036546 |
lefty 1 isoform 1 cleaved 1 (human)
|
hLEFTY1/iso:1/Clv:1
|
"A lefty 1 isoform 1 cleaved 1 in human. UniProtKB:O75610-1, 77-366." [PMID:11278322, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036547 |
lefty 1 isoform 1 cleaved 1 (mouse)
|
mLEFTY1/iso:1/Clv:1
|
"A lefty 1 isoform 1 cleaved 1 in mouse. UniProtKB:Q64280-1, 77-368." [PMID:15004567, PMID:18039650, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000644 |
lefty 1 isoform 1 cleaved 2
|
LEFTY1/iso:1/Clv:2
|
"A lefty 1 isoform 1 that is the C-terminal part after processing by proteolytic cleavage at the second dibasic RxxR cleavage site within the propeptide region." [PMID:11278322]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036548 |
lefty 1 isoform 1 cleaved 2 (human)
|
hLEFTY1/iso:1/Clv:2
|
"A lefty 1 isoform 1 cleaved 2 in human. UniProtKB:O75610-1, 135-366." [PMID:11278322, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025432 |
lefty 2 proteolytic cleavage product
|
LEFTY2/ClvPrd
|
"A lefty 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000645 |
lefty 2 isoform 1 cleaved 1
|
LEFTY2/iso:1/Clv:1
|
"A lefty 2 isoform 1 that is the C-terminal part after processing by proteolytic cleavage at the first dibasic RxxR cleavage site within the propeptide region." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036549 |
lefty 2 isoform 1 cleaved 1 (human)
|
hLEFTY2/iso:1/Clv:1
|
"A lefty 2 isoform 1 cleaved 1 in human. UniProtKB:O00292-1, 77-366." [PMID:10053005, PMID:11278322, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000646 |
lefty 2 isoform 1 cleaved 2
|
LEFTY2/iso:1/Clv:2
|
"A lefty 2 isoform 1 that is the C-terminal part after processing by proteolytic cleavage at the second dibasic RxxR cleavage site within the propeptide region." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036550 |
lefty 2 isoform 1 cleaved 2 (human)
|
hLEFTY2/iso:1/Clv:2
|
"A lefty 2 isoform 1 cleaved 2 in human. UniProtKB:O00292-1, 135-366." [PMID:11278322, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025433 |
nodal protein proteolytic cleavage product
|
NODAL/ClvPrd
|
"A nodal protein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025434 |
noggin proteolytic cleavage product
|
NOG/ClvPrd
|
"A noggin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025435 |
Rho-associated protein kinase 1 proteolytic cleavage product
|
ROCK1/ClvPrd
|
"A Rho-associated protein kinase 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000563 |
Rho-associated protein kinase 1 isoform 1 cleaved 1
|
ROCK1/iso:1/Clv:1
|
"A Rho-associated protein kinase 1 isoform 1 that has been processed by caspase-3 downstream the sequence motif DETD, removing the inhibitory C-terminus." [PMID:11283607, PMID:16983089]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000026340 |
Rho-associated protein kinase 1 isoform 1 cleaved 1 (human)
|
hROCK1/iso:1/Clv:1
|
"A Rho-associated protein kinase 1 isoform 1 cleaved 1 in human. UniProtKB:Q13464-1, 1-1113." [PRO:DNx, UniProtKB:Q13464]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036476 |
Rho-associated protein kinase 1 isoform 1 cleaved 1 (mouse)
|
mROCK1/iso:1/Clv:1
|
"A Rho-associated protein kinase 1 isoform 1 cleaved 1 in mouse. UniProtKB:P70335-1, 1-1113." [PMID:11283607, PMID:16983089, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025436 |
Rho-associated protein kinase 2 proteolytic cleavage product
|
ROCK2/ClvPrd
|
"A Rho-associated protein kinase 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000564 |
Rho-associated protein kinase 2 isoform 1 cleaved 1
|
ROCK2/iso:1/Clv:1
|
"A Rho-associated protein kinase 2 isoform 1 that has been cleaved in the granzyme B consensus motif [IVL][GE]xD located between the Rho binding and the PH domains, removing the C-terminus." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036477 |
Rho-associated protein kinase 2 isoform 1 cleaved 1 (human)
|
hROCK2/iso:1/Clv:1
|
"A Rho-associated protein kinase 2 isoform 1 cleaved 1 in human. UniProtKB:O75116-1, 1-1131." [PMID:15699075, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025437 |
thrombospondin-1 proteolytic cleavage product
|
THBS1/ClvPrd
|
"A thrombospondin-1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000485 |
thrombospondin-1 isoform 1 cleaved and glycosylated form
|
THBS1/iso:1/ClvGlyco+
|
"A thrombospondin-1 isoform 1, signal peptide removed form that has been processed by proteolytic cleavage and includes at least one glycosylated residue." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000000590 |
thrombospondin-1 isoform 1 cleaved 2 glycosylated form
|
THBS1/iso:1/Clv:2/GlycoRes+
|
"A thrombospondin-1 isoform 1 cleaved and glycosylated form that has been proteolytically processed by ADAMTS1 to render a C-terminal domain product." [PMID:17082774]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000036489 |
thrombospondin-1 isoform 1 cleaved 2 glycosylated 1 (human)
|
hTHBS1/iso:1/Clv:2/Glyco:1
|
"A thrombospondin-1 isoform 1 cleaved 2 glycosylated form in human and that has been post-translationally modified at four Trp residues, one Ser residue, and two Thr residues. UniProtKB:P07996-1, 312-1170, Trp-385/Trp-438/Trp-441/Trp-498, MOD:00222|Ser-394, MOD:00812|Thr-450/Thr-507, MOD:00813." [PMID:11067851, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000036490 |
thrombospondin-1 isoform 1 cleaved 2 glycosylated form (mouse)
|
mTHBS1/iso:1/Clv:2/GlycoRes+
|
"A thrombospondin-1 isoform 1 cleaved 2 glycosylated form in mouse. UniProtKB:P35441-1, 312-1170, MOD:00693." [PMID:17082774, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000588 |
thrombospondin-1 isoform 1 cleaved 2
|
THBS1/iso:1/Clv:2
|
"A thrombospondin-1 isoform 1 that has been proteolytically processed by ADAMTS1 to render an N-terminal domain product." [PMID:17082774]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000028966 |
thrombospondin-1 isoform 1 cleaved 2 (human)
|
hTHBS1/iso:1/Clv:2
|
"A thrombospondin-1 isoform 1 cleaved 2 in human. UniProtKB:P07996-1, 19-311." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036486 |
thrombospondin-1 isoform 1 cleaved 2 (mouse)
|
mTHBS1/iso:1/Clv:2
|
"A thrombospondin-1 isoform 1 cleaved 2 in mouse. UniProtKB:P35441-1, 19-311." [PMID:17082774, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025438 |
thrombospondin-2 proteolytic cleavage product
|
THBS2/ClvPrd
|
"A thrombospondin-2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000592 |
thrombospondin-2 isoform 1 cleaved 2
|
THBS2/iso:1/Clv:2
|
"A thrombospondin-2 isoform 1 that has been proteolytically processed by ADAMTS1 to render an N-terminal domain product." [PMID:17082774]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036492 |
thrombospondin-2 isoform 1 cleaved 2 (mouse)
|
mTHBS2/iso:1/Clv:2
|
"A thrombospondin-2 isoform 1 cleaved 2 in mouse. UniProtKB:Q03350-1, 19-306." [PMID:17082774, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044787 |
thrombospondin-2 isoform 1 cleaved 2 (human)
|
hTHBS2/iso:1/Clv:2
|
"A thrombospondin-2 isoform 1 cleaved 2 in human. UniProtKB:P35442-1, 19-306." [PMID:17082774, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000593 |
thrombospondin-2 isoform 1 cleaved 3
|
THBS2/iso:1/Clv:3
|
"A thrombospondin-2 isoform 1 that has been proteolytically processed by ADAMTS1 to render a C-terminal domain product." [PMID:17082774]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036493 |
thrombospondin-2 isoform 1 cleaved 3 (mouse)
|
mTHBS2/iso:1/Clv:3
|
"A thrombospondin-2 isoform 1 cleaved 3 in mouse. UniProtKB:Q03350-1, 307-1172." [PMID:17082774, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044788 |
thrombospondin-2 isoform 1 cleaved 3 (human)
|
hTHBS2/iso:1/Clv:3
|
"A thrombospondin-2 isoform 1 cleaved 3 in human. UniProtKB:P35442-1, 307-1172." [PMID:17082774, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025439 |
thrombospondin-3 proteolytic cleavage product
|
THBS3/ClvPrd
|
"A thrombospondin-3 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025440 |
thrombospondin-4 proteolytic cleavage product
|
THBS4/ClvPrd
|
"A thrombospondin-4 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025441 |
transcription factor Sp1 proteolytic cleavage product
|
SP1/ClvPrd
|
"A transcription factor Sp1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000000597 |
transcription factor Sp1 isoform 1 cleaved 1
|
SP1/iso:1/Clv:1
|
"A transcription factor Sp1 isoform 1 that has had the N-terminal inhibitory domain released." [PMID:16407261]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036497 |
transcription factor Sp1 isoform 1 cleaved 1 (human)
|
hSP1/iso:1/Clv:1
|
"A transcription factor Sp1 isoform 1 cleaved 1 in human. UniProtKB:P08047-1, 65-785." [PMID:16407261, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025442 |
transmembrane protease serine 9 proteolytic cleavage product
|
TMPRSS9/ClvPrd
|
"A transmembrane protease serine 9 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000003056 |
transmembrane protease serine 9 isoform 3 cleaved 1
|
TMPRSS9/iso:3/Clv:1
|
"A transmembrane protease serine 9 isoform 3 that has been activated by trypsin proteolytic cleavage." [PMID:16872279, PRO:CL]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036627 |
transmembrane protease serine 9 isoform 3 cleaved 1 (mouse)
|
mTMPRSS9/iso:3/Clv:1
|
"A transmembrane protease serine 9 isoform 3 cleaved 1 in mouse. UniProtKB:Q0X0F1, 83-620." [PMID:16872279, PRO:CL]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025443 |
vascular endothelial growth factor B proteolytic cleavage product
|
VEGFB/ClvPrd
|
"A vascular endothelial growth factor B that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000003100 |
vascular endothelial growth factor B isoform 1 cleaved 1
|
VEGFB/iso:1/Clv:1
|
"A vascular endothelial growth factor B isoform 1, signal peptide removed form that contains the N-terminal cystine knot domain after proteolytic processing." [PMID:10409677, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036636 |
vascular endothelial growth factor B isoform 1 cleaved 1 (mouse)
|
mVEGFB/iso:1/Clv:1
|
"A vascular endothelial growth factor B isoform 1 cleaved 1 in mouse. UniProtKB:P49766-1, 22-127." [PMID:10409677, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025455 |
CD2 molecule proteolytic cleavage product
|
CD2/ClvPrd
|
"A CD2 molecule that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025457 |
follistatin proteolytic cleavage product
|
FST/ClvPrd
|
"A follistatin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025458 |
mitogen-activated protein kinase 1 proteolytic cleavage product
|
MAPK1/ClvPrd
|
"A mitogen-activated protein kinase 1 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000025488 |
agglutinin isolectin 2 proteolytic cleavage product
|
WGA2/ClvPrd
|
"An agglutinin isolectin 2 that has been processed by proteolytic cleavage." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000028527 |
casein derived peptide
|
CN (f)
|
"A proteolytic cleavage product that is derived from any of the casein milk proteins." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036522 |
alpha-S1-casein derived peptide
|
aS1-CN (f)
|
"A casein derived peptide that is derived from alpha-S1-casein." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044352 |
alpha-S1-casein peptide (f16-23) (cow)
|
cow-aS1-CN(f16-23)
|
"An alpha-S1-casein derived peptide in cow that corresponds to amino acids 16-23 of UniProtKB:P02662, with the sequence RPKHPIKH. UniProtKB:P02662, 16-23." [PMID:24399684, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044353 |
alpha-S1-casein peptide (f16-24) (cow)
|
cow-aS1-CN(f16-24)
|
"An alpha-S1-casein derived peptide in cow that corresponds to amino acids 16-24 of UniProtKB:P02662, with the sequence RPKHPIKHQ. UniProtKB:P02662, 16-24." [PMID:24399684, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044354 |
alpha-S1-casein peptide (f17-25) (cow)
|
cow-aS1-CN(f17-25)
|
"An alpha-S1-casein derived peptide in cow that corresponds to amino acids 17-25 of UniProtKB:P02662, with the sequence PKHPIKHQG. UniProtKB:P02662, 17-25." [PMID:24399684, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044355 |
alpha-S1-casein peptide (f46-52) (cow)
|
cow-aS1-CN(f46-52)
|
"An alpha-S1-casein derived peptide in cow that corresponds to amino acids 46-52 of UniProtKB:P02662, with the sequence VFGKEKV. UniProtKB:P02662, 46-52." [PMID:24399684, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044356 |
alpha-S1-casein antioxidant peptide (cow)
|
cow-aS1-CN(f95-105)
|
"An alpha-S1-casein derived peptide in cow that corresponds to amino acids 95-105 of UniProtKB:P02662, with the sequence HIQKEDVPSER. UniProtKB:P02662, 95-105." [PRO:DAN, UniProtKB:P02662]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044363 |
alpha-S1-casein antioxidant peptide sequence variant E99D (cow)
|
cow-aS1-CN(f95-105)/var:E99D
|
"An alpha-S1-casein derived peptide in cow that corresponds to amino acids 95-105 of UniProtKB:P02662 and has an Asp residue at the position equivalent to Glu-99 of the amino acid sequence represented by UniProtKB:P02662. This also corresponds to amino acids 95-105 of UniProtKB:B5B3R8, with the sequence HIQKDDVPSER. UniProtKB:P02662, 95-105, Glu-99, CHEBI:29958." [PRO:DAN, UniProtKB:B5B3R8]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036523 |
alpha-S2-casein derived peptide
|
aS2-CN (f)
|
"A casein derived peptide that is derived from alpha-S2-casein." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036524 |
beta-casein derived peptide
|
b-CN (f)
|
"A casein derived peptide that is derived from beta-casein." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044357 |
beta-casein peptide (f121-128) (cow)
|
cow-b-CN(f121-128)
|
"A beta-casein derived peptide in cow that corresponds to amino acids 121-128 of UniProtKB:P02666, with the sequence HKEMPFPK. UniProtKB:P02666, 121-128." [PMID:24399684, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044358 |
beta-casein peptide (f16-43) (cow)
|
cow-b-CN(f16-43)
|
"A beta-casein derived peptide in cow that corresponds to amino acids 16-43 of UniProtKB:P02666, with the sequence RELEELNVPGEIVESLSSSEESITRINK. UniProtKB:P02666, 16-43." [PMID:19563620, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044359 |
beta-casein antioxidant peptide (cow)
|
cow-b-CN(f113-120)
|
"A beta-casein derived peptide in cow that corresponds to amino acids 113-120 of UniProtKB:P02666, with the sequence VKEAMAPK. UniProtKB:P02666, 113-120." [PRO:DAN, UniProtKB:P02666]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044360 |
casoparan (cow)
|
cow-b-CN(f41-45)
|
"A beta-casein derived peptide in cow that corresponds to amino acids 41-45 of UniProtKB:P02666, with the sequence INKKI. UniProtKB:P02666, 41-45." [PRO:DAN, UniProtKB:P02666]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044361 |
casohypotensin (cow)
|
cow-b-CN(f129-136)
|
"A beta-casein derived peptide in cow that corresponds to amino acids 129-136 of UniProtKB:P02666, with the sequence YPVEPFTE. UniProtKB:P02666, 129-136." [PRO:DAN, UniProtKB:P02666]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044362 |
gamma-1-casein (cow)
|
cow-b-CN(f44-224)
|
"A beta-casein derived peptide in cow that corresponds to amino acids 44-224 of UniProtKB:P02666. UniProtKB:P02666, 44-224." [PMID:19563620, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044364 |
beta-casein peptide (f121-128) (Bos mutus)
|
yak-CN(f121-128)
|
"A beta-casein derived peptide in Bos mutus that corresponds to amino acids 121-128 of UniProtKB:L8I8G5, with the sequence HKEMPFPK. UniProtKB:L8I8G5, 121-128." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044365 |
beta-casein peptide (f16-43) (Bos mutus)
|
yak-CN(f16-43)
|
"A beta-casein derived peptide in Bos mutus that corresponds to amino acids 16-43 of UniProtKB:L8I8G5, with the sequence RELEELNVPGEIVESLSSSEESITRINK. UniProtKB:L8I8G5, 16-43." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044366 |
beta-casein antioxidant peptide (Bos mutus)
|
yak-CN(f113-120)
|
"A beta-casein derived peptide in Bos mutus that corresponds to amino acids 113-120 of UniProtKB:L8I8G5, with the sequence VKEAMAPK. UniProtKB:L8I8G5, 113-120." [PRO:DAN, UniProtKB:L8I8G5]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044367 |
casoparan (Bos mutus)
|
yak-CN(f41-45)
|
"A beta-casein derived peptide in Bos mutus that corresponds to amino acids 41-45 of UniProtKB:L8I8G5, with the sequence INKKI. UniProtKB:L8I8G5, 41-45." [PRO:DAN, UniProtKB:L8I8G5]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044368 |
casohypotensin (Bos mutus)
|
yak-CN(f129-136)
|
"A beta-casein derived peptide in Bos mutus that corresponds to amino acids 129-136 of UniProtKB:L8I8G5, with the sequence YPVEPFTE. UniProtKB:L8I8G5, 129-136." [PRO:DAN, UniProtKB:L8I8G5]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044369 |
gamma-1-casein (Bos mutus)
|
yak-CN(f44-224)
|
"A beta-casein derived peptide in Bos mutus that corresponds to amino acids 44-224 of UniProtKB:L8I8G5. UniProtKB:L8I8G5, 44-224." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000028990 |
sre1-type sterol regulatory element-binding protein 1 proteolytic cleavage product
|
sre1/ClvPrd
|
"An sre1-type sterol regulatory element-binding protein 1 that has been processed by proteolytic cleavage." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000028991 |
sre1-type sterol regulatory element-binding protein 1 cleaved 1
|
sre1/Clv:1
|
"An sre1-type sterol regulatory element-binding protein 1 that has been processed by proteolytic cleavage yielding the N-terminal domain. Example: UniProtKB:Q9UUD1, 1-440." [PMID:22017871, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000028992 |
Sre1N (Schizosaccharomyces pombe)
|
Spom-sre1/Clv:1
|
"An sre1-type sterol regulatory element-binding protein 1 cleaved 1 in Schizosaccharomyces pombe. This form is the N-terminal domain of the membrane protein sre1 that is cleaved off upon activation (e.g. by hypoxia). UniProtKB:Q9UUD1, 1-440." [PMID:22017871, PomBase:AL]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000029211 |
iron-regulated surface determinant protein A mature form
|
isdA/mature
|
"An iron-regulated surface determinant protein A, signal peptide removed form that has been processed by subsequent removal of the C-terminal propeptide." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000029212 |
iron-regulated surface determinant protein B mature form
|
isdB/mature
|
"An iron-regulated surface determinant protein B, signal peptide removed form that has been processed by subsequent removal of the C-terminal propeptide." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000029565 |
ubiquitin-like protein ISG15 proteolytic cleavage product
|
ISG15/ClvPrd
|
"A ubiquitin-like protein ISG15 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000029651 |
pro-neuregulin-1, membrane-bound isoform proteolytic cleavage product
|
NRG1/ClvPrd
|
"A pro-neuregulin-1, membrane-bound isoform that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000044821 |
neuregulin-1 type I-beta1a mature form (mouse)
|
mNRG1/iso:Ibeta1a/mature
|
"A neuregulin-1 type I-beta1a (mouse) that has been proteolytically processed by the Meltrin beta/ADAM19 metalloprotease to produce a soluble form consisting of the ectodomain." [PMID:11116142, PRO:KRC]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000044839 |
neuregulin-1 type I-beta4a mature form (mouse)
|
mNRG1/iso:Ibeta4a/mature
|
"A neuregulin-1 type I-beta4a (mouse) that has been proteolytically processed by the Meltrin beta/ADAM19 metalloprotease to produced a soluble form consisting of the ectodomain." [PMID:11116142, PRO:KRC]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000044843 |
neuregulin-1 intracellular domain (mouse)
|
mNRG1/Clv:intracellular
|
"A pro-neuregulin-1, membrane-bound isoform (mouse) that corresponds to the intracellular domain after proteolytic cleavage. Example: UniProtKB:Q6DR99, 326-700." [PMID:20610754, PMID:24083437, PRO:KRC]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000029684 |
putative phospholipase B-like 2 proteolytic cleavage product
|
PLBD2/ClvPrd
|
"A putative phospholipase B-like 2 that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000029707 |
GTPase HRas proteolytic cleavage product
|
HRAS/ClvPrd
|
"A GTPase HRas that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000035716 |
ubiquitin (RPS27A)
|
RPS27A/Clv:ubiq
|
"A ubiquitin-ribosomal protein eS31 fusion protein that has been processed by proteolytic cleavage. This form is the N-terminal region consisting of the Ubiquitin (Pfam:PF00240) domain. Example: UniProtKB:P62979, 1-76." [PMID:124018, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000035717 |
ubiquitin (RPS27A) (human)
|
hRPS27A/Clv:ubiq
|
"A ubiquitin (RPS27A) in human. UniProtKB:P62979, 1-76." [PMID:124018, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000059717 |
ubiquitin (RPS27A) (mouse)
|
mRPS27A/Clv:ubiq
|
"A ubiquitin (RPS27A) in mouse. UniProtKB:P62983, 1-76." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000035718 |
40S ribosomal protein S27a
|
RPS27A/Clv:RPS27a
|
"A ubiquitin-ribosomal protein eS31 fusion protein that has been processed by proteolytic cleavage. This form is the C-terminal region consisting of the Ribosomal_S27 (Pfam:PF01599) domain. Example: UniProtKB:P62979, 77-156." [PMID:9582194, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000035719 |
40S ribosomal protein S27a (human)
|
hRPS27A/Clv:RPS27a
|
"A 40S ribosomal protein S27a in human. UniProtKB:P62979, 77-156." [PMID:9582194, PRO:CNA]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000035720 |
ubiquitin (UBC)
|
UBC/Clv:ubiq
|
"A polyubiquitin-C that has been processed by proteolytic cleavage to produce a protein consisting of a Ubiquitin (Pfam:PF00240) domain. There are nine copies of ubiquitin in polyubiquitin C. Example: UniProtKB:P0CG48, (1-76) or (77-152) or (153-228) or (229-304) or (305-380) or (381-456) or (457-532) or (533-608) or (609-684)." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000035721 |
ubiquitin (UBC) (mouse)
|
mUBC/Clv:ubiq
|
"A ubiquitin (UBC) in mouse. UniProtKB:P0CG50, (1-76) or (77-152) or (153-228) or (229-304) or (305-380) or (381-456) or (457-532) or (533-608) or (609-684) or (685-734)." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000035722 |
ubiquitin (UBA52)
|
UBA52/Clv:ubiq
|
"A ubiquitin-ribosomal protein eL40 fusion protein that has been processed by proteolytic cleavage. This form is the N-terminal region consisting of the Ubiquitin (Pfam:PF00240) domain. Example: UniProtKB:P62987, 1-76." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000035723 |
ubiquitin (UBA52) (human)
|
hUBA52/Clv:ubiq
|
"A ubiquitin (UBA52) in human. UniProtKB:P62987, 1-76." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000060216 |
ubiquitin (UBA52) (mouse)
|
mUBA52/Clv:ubiq
|
"A ubiquitin (UBA52) in mouse. UniProtKB:P62984, 1-76." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000035724 |
60S ribosomal protein L40
|
UBA52/Clv:RPL40
|
"A ubiquitin-ribosomal protein eL40 fusion protein that has been processed by proteolytic cleavage to yield the C-terminal region consisting of the Ribosomal_L40e (Pfam:PF01020) domain. Example: UniProtKB:P62987, 77-128." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000035725 |
60S ribosomal protein L40 (human)
|
hUBA52/Clv:RPL40
|
"A 60S ribosomal protein L40 in human. UniProtKB:P62987, 77-128." [PRO:CNA]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000035726 |
ubiquitin (UBB)
|
UBB/Clv:ubiq
|
"A polyubiquitin-B that has been processed by proteolytic cleavage to produce a protein consisting of a Ubiquitin (Pfam:PF00240) domain. There are three copies of ubiquitin in polyubiquitin B. Example: UniProtKB:P0CG47, (1-76) or (77-152) or (153-228)." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000035727 |
ubiquitin (UBB) (human)
|
hUBB/Clv:ubiq
|
"A ubiquitin (UBB) in human. UniProtKB:P0CG47, (1-76) or (77-152) or (153-228)." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000060217 |
ubiquitin (UBB) (mouse)
|
mUBB/Clv:ubiq
|
"A ubiquitin (UBB) in mouse. UniProtKB:P0CG49, (1-76) or (77-152) or (153-228)." [PRO:CNA]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
union
|
|
PR:000035728 |
ubiquitin
|
Ubiq
|
"A proteolytic cleavage product that gives rise to a protein that corresponds to the stand-alone version of the Ubiquitin (Pfam:PF00240) domain. Example: UniProtKB:P0CG48, 1-76." [Pfam:PF00240]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000035716 |
ubiquitin (RPS27A)
|
RPS27A/Clv:ubiq
|
"A ubiquitin-ribosomal protein eS31 fusion protein that has been processed by proteolytic cleavage. This form is the N-terminal region consisting of the Ubiquitin (Pfam:PF00240) domain. Example: UniProtKB:P62979, 1-76." [PMID:124018, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000035717 |
ubiquitin (RPS27A) (human)
|
hRPS27A/Clv:ubiq
|
"A ubiquitin (RPS27A) in human. UniProtKB:P62979, 1-76." [PMID:124018, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000059717 |
ubiquitin (RPS27A) (mouse)
|
mRPS27A/Clv:ubiq
|
"A ubiquitin (RPS27A) in mouse. UniProtKB:P62983, 1-76." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000035720 |
ubiquitin (UBC)
|
UBC/Clv:ubiq
|
"A polyubiquitin-C that has been processed by proteolytic cleavage to produce a protein consisting of a Ubiquitin (Pfam:PF00240) domain. There are nine copies of ubiquitin in polyubiquitin C. Example: UniProtKB:P0CG48, (1-76) or (77-152) or (153-228) or (229-304) or (305-380) or (381-456) or (457-532) or (533-608) or (609-684)." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000035721 |
ubiquitin (UBC) (mouse)
|
mUBC/Clv:ubiq
|
"A ubiquitin (UBC) in mouse. UniProtKB:P0CG50, (1-76) or (77-152) or (153-228) or (229-304) or (305-380) or (381-456) or (457-532) or (533-608) or (609-684) or (685-734)." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000035722 |
ubiquitin (UBA52)
|
UBA52/Clv:ubiq
|
"A ubiquitin-ribosomal protein eL40 fusion protein that has been processed by proteolytic cleavage. This form is the N-terminal region consisting of the Ubiquitin (Pfam:PF00240) domain. Example: UniProtKB:P62987, 1-76." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000035723 |
ubiquitin (UBA52) (human)
|
hUBA52/Clv:ubiq
|
"A ubiquitin (UBA52) in human. UniProtKB:P62987, 1-76." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000060216 |
ubiquitin (UBA52) (mouse)
|
mUBA52/Clv:ubiq
|
"A ubiquitin (UBA52) in mouse. UniProtKB:P62984, 1-76." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000035726 |
ubiquitin (UBB)
|
UBB/Clv:ubiq
|
"A polyubiquitin-B that has been processed by proteolytic cleavage to produce a protein consisting of a Ubiquitin (Pfam:PF00240) domain. There are three copies of ubiquitin in polyubiquitin B. Example: UniProtKB:P0CG47, (1-76) or (77-152) or (153-228)." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000035727 |
ubiquitin (UBB) (human)
|
hUBB/Clv:ubiq
|
"A ubiquitin (UBB) in human. UniProtKB:P0CG47, (1-76) or (77-152) or (153-228)." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000060217 |
ubiquitin (UBB) (mouse)
|
mUBB/Clv:ubiq
|
"A ubiquitin (UBB) in mouse. UniProtKB:P0CG49, (1-76) or (77-152) or (153-228)." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
polymer
|
|
PR:000050235 |
polyubiquitin
|
polyUbiq
|
"A ubiquitin that is a polymer formed through ubiquitin-ubiquitin conjugation. Example: UniProtKB:P0CG47, 1-76, MOD:01148." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
polymer
|
|
PR:000035731 |
K63-polyubiquitin
|
K63polyUbiq
|
"A polyubiquitin that is a polymer formed through ubiquitin-ubiquitin conjugation via Lys-63." [PMID:15556404]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-polymer
|
|
PR:000035732 |
K63-polyubiquitin (human)
|
hK63polyUbiq
|
"A K63-polyubiquitin in human." [Reactome:R-HSA-450152, Reactome:R-HSA-5682839, Reactome:R-HSA-6782513]
|
|
Yes |
|
|
|
|
| | | | | | | | | | |
| | | |
organism-polymer
|
|
PR:000036039 |
K63-polyubiquitin (mouse)
|
mK63polyUbiq
|
"A K63-polyubiquitin in mouse." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000049734 |
K63-diubiquitin
|
K63diUbiq
|
"A polyubiquitin that is a dimer formed through ubiquitin-ubiquitin conjugation via Lys-63." [PMID:27151298]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-polymer
|
|
PR:000050248 |
polyubiquitin (human)
|
hpolyUbiq
|
"A polyubiquitin in human. Example: UniProtKB:P0CG47, 1-76, MOD:01148." [PRO:DAN, Reactome:R-HSA-5689096, Reactome:R-HSA-6782682, Reactome:R-HSA-6783021]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-polymer
|
|
PR:000035732 |
K63-polyubiquitin (human)
|
hK63polyUbiq
|
"A K63-polyubiquitin in human." [Reactome:R-HSA-450152, Reactome:R-HSA-5682839, Reactome:R-HSA-6782513]
|
|
Yes |
|
|
|
|
| | | | | | | | | | |
| | | |
organism-polymer
|
|
PR:000050237 |
K48-polyubiquitin (human)
|
hK48polyUbiq
|
"A K48-polyubiquitin in human. Example: UniProtKB:P0CG47, 1-76, Lys-48, MOD:01148." [PRO:DAN, Reactome:R-HSA-912740]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-polymer
|
|
PR:000050239 |
K6-polyubiquitin (human)
|
hK6polyUbiq
|
"A K6-polyubiquitin in human. Example: UniProtKB:P0CG47, 1-76, Lys-6, MOD:01148." [PRO:DAN, Reactome:R-HSA-5689106]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-polymer
|
|
PR:000050241 |
K11-polyubiquitin (human)
|
hK11polyUbiq
|
"A K11-polyubiquitin in human. Example: UniProtKB:P0CG47, 1-76, Lys-11, MOD:01148." [PRO:DAN, Reactome:R-HSA-3095921]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-polymer
|
|
PR:000050243 |
K27-polyubiquitin (human)
|
hK27polyUbiq
|
"A K27-polyubiquitin in human. Example: UniProtKB:P0CG47, 1-76, Lys-27, MOD:01148." [PRO:DAN, Reactome:R-HSA-5689212]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-polymer
|
|
PR:000050245 |
K29-polyubiquitin (human)
|
hK29polyUbiq
|
"A K29-polyubiquitin in human. Example: UniProtKB:P0CG47, 1-76, Lys-29, MOD:01148." [PRO:DAN, Reactome:R-HSA-5689192]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-polymer
|
|
PR:000050247 |
K33-polyubiquitin (human)
|
hK33polyUbiq
|
"A K33-polyubiquitin in human. Example: UniProtKB:P0CG47, 1-76, Lys-33, MOD:01148." [PRO:DAN, Reactome:R-HSA-5689142]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
union
|
|
PR:000060230 |
K48- or K63-linked polyubiquitin (human)
|
h[K48/K63]-polyUbiq
|
"A polyubiquitin (human) that is either K48-linked or K63-linked." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
| |
organism-polymer
|
|
PR:000035732 |
K63-polyubiquitin (human)
|
hK63polyUbiq
|
"A K63-polyubiquitin in human." [Reactome:R-HSA-450152, Reactome:R-HSA-5682839, Reactome:R-HSA-6782513]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
| |
organism-polymer
|
|
PR:000050237 |
K48-polyubiquitin (human)
|
hK48polyUbiq
|
"A K48-polyubiquitin in human. Example: UniProtKB:P0CG47, 1-76, Lys-48, MOD:01148." [PRO:DAN, Reactome:R-HSA-912740]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
polymer
|
|
PR:000050236 |
K48-polyubiquitin
|
K48polyUbiq
|
"A polyubiquitin that is a polymer formed through ubiquitin-ubiquitin conjugation via Lys-48. Example: UniProtKB:P0CG47, 1-76, Lys-48, MOD:01148." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-polymer
|
|
PR:000050237 |
K48-polyubiquitin (human)
|
hK48polyUbiq
|
"A K48-polyubiquitin in human. Example: UniProtKB:P0CG47, 1-76, Lys-48, MOD:01148." [PRO:DAN, Reactome:R-HSA-912740]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
polymer
|
|
PR:000050238 |
K6-polyubiquitin
|
K6polyUbiq
|
"A polyubiquitin that is a polymer formed through ubiquitin-ubiquitin conjugation via Lys-6. Example: UniProtKB:P0CG47, 1-76, Lys-6, MOD:01148." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-polymer
|
|
PR:000050239 |
K6-polyubiquitin (human)
|
hK6polyUbiq
|
"A K6-polyubiquitin in human. Example: UniProtKB:P0CG47, 1-76, Lys-6, MOD:01148." [PRO:DAN, Reactome:R-HSA-5689106]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
polymer
|
|
PR:000050240 |
K11-polyubiquitin
|
K11polyUbiq
|
"A polyubiquitin that is a polymer formed through ubiquitin-ubiquitin conjugation via Lys-11. Example: UniProtKB:P0CG47, 1-76, Lys-11, MOD:01148." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-polymer
|
|
PR:000050241 |
K11-polyubiquitin (human)
|
hK11polyUbiq
|
"A K11-polyubiquitin in human. Example: UniProtKB:P0CG47, 1-76, Lys-11, MOD:01148." [PRO:DAN, Reactome:R-HSA-3095921]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
polymer
|
|
PR:000050242 |
K27-polyubiquitin
|
K27polyUbiq
|
"A polyubiquitin that is a polymer formed through ubiquitin-ubiquitin conjugation via Lys-27. Example: UniProtKB:P0CG47, 1-76, Lys-27, MOD:01148." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-polymer
|
|
PR:000050243 |
K27-polyubiquitin (human)
|
hK27polyUbiq
|
"A K27-polyubiquitin in human. Example: UniProtKB:P0CG47, 1-76, Lys-27, MOD:01148." [PRO:DAN, Reactome:R-HSA-5689212]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
polymer
|
|
PR:000050244 |
K29-polyubiquitin
|
K29polyUbiq
|
"A polyubiquitin that is a polymer formed through ubiquitin-ubiquitin conjugation via Lys-29. Example: UniProtKB:P0CG47, 1-76, Lys-29, MOD:01148." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-polymer
|
|
PR:000050245 |
K29-polyubiquitin (human)
|
hK29polyUbiq
|
"A K29-polyubiquitin in human. Example: UniProtKB:P0CG47, 1-76, Lys-29, MOD:01148." [PRO:DAN, Reactome:R-HSA-5689192]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
polymer
|
|
PR:000050246 |
K33-polyubiquitin
|
K33polyUbiq
|
"A polyubiquitin that is a polymer formed through ubiquitin-ubiquitin conjugation via Lys-33. Example: UniProtKB:P0CG47, 1-76, Lys-33, MOD:01148." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-polymer
|
|
PR:000050247 |
K33-polyubiquitin (human)
|
hK33polyUbiq
|
"A K33-polyubiquitin in human. Example: UniProtKB:P0CG47, 1-76, Lys-33, MOD:01148." [PRO:DAN, Reactome:R-HSA-5689142]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000050249 |
ubiquitin (human)
|
hUbiq
|
"A ubiquitin in human. Example: UniProtKB:P0CG47, 1-76." [PRO:DAN, Reactome:R-HSA-113595]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-polymer
|
|
PR:000050248 |
polyubiquitin (human)
|
hpolyUbiq
|
"A polyubiquitin in human. Example: UniProtKB:P0CG47, 1-76, MOD:01148." [PRO:DAN, Reactome:R-HSA-5689096, Reactome:R-HSA-6782682, Reactome:R-HSA-6783021]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-polymer
|
|
PR:000035732 |
K63-polyubiquitin (human)
|
hK63polyUbiq
|
"A K63-polyubiquitin in human." [Reactome:R-HSA-450152, Reactome:R-HSA-5682839, Reactome:R-HSA-6782513]
|
|
Yes |
|
|
|
|
| | | | | | | | | | |
| | | |
organism-polymer
|
|
PR:000050237 |
K48-polyubiquitin (human)
|
hK48polyUbiq
|
"A K48-polyubiquitin in human. Example: UniProtKB:P0CG47, 1-76, Lys-48, MOD:01148." [PRO:DAN, Reactome:R-HSA-912740]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-polymer
|
|
PR:000050239 |
K6-polyubiquitin (human)
|
hK6polyUbiq
|
"A K6-polyubiquitin in human. Example: UniProtKB:P0CG47, 1-76, Lys-6, MOD:01148." [PRO:DAN, Reactome:R-HSA-5689106]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-polymer
|
|
PR:000050241 |
K11-polyubiquitin (human)
|
hK11polyUbiq
|
"A K11-polyubiquitin in human. Example: UniProtKB:P0CG47, 1-76, Lys-11, MOD:01148." [PRO:DAN, Reactome:R-HSA-3095921]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-polymer
|
|
PR:000050243 |
K27-polyubiquitin (human)
|
hK27polyUbiq
|
"A K27-polyubiquitin in human. Example: UniProtKB:P0CG47, 1-76, Lys-27, MOD:01148." [PRO:DAN, Reactome:R-HSA-5689212]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-polymer
|
|
PR:000050245 |
K29-polyubiquitin (human)
|
hK29polyUbiq
|
"A K29-polyubiquitin in human. Example: UniProtKB:P0CG47, 1-76, Lys-29, MOD:01148." [PRO:DAN, Reactome:R-HSA-5689192]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-polymer
|
|
PR:000050247 |
K33-polyubiquitin (human)
|
hK33polyUbiq
|
"A K33-polyubiquitin in human. Example: UniProtKB:P0CG47, 1-76, Lys-33, MOD:01148." [PRO:DAN, Reactome:R-HSA-5689142]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
union
|
|
PR:000060230 |
K48- or K63-linked polyubiquitin (human)
|
h[K48/K63]-polyUbiq
|
"A polyubiquitin (human) that is either K48-linked or K63-linked." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
| |
organism-polymer
|
|
PR:000035732 |
K63-polyubiquitin (human)
|
hK63polyUbiq
|
"A K63-polyubiquitin in human." [Reactome:R-HSA-450152, Reactome:R-HSA-5682839, Reactome:R-HSA-6782513]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
| |
organism-polymer
|
|
PR:000050237 |
K48-polyubiquitin (human)
|
hK48polyUbiq
|
"A K48-polyubiquitin in human. Example: UniProtKB:P0CG47, 1-76, Lys-48, MOD:01148." [PRO:DAN, Reactome:R-HSA-912740]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-polymer
|
|
PR:000060229 |
monoubiquitin (human)
|
hmonoUbiq
|
"A ubiquitin (human) that is a monomer." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000060218 |
ubiquitin (mouse)
|
mUbiq
|
"A ubiquitin in mouse. Example: UniProtKB:P0CG49, 1-76." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-polymer
|
|
PR:000036039 |
K63-polyubiquitin (mouse)
|
mK63polyUbiq
|
"A K63-polyubiquitin in mouse." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
polymer
|
|
PR:000060228 |
monoubiquitin
|
monoUbiq
|
"A ubiquitin that is a monomer." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000035906 |
serine/threonine-protein kinase 3 36kDa subunit
|
STK3/Clv:36kDa
|
"A serine/threonine-protein kinase 3 that has been phosphorylated on the residue at the position equivalent to Thr-180 of the amino acid sequence represented by UniProtKB:Q13188 or a 1:1 ortholog thereof, and that consists of the N-terminal portion after cleavage by caspase. Example: UniProtKB:Q13188, 1-322, Thr-180, MOD:00047." [PMID:11278283, PRO:DAN, Reactome:R-HSA-2028696]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000035907 |
serine/threonine-protein kinase 3 36kDa subunit (human)
|
hSTK3/Clv:36kDa
|
"A serine/threonine-protein kinase 3 36kDa subunit in human. Example: UniProtKB:Q13188-1, 1-322, Thr-180, MOD:00047." [PMID:11278283, Reactome:R-HSA-2028696]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000035908 |
serine/threonine-protein kinase 4 37kDa subunit
|
STK4/Clv:37kDa
|
"A serine/threonine-protein kinase 4 that has been processed by proteolytic cleavage and phosphorylated at a residue equivalent to Thr-183 of the amino acid sequence represented by UniProtKB:Q13043. Example: UniProtKB:Q13043, 1-326, Thr-183, MOD:00047." [PMID:11278283, PMID:9545236, PRO:DAN, Reactome:R-HSA-2028682]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000035909 |
serine/threonine-protein kinase 4 37kDa subunit (human)
|
hSTK4/Clv:37kDa
|
"A serine/threonine-protein kinase 4 37kDa subunit in human. Example: UniProtKB:Q13043-1, 1-326, Thr-183, MOD:00047." [PMID:11278283, PMID:9545236, Reactome:R-HSA-2028682]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000036445 |
HIV-type integrase
|
HIVintegrase
|
"A lentivirus-type gag-pol polyprotein that has been processed by proteolytic cleavage to yield the standalone integrase domain. Example: UniProtKB:P04585, 1148-1435." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000036446 |
HIV-type p15
|
HIVp15
|
"A lentivirus-type gag-pol polyprotein that has been processed by proteolytic cleavage to yield the standalone p15 domain. Example: UniProtKB:P04585, 1028-1147." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000036447 |
HIV-type reverse transcriptase/ribonuclease H
|
HIVrt+rnaseH
|
"A lentivirus-type gag-pol polyprotein that has been processed by proteolytic cleavage to yield a standalone protein containing the Reverse transcriptase (Pfam:PF00078) and the RNase H (Pfam:00075) domains. Example: UniProtKB:P04585, 588-1147." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000036450 |
hepatitis C-type RNA-directed RNA polymerase
|
RdRP
|
"A hepatitis C-type genome polyprotein that has been processed by proteolytic cleavage to yield a standalone Viral RNA dependent RNA polymerase (Pfam:PF00998) domain. Example: UniProtKB:P27958, 2421-3011." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000036818 |
dengue virus genome polyprotein proteolytic cleavage product
|
DenV-polyprot/ClvPrd
|
"A dengue virus genome polyprotein, N-glycosylated form that has been processed by proteolytic cleavage." [PRO:DAN, PRO:ES]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036819 |
capsid protein C
|
DenV-C
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a structural protein processed at the N-terminal end of the dengue virus RNA genome." [PRO:ES]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036820 |
pr protein
|
DenV-pr
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from its precursor form prM protein on the surface of immature dengue virus by host protease during virion maturation." [PMID:23559476, PRO:ES]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036821 |
M protein
|
DenV-M
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from its precursor prM and localizes to the endoplasmic reticulum and forms oligomers." [PMID:22569259, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044757 |
M protein (Dengue virus 2 Thailand/16681/84)
|
M (DEN26)
|
"An M protein in Dengue virus 2 Thailand/16681/84. UniProtKB:P29990, 206-280." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036822 |
E protein
|
DenV-E
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a structural protein containing two alpha-helices (EH1 and EH2) at the C-terminus and two transmembrane domains (ET1 and ET2) of the dengue virus RNA genome. It contains two N-linked glycosylation sites, at Asn-67 and Asn-153. Example: UniProtKB:P29990, 281-775, Asn-347/Asn-433, MOD:00160." [PMID:17459925, PMID:23300717, PRO:DAN, PRO:ES]
|
|
Yes |
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036824 |
NS1
|
DenV-NS1
|
"A dengue virus genome polyprotein proteolytic cleavage product that is the N-terminal most non-structural protein within the dengue virus genome polyprotein. Example: UniProtKB:P29990, 776-1127, Asn-905/Asn-982, MOD:00160." [PRO:ES]
|
|
Yes |
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000037000 |
NS1, with complex sugar attached
|
DenV-NS1/sugar(+)
|
"An NS1 that has had the glycan attached to the Asn-130 site modified to a complex sugar." [PRO:ES]
|
|
Yes |
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000037001 |
NS1, without complex sugar attached
|
DenV-NS1/sugar(-)
|
"An NS1 that has not had the glycan attached to the Asn-130 site modified to a complex sugar." [PRO:ES]
|
|
Yes |
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044758 |
NS1 (Dengue virus 2 Thailand/NGS-C/1944)
|
NS1 (DEN2N)
|
"An NS1 in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 776-1127, Asn-905/Asn-982, MOD:00160." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036825 |
NS2A
|
DenV-NS2A
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a non-structural protein encoded by the dengue virus RNA genome and a component of the viral replication complex." [PMID:23408612, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044759 |
NS2A (Dengue virus 2 Thailand/NGS-C/1944)
|
NS2A (DEN2N)
|
"An NS2A in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 1128-1345." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044760 |
NS2A (Dengue virus 2 Thailand/16681/84)
|
NS2A (DEN26)
|
"An NS2A in Dengue virus 2 Thailand/16681/84. UniProtKB:P29990, 1128-1345." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036826 |
NS2A-alpha
|
DenV-NS2Aalpha
|
"A dengue virus genome polyprotein proteolytic cleavage product that consists of 188 amino acids at the N-terminal end of NS2A." [PMID:23408612, PRO:ES]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036827 |
NS2B
|
DenV-NS2B
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a non-structural protein encoded by the dengue virus RNA genome containing a conserved hydrophilic domain necessary for protease activity in cleavage of the dengue virus genome polyprotein, N-glycosylated form." [PMID:10744671, PRO:ES]
|
|
Yes |
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044761 |
NS2B (Dengue virus 2 Thailand/NGS-C/1944)
|
NS2B (DEN2N)
|
"An NS2B in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 1346-1475." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036828 |
NS3
|
DenV-NS3
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a non-structural, multifunctional protein encoded by the dengue virus RNA genome with a serine protease domain." [PMID:10744671, PRO:ES]
|
|
Yes |
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044762 |
NS3 (Dengue virus 2 Thailand/NGS-C/1944)
|
NS3 (DEN2N)
|
"An NS3 in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 1476-2093." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036830 |
NS4A
|
DenV-NS4A
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a highly hydrophobic non-structural protein encoded by the dengue virus RNA genome that associates with membranes via 4 internal hydrophobic regions which are all able to mediate membrane targeting of a cytosolic reporter protein." [PMID:17276984, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044763 |
NS4A (Dengue virus 2 Thailand/NGS-C/1944)
|
NS4A (DEN2N)
|
"An NS4A in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 2094-2220." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044764 |
NS4A (Dengue virus 2 Thailand/16681/84)
|
NS4A (DEN26)
|
"An NS4A in Dengue virus 2 Thailand/16681/84. UniProtKB:P29990, 2094-2220." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036831 |
2K
|
DenV-2K
|
"A dengue virus genome polyprotein proteolytic cleavage product that is the C-terminal region of NS4A serving as a signal sequence for the translocation of the adjacent NS4B into the endoplasmic reticulum (ER) lumen." [PMID:17276984, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044765 |
2K (Dengue virus 2 Thailand/NGS-C/1944)
|
2K (DEN2N)
|
"A 2K in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 2221-2243." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036832 |
precursor of NS4B
|
DenV-preNS4B
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a precursor of NS4B." [PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036833 |
NS4B
|
DenV-NS4B
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a highly hydrophobic transmembrane non-structural protein encoded by the dengue virus RNA genome which is, in part, responsible for the membrane arrangements leading to the formation of the viral replication complex." [PMID:22772157, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000044766 |
NS4B (Dengue virus 2 Thailand/NGS-C/1944)
|
NS4B (DEN2N)
|
"An NS4B in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 2244-2491." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000044767 |
NS4B (Dengue virus 2 Thailand/16681/84)
|
NS4B (DEN26)
|
"An NS4B in Dengue virus 2 Thailand/16681/84. UniProtKB:P29990, 2244-2491." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036841 |
NS4AB
|
DenV-NS4AB
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from NS4A-NS4B-NS5 by the two-component proteinase NS2B-NS3 at the NS4B-NS5 sites consisting of NS4A, 2K, and NS4B." [PMID:1531368, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000036830 |
NS4A
|
DenV-NS4A
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a highly hydrophobic non-structural protein encoded by the dengue virus RNA genome that associates with membranes via 4 internal hydrophobic regions which are all able to mediate membrane targeting of a cytosolic reporter protein." [PMID:17276984, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
| |
organism-modification
|
|
PR:000044763 |
NS4A (Dengue virus 2 Thailand/NGS-C/1944)
|
NS4A (DEN2N)
|
"An NS4A in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 2094-2220." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | | | | | |
| |
organism-modification
|
|
PR:000044764 |
NS4A (Dengue virus 2 Thailand/16681/84)
|
NS4A (DEN26)
|
"An NS4A in Dengue virus 2 Thailand/16681/84. UniProtKB:P29990, 2094-2220." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000036842 |
2KNS4B
|
DenV-2KNS4B
|
"A dengue virus genome polyprotein proteolytic cleavage product that assists in the processing of NS4AB consisting of 2K and NS4B." [PMID:21810535, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
| |
modification
|
|
PR:000036831 |
2K
|
DenV-2K
|
"A dengue virus genome polyprotein proteolytic cleavage product that is the C-terminal region of NS4A serving as a signal sequence for the translocation of the adjacent NS4B into the endoplasmic reticulum (ER) lumen." [PMID:17276984, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | | | | | |
organism-modification
|
|
PR:000044765 |
2K (Dengue virus 2 Thailand/NGS-C/1944)
|
2K (DEN2N)
|
"A 2K in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 2221-2243." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036843 |
NS4B-NS5
|
DenV-NS4B5
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from NS4A-NS4B-NS5 at the NS4A-NS4B site consisting of NS4B and NS5, which is believed to be mediated by a host cell signal peptidase." [PMID:1531368, PRO:ES]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036833 |
NS4B
|
DenV-NS4B
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a highly hydrophobic transmembrane non-structural protein encoded by the dengue virus RNA genome which is, in part, responsible for the membrane arrangements leading to the formation of the viral replication complex." [PMID:22772157, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044766 |
NS4B (Dengue virus 2 Thailand/NGS-C/1944)
|
NS4B (DEN2N)
|
"An NS4B in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 2244-2491." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044767 |
NS4B (Dengue virus 2 Thailand/16681/84)
|
NS4B (DEN26)
|
"An NS4B in Dengue virus 2 Thailand/16681/84. UniProtKB:P29990, 2244-2491." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036834 |
precursor of NS5
|
DenV-preNS5
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a precursor of NS5." [PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036835 |
NS5
|
DenV-NS5
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a large non-structural protein encoded by the dengue virus RNA genome containing a methyltransferase (MTase) domain and an RNA dependent RNA polymerase (POL) domain that possesses a capping enzyme." [PMID:22022449, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000044768 |
NS5 (Dengue virus 2 Thailand/NGS-C/1944)
|
NS5 (DEN2N)
|
"An NS5 in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 2492-3391." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036840 |
NS4A-NS4B-NS5
|
DenV-NS4AB5
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from NS345 by the two-component proteinase NS2B-NS3 at the NS3-NS4A site consisting of NS4A, 2K, NS4B, and NS5." [PMID:1531368, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000036841 |
NS4AB
|
DenV-NS4AB
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from NS4A-NS4B-NS5 by the two-component proteinase NS2B-NS3 at the NS4B-NS5 sites consisting of NS4A, 2K, and NS4B." [PMID:1531368, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
| |
modification
|
|
PR:000036830 |
NS4A
|
DenV-NS4A
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a highly hydrophobic non-structural protein encoded by the dengue virus RNA genome that associates with membranes via 4 internal hydrophobic regions which are all able to mediate membrane targeting of a cytosolic reporter protein." [PMID:17276984, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | | | | | |
organism-modification
|
|
PR:000044763 |
NS4A (Dengue virus 2 Thailand/NGS-C/1944)
|
NS4A (DEN2N)
|
"An NS4A in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 2094-2220." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | | | | | | | |
organism-modification
|
|
PR:000044764 |
NS4A (Dengue virus 2 Thailand/16681/84)
|
NS4A (DEN26)
|
"An NS4A in Dengue virus 2 Thailand/16681/84. UniProtKB:P29990, 2094-2220." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | | | | | |
| |
modification
|
|
PR:000036842 |
2KNS4B
|
DenV-2KNS4B
|
"A dengue virus genome polyprotein proteolytic cleavage product that assists in the processing of NS4AB consisting of 2K and NS4B." [PMID:21810535, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | | | | | |
modification
|
|
PR:000036831 |
2K
|
DenV-2K
|
"A dengue virus genome polyprotein proteolytic cleavage product that is the C-terminal region of NS4A serving as a signal sequence for the translocation of the adjacent NS4B into the endoplasmic reticulum (ER) lumen." [PMID:17276984, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | | | | | | | |
organism-modification
|
|
PR:000044765 |
2K (Dengue virus 2 Thailand/NGS-C/1944)
|
2K (DEN2N)
|
"A 2K in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 2221-2243." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000036843 |
NS4B-NS5
|
DenV-NS4B5
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from NS4A-NS4B-NS5 at the NS4A-NS4B site consisting of NS4B and NS5, which is believed to be mediated by a host cell signal peptidase." [PMID:1531368, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036843 |
NS4B-NS5
|
DenV-NS4B5
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from NS4A-NS4B-NS5 at the NS4A-NS4B site consisting of NS4B and NS5, which is believed to be mediated by a host cell signal peptidase." [PMID:1531368, PRO:ES]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036835 |
NS5
|
DenV-NS5
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a large non-structural protein encoded by the dengue virus RNA genome containing a methyltransferase (MTase) domain and an RNA dependent RNA polymerase (POL) domain that possesses a capping enzyme." [PMID:22022449, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044768 |
NS5 (Dengue virus 2 Thailand/NGS-C/1944)
|
NS5 (DEN2N)
|
"An NS5 in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 2492-3391." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036836 |
C-prM
|
DenV-CprM
|
"A dengue virus genome polyprotein proteolytic cleavage product that is derived from dengue virus genome polyprotein, glycosylated form and that consists only of the C (capsid) protein and the prM (pre-membrane) structural proteins of the dengue virus genome polyprotein. It has a single N-linked glycosylation site at position Asn-69. Example: UniProtKB:P29990, 1-280, Asn-183, MOD:00160." [PMID:14963133, PRO:DAN, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036819 |
capsid protein C
|
DenV-C
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a structural protein processed at the N-terminal end of the dengue virus RNA genome." [PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036837 |
prM
|
DenV-prM
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a product of the cleavage of C-prM by host signalase. It has a single N-linked glycosylation site at position Asn-69. Example: UniProtKB:P29990, 115-280, Asn-183, MOD:00160." [PMID:14963133, PRO:DAN, PRO:ES]
|
|
Yes |
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000036820 |
pr protein
|
DenV-pr
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from its precursor form prM protein on the surface of immature dengue virus by host protease during virion maturation." [PMID:23559476, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000036821 |
M protein
|
DenV-M
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from its precursor prM and localizes to the endoplasmic reticulum and forms oligomers." [PMID:22569259, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
| |
organism-modification
|
|
PR:000044757 |
M protein (Dengue virus 2 Thailand/16681/84)
|
M (DEN26)
|
"An M protein in Dengue virus 2 Thailand/16681/84. UniProtKB:P29990, 206-280." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000044769 |
prM (Dengue virus 2 Thailand/16681/84)
|
prM (DEN26)
|
"A prM in Dengue virus 2 Thailand/16681/84. UniProtKB:P29990, 115-280, Asn-183, MOD:00160." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000044770 |
prM (Dengue virus 2 Thailand/NGS-C/1944)
|
prM (DEN2N)
|
"A prM in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 115-280, Asn-183, MOD:00160." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036837 |
prM
|
DenV-prM
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a product of the cleavage of C-prM by host signalase. It has a single N-linked glycosylation site at position Asn-69. Example: UniProtKB:P29990, 115-280, Asn-183, MOD:00160." [PMID:14963133, PRO:DAN, PRO:ES]
|
|
Yes |
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036820 |
pr protein
|
DenV-pr
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from its precursor form prM protein on the surface of immature dengue virus by host protease during virion maturation." [PMID:23559476, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036821 |
M protein
|
DenV-M
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from its precursor prM and localizes to the endoplasmic reticulum and forms oligomers." [PMID:22569259, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000044757 |
M protein (Dengue virus 2 Thailand/16681/84)
|
M (DEN26)
|
"An M protein in Dengue virus 2 Thailand/16681/84. UniProtKB:P29990, 206-280." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044769 |
prM (Dengue virus 2 Thailand/16681/84)
|
prM (DEN26)
|
"A prM in Dengue virus 2 Thailand/16681/84. UniProtKB:P29990, 115-280, Asn-183, MOD:00160." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000044770 |
prM (Dengue virus 2 Thailand/NGS-C/1944)
|
prM (DEN2N)
|
"A prM in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 115-280, Asn-183, MOD:00160." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036838 |
NS12345
|
DenV-NS12345
|
"A dengue virus genome polyprotein proteolytic cleavage product that is derived from dengue virus genome polyprotein, N-glycosylated form and that contains the entire non-structural region of the dengue virus genome polyprotein only and is responsible for directing viral genomic RNA replication, including synthesizing negative- and positive-strand RNAs and forming the viral RNA cap structure. It consists of NS1, NS2A, NS3, NS4A, 2K, NS4B, and NS5." [PMID:1433530, PMID:22022449, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036826 |
NS2A-alpha
|
DenV-NS2Aalpha
|
"A dengue virus genome polyprotein proteolytic cleavage product that consists of 188 amino acids at the N-terminal end of NS2A." [PMID:23408612, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036827 |
NS2B
|
DenV-NS2B
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a non-structural protein encoded by the dengue virus RNA genome containing a conserved hydrophilic domain necessary for protease activity in cleavage of the dengue virus genome polyprotein, N-glycosylated form." [PMID:10744671, PRO:ES]
|
|
Yes |
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000044761 |
NS2B (Dengue virus 2 Thailand/NGS-C/1944)
|
NS2B (DEN2N)
|
"An NS2B in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 1346-1475." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036839 |
NS345
|
DenV-NS345
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from NS12345 by the two-component proteinase NS2B-NS3 at the NS2B-NS3 site consisting of NS3, NS4A, NS4B, and NS5." [PMID:1433530, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000036828 |
NS3
|
DenV-NS3
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a non-structural, multifunctional protein encoded by the dengue virus RNA genome with a serine protease domain." [PMID:10744671, PRO:ES]
|
|
Yes |
|
|
|
|
| | | | | | | | | | | | |
| |
organism-modification
|
|
PR:000044762 |
NS3 (Dengue virus 2 Thailand/NGS-C/1944)
|
NS3 (DEN2N)
|
"An NS3 in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 1476-2093." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000036840 |
NS4A-NS4B-NS5
|
DenV-NS4AB5
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from NS345 by the two-component proteinase NS2B-NS3 at the NS3-NS4A site consisting of NS4A, 2K, NS4B, and NS5." [PMID:1531368, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
| |
modification
|
|
PR:000036841 |
NS4AB
|
DenV-NS4AB
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from NS4A-NS4B-NS5 by the two-component proteinase NS2B-NS3 at the NS4B-NS5 sites consisting of NS4A, 2K, and NS4B." [PMID:1531368, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | | | | | |
modification
|
|
PR:000036830 |
NS4A
|
DenV-NS4A
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a highly hydrophobic non-structural protein encoded by the dengue virus RNA genome that associates with membranes via 4 internal hydrophobic regions which are all able to mediate membrane targeting of a cytosolic reporter protein." [PMID:17276984, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | | | | | | | |
organism-modification
|
|
PR:000044763 |
NS4A (Dengue virus 2 Thailand/NGS-C/1944)
|
NS4A (DEN2N)
|
"An NS4A in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 2094-2220." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | | | | | | | | | |
organism-modification
|
|
PR:000044764 |
NS4A (Dengue virus 2 Thailand/16681/84)
|
NS4A (DEN26)
|
"An NS4A in Dengue virus 2 Thailand/16681/84. UniProtKB:P29990, 2094-2220." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | | | | | | | |
modification
|
|
PR:000036842 |
2KNS4B
|
DenV-2KNS4B
|
"A dengue virus genome polyprotein proteolytic cleavage product that assists in the processing of NS4AB consisting of 2K and NS4B." [PMID:21810535, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | | | | | | | |
modification
|
|
PR:000036831 |
2K
|
DenV-2K
|
"A dengue virus genome polyprotein proteolytic cleavage product that is the C-terminal region of NS4A serving as a signal sequence for the translocation of the adjacent NS4B into the endoplasmic reticulum (ER) lumen." [PMID:17276984, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | | | | | | | | | |
organism-modification
|
|
PR:000044765 |
2K (Dengue virus 2 Thailand/NGS-C/1944)
|
2K (DEN2N)
|
"A 2K in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 2221-2243." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | | | | | |
| |
modification
|
|
PR:000036843 |
NS4B-NS5
|
DenV-NS4B5
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from NS4A-NS4B-NS5 at the NS4A-NS4B site consisting of NS4B and NS5, which is believed to be mediated by a host cell signal peptidase." [PMID:1531368, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036873 |
NS2B-NS3 polyprotein precursor
|
DenV-NS2B3
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from NS12345 by the two-component protease NS2B-NS3 at the NS2A-NS2B and NS3-NS4 sites and consists of NS2B and NS3." [PMID:10744671, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036998 |
NS1-NS2A
|
DenV-NS12A
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from NS12345 consisting of NS1 and NS2A. It includes two N-glycosylated residues at Asn-130 and Asn-207. Example: UniProtKB:P29990, 776-1345, Asn-905/Asn-982, MOD:00160." [PMID:15592895, PRO:DAN, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000036824 |
NS1
|
DenV-NS1
|
"A dengue virus genome polyprotein proteolytic cleavage product that is the N-terminal most non-structural protein within the dengue virus genome polyprotein. Example: UniProtKB:P29990, 776-1127, Asn-905/Asn-982, MOD:00160." [PRO:ES]
|
|
Yes |
|
|
|
|
| | | | | | | | | | | | |
| |
modification
|
|
PR:000037000 |
NS1, with complex sugar attached
|
DenV-NS1/sugar(+)
|
"An NS1 that has had the glycan attached to the Asn-130 site modified to a complex sugar." [PRO:ES]
|
|
Yes |
|
|
|
|
| | | | | | | | | | | | |
| |
modification
|
|
PR:000037001 |
NS1, without complex sugar attached
|
DenV-NS1/sugar(-)
|
"An NS1 that has not had the glycan attached to the Asn-130 site modified to a complex sugar." [PRO:ES]
|
|
Yes |
|
|
|
|
| | | | | | | | | | | | |
| |
organism-modification
|
|
PR:000044758 |
NS1 (Dengue virus 2 Thailand/NGS-C/1944)
|
NS1 (DEN2N)
|
"An NS1 in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 776-1127, Asn-905/Asn-982, MOD:00160." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000036825 |
NS2A
|
DenV-NS2A
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a non-structural protein encoded by the dengue virus RNA genome and a component of the viral replication complex." [PMID:23408612, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
| |
organism-modification
|
|
PR:000044759 |
NS2A (Dengue virus 2 Thailand/NGS-C/1944)
|
NS2A (DEN2N)
|
"An NS2A in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 1128-1345." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | | | | | |
| |
organism-modification
|
|
PR:000044760 |
NS2A (Dengue virus 2 Thailand/16681/84)
|
NS2A (DEN26)
|
"An NS2A in Dengue virus 2 Thailand/16681/84. UniProtKB:P29990, 1128-1345." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036839 |
NS345
|
DenV-NS345
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from NS12345 by the two-component proteinase NS2B-NS3 at the NS2B-NS3 site consisting of NS3, NS4A, NS4B, and NS5." [PMID:1433530, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036828 |
NS3
|
DenV-NS3
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a non-structural, multifunctional protein encoded by the dengue virus RNA genome with a serine protease domain." [PMID:10744671, PRO:ES]
|
|
Yes |
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000044762 |
NS3 (Dengue virus 2 Thailand/NGS-C/1944)
|
NS3 (DEN2N)
|
"An NS3 in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 1476-2093." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036840 |
NS4A-NS4B-NS5
|
DenV-NS4AB5
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from NS345 by the two-component proteinase NS2B-NS3 at the NS3-NS4A site consisting of NS4A, 2K, NS4B, and NS5." [PMID:1531368, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000036841 |
NS4AB
|
DenV-NS4AB
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from NS4A-NS4B-NS5 by the two-component proteinase NS2B-NS3 at the NS4B-NS5 sites consisting of NS4A, 2K, and NS4B." [PMID:1531368, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
| |
modification
|
|
PR:000036830 |
NS4A
|
DenV-NS4A
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a highly hydrophobic non-structural protein encoded by the dengue virus RNA genome that associates with membranes via 4 internal hydrophobic regions which are all able to mediate membrane targeting of a cytosolic reporter protein." [PMID:17276984, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | | | | | |
organism-modification
|
|
PR:000044763 |
NS4A (Dengue virus 2 Thailand/NGS-C/1944)
|
NS4A (DEN2N)
|
"An NS4A in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 2094-2220." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | | | | | | | |
organism-modification
|
|
PR:000044764 |
NS4A (Dengue virus 2 Thailand/16681/84)
|
NS4A (DEN26)
|
"An NS4A in Dengue virus 2 Thailand/16681/84. UniProtKB:P29990, 2094-2220." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | | | | | |
| |
modification
|
|
PR:000036842 |
2KNS4B
|
DenV-2KNS4B
|
"A dengue virus genome polyprotein proteolytic cleavage product that assists in the processing of NS4AB consisting of 2K and NS4B." [PMID:21810535, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | | | | | |
modification
|
|
PR:000036831 |
2K
|
DenV-2K
|
"A dengue virus genome polyprotein proteolytic cleavage product that is the C-terminal region of NS4A serving as a signal sequence for the translocation of the adjacent NS4B into the endoplasmic reticulum (ER) lumen." [PMID:17276984, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | | | | | | | |
organism-modification
|
|
PR:000044765 |
2K (Dengue virus 2 Thailand/NGS-C/1944)
|
2K (DEN2N)
|
"A 2K in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 2221-2243." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000036843 |
NS4B-NS5
|
DenV-NS4B5
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from NS4A-NS4B-NS5 at the NS4A-NS4B site consisting of NS4B and NS5, which is believed to be mediated by a host cell signal peptidase." [PMID:1531368, PRO:ES]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036840 |
NS4A-NS4B-NS5
|
DenV-NS4AB5
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from NS345 by the two-component proteinase NS2B-NS3 at the NS3-NS4A site consisting of NS4A, 2K, NS4B, and NS5." [PMID:1531368, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036841 |
NS4AB
|
DenV-NS4AB
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from NS4A-NS4B-NS5 by the two-component proteinase NS2B-NS3 at the NS4B-NS5 sites consisting of NS4A, 2K, and NS4B." [PMID:1531368, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000036830 |
NS4A
|
DenV-NS4A
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a highly hydrophobic non-structural protein encoded by the dengue virus RNA genome that associates with membranes via 4 internal hydrophobic regions which are all able to mediate membrane targeting of a cytosolic reporter protein." [PMID:17276984, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
| |
organism-modification
|
|
PR:000044763 |
NS4A (Dengue virus 2 Thailand/NGS-C/1944)
|
NS4A (DEN2N)
|
"An NS4A in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 2094-2220." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | | | | | |
| |
organism-modification
|
|
PR:000044764 |
NS4A (Dengue virus 2 Thailand/16681/84)
|
NS4A (DEN26)
|
"An NS4A in Dengue virus 2 Thailand/16681/84. UniProtKB:P29990, 2094-2220." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000036842 |
2KNS4B
|
DenV-2KNS4B
|
"A dengue virus genome polyprotein proteolytic cleavage product that assists in the processing of NS4AB consisting of 2K and NS4B." [PMID:21810535, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
| |
modification
|
|
PR:000036831 |
2K
|
DenV-2K
|
"A dengue virus genome polyprotein proteolytic cleavage product that is the C-terminal region of NS4A serving as a signal sequence for the translocation of the adjacent NS4B into the endoplasmic reticulum (ER) lumen." [PMID:17276984, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | | | | | |
organism-modification
|
|
PR:000044765 |
2K (Dengue virus 2 Thailand/NGS-C/1944)
|
2K (DEN2N)
|
"A 2K in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 2221-2243." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036843 |
NS4B-NS5
|
DenV-NS4B5
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from NS4A-NS4B-NS5 at the NS4A-NS4B site consisting of NS4B and NS5, which is believed to be mediated by a host cell signal peptidase." [PMID:1531368, PRO:ES]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036841 |
NS4AB
|
DenV-NS4AB
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from NS4A-NS4B-NS5 by the two-component proteinase NS2B-NS3 at the NS4B-NS5 sites consisting of NS4A, 2K, and NS4B." [PMID:1531368, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036830 |
NS4A
|
DenV-NS4A
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a highly hydrophobic non-structural protein encoded by the dengue virus RNA genome that associates with membranes via 4 internal hydrophobic regions which are all able to mediate membrane targeting of a cytosolic reporter protein." [PMID:17276984, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000044763 |
NS4A (Dengue virus 2 Thailand/NGS-C/1944)
|
NS4A (DEN2N)
|
"An NS4A in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 2094-2220." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000044764 |
NS4A (Dengue virus 2 Thailand/16681/84)
|
NS4A (DEN26)
|
"An NS4A in Dengue virus 2 Thailand/16681/84. UniProtKB:P29990, 2094-2220." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036842 |
2KNS4B
|
DenV-2KNS4B
|
"A dengue virus genome polyprotein proteolytic cleavage product that assists in the processing of NS4AB consisting of 2K and NS4B." [PMID:21810535, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000036831 |
2K
|
DenV-2K
|
"A dengue virus genome polyprotein proteolytic cleavage product that is the C-terminal region of NS4A serving as a signal sequence for the translocation of the adjacent NS4B into the endoplasmic reticulum (ER) lumen." [PMID:17276984, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
| |
organism-modification
|
|
PR:000044765 |
2K (Dengue virus 2 Thailand/NGS-C/1944)
|
2K (DEN2N)
|
"A 2K in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 2221-2243." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036842 |
2KNS4B
|
DenV-2KNS4B
|
"A dengue virus genome polyprotein proteolytic cleavage product that assists in the processing of NS4AB consisting of 2K and NS4B." [PMID:21810535, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036831 |
2K
|
DenV-2K
|
"A dengue virus genome polyprotein proteolytic cleavage product that is the C-terminal region of NS4A serving as a signal sequence for the translocation of the adjacent NS4B into the endoplasmic reticulum (ER) lumen." [PMID:17276984, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000044765 |
2K (Dengue virus 2 Thailand/NGS-C/1944)
|
2K (DEN2N)
|
"A 2K in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 2221-2243." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036843 |
NS4B-NS5
|
DenV-NS4B5
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from NS4A-NS4B-NS5 at the NS4A-NS4B site consisting of NS4B and NS5, which is believed to be mediated by a host cell signal peptidase." [PMID:1531368, PRO:ES]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036873 |
NS2B-NS3 polyprotein precursor
|
DenV-NS2B3
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from NS12345 by the two-component protease NS2B-NS3 at the NS2A-NS2B and NS3-NS4 sites and consists of NS2B and NS3." [PMID:10744671, PRO:ES]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036998 |
NS1-NS2A
|
DenV-NS12A
|
"A dengue virus genome polyprotein proteolytic cleavage product that is cleaved from NS12345 consisting of NS1 and NS2A. It includes two N-glycosylated residues at Asn-130 and Asn-207. Example: UniProtKB:P29990, 776-1345, Asn-905/Asn-982, MOD:00160." [PMID:15592895, PRO:DAN, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036824 |
NS1
|
DenV-NS1
|
"A dengue virus genome polyprotein proteolytic cleavage product that is the N-terminal most non-structural protein within the dengue virus genome polyprotein. Example: UniProtKB:P29990, 776-1127, Asn-905/Asn-982, MOD:00160." [PRO:ES]
|
|
Yes |
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000037000 |
NS1, with complex sugar attached
|
DenV-NS1/sugar(+)
|
"An NS1 that has had the glycan attached to the Asn-130 site modified to a complex sugar." [PRO:ES]
|
|
Yes |
|
|
|
|
| | | | | | | | | | |
| | | |
modification
|
|
PR:000037001 |
NS1, without complex sugar attached
|
DenV-NS1/sugar(-)
|
"An NS1 that has not had the glycan attached to the Asn-130 site modified to a complex sugar." [PRO:ES]
|
|
Yes |
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000044758 |
NS1 (Dengue virus 2 Thailand/NGS-C/1944)
|
NS1 (DEN2N)
|
"An NS1 in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 776-1127, Asn-905/Asn-982, MOD:00160." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| | | | | |
modification
|
|
PR:000036825 |
NS2A
|
DenV-NS2A
|
"A dengue virus genome polyprotein proteolytic cleavage product that is a non-structural protein encoded by the dengue virus RNA genome and a component of the viral replication complex." [PMID:23408612, PRO:ES]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000044759 |
NS2A (Dengue virus 2 Thailand/NGS-C/1944)
|
NS2A (DEN2N)
|
"An NS2A in Dengue virus 2 Thailand/NGS-C/1944. UniProtKB:P14340, 1128-1345." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | | | | | | | |
| | | |
organism-modification
|
|
PR:000044760 |
NS2A (Dengue virus 2 Thailand/16681/84)
|
NS2A (DEN26)
|
"An NS2A in Dengue virus 2 Thailand/16681/84. UniProtKB:P29990, 1128-1345." [PRO:DNx]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000036849 |
CD14 molecule cleaved and soluble form
|
CD14/ClvPrd/soluble
|
"A CD14 molecule, signal peptide removed form that has been processed by proteolytic cleavage to yield the N-terminal domain lacking a GPI-anchor." [PRO:DAN]
|
|
Yes |
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000002146 |
CD14 molecule cleaved 1 soluble form
|
CD14/Clv:1/soluble
|
"A CD14 molecule, signal peptide removed form that lacks the GPI-anchor and has been processed by proteolytic cleavage to yield the N-terminal domain with extra C-terminal residues as compared to cleaved 2 form." [PMID:7519994]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036615 |
CD14 molecule cleaved 1 soluble form (human)
|
hCD14/Clv:1/soluble
|
"A CD14 molecule cleaved 1 soluble form in human. UniProtKB:P08571, 20-367." [PMID:7519994, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000037469 |
CD14 molecule cleaved 1 soluble form (mouse)
|
mCD14/Clv:1/soluble
|
"A CD14 molecule cleaved 1 soluble form in mouse. UniProtKB:P10810, 16-358." [PMID:10601848, PMID:18606699, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000002147 |
CD14 molecule cleaved 2 soluble form
|
CD14/Clv:2/soluble
|
"A CD14 molecule cleaved 2 that lacks the GPI-anchor." [PMID:2779588]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000035703 |
CD14 molecule cleaved 2 soluble form (human)
|
hCD14/Clv:2/soluble
|
"A CD14 molecule cleaved 2 soluble form in human." [PRO:DNx, UniProtKB:P08571]
|
Yes |
Yes |
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000029986 |
CD14 molecule cleaved 2 soluble form (mouse)
|
mCD14/Clv:2/soluble
|
"A CD14 molecule cleaved 2 soluble form in mouse." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000036850 |
CD14 molecule cleaved and soluble form (mouse)
|
mCD14/ClvPrd/soluble
|
"A CD14 molecule cleaved and soluble form in mouse." [PRO:DAN]
|
|
Yes |
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000029986 |
CD14 molecule cleaved 2 soluble form (mouse)
|
mCD14/Clv:2/soluble
|
"A CD14 molecule cleaved 2 soluble form in mouse." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000037469 |
CD14 molecule cleaved 1 soluble form (mouse)
|
mCD14/Clv:1/soluble
|
"A CD14 molecule cleaved 1 soluble form in mouse. UniProtKB:P10810, 16-358." [PMID:10601848, PMID:18606699, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000036945 |
CD14 molecule cleaved and soluble form (human)
|
hCD14/ClvPrd/soluble
|
"A CD14 molecule cleaved and soluble form in human." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000035703 |
CD14 molecule cleaved 2 soluble form (human)
|
hCD14/Clv:2/soluble
|
"A CD14 molecule cleaved 2 soluble form in human." [PRO:DNx, UniProtKB:P08571]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036615 |
CD14 molecule cleaved 1 soluble form (human)
|
hCD14/Clv:1/soluble
|
"A CD14 molecule cleaved 1 soluble form in human. UniProtKB:P08571, 20-367." [PMID:7519994, PRO:CNA]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000036880 |
presenilin-2 proteolytic cleavage product
|
PSEN2/ClvPrd
|
"A presenilin-2 that has been processed by proteolytic cleavage." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036881 |
presenilin-2 isoform 1 C-terminal fragment
|
PSEN2/iso:1/Clv:Cter
|
"A presenilin-2 isoform 1 that has been cleaved at the caspase-3 consensus site DSYD to yield the C-terminal region. Example: UniProtKB:Q61144-1, 330-448." [PMID:9353287, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036886 |
presenilin-2 isoform 1 C-terminal fragment (mouse)
|
mPSEN2/iso:1/Clv:Cter
|
"A presenilin-2 isoform 1 C-terminal fragment in mouse. UniProtKB:Q61144-1, 330-448." [PMID:9353287, PRO:KRC]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036887 |
presenilin-2 isoform 1 N-terminal fragment
|
PSEN2/iso:1/Clv:Nter
|
"A presenilin-2 isoform 1 that has been cleaved at the caspase-3 consensus site DSYD to yield the N-terminal region. Example: UniProtKB:Q61144-1, 1-329." [PMID:9353287, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036888 |
presenilin-2 isoform 1 N-terminal fragment (mouse)
|
mPSEN2/iso:1/Clv:Nter
|
"A presenilin-2 isoform 1 N-terminal fragment in mouse. UniProtKB:Q61144-1, 1-329." [PMID:9353287, PRO:KRC]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000036889 |
presenilin-2 isoform 1 CTF subunit
|
PSEN2/iso:1/Clv:CTF
|
"A presenilin-2 isoform 1 that has been proteolytically cleaved to yield the C-terminal region analogous to the amino acid region 298-448 in mouse sequence. Example: UniProtKB:Q61144-1, 298-448." [PMID:9353287, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000036890 |
presenilin-2 isoform 1 CTF subunit (mouse)
|
mPSEN2/iso:1/Clv:CTF
|
"A presenilin-2 isoform 1 CTF subunit in mouse. UniProtKB:Q61144-1, 298-448." [PMID:9353287, PRO:CNA]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000037270 |
cochlin proteolytic cleavage product
|
COCH/ClvPrd
|
"A cochlin that has been processed by proteolytic cleavage." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000037261 |
cochlin p8 (mouse)
|
mCOCH/Clv:p8
|
"A cochlin, signal peptide removed form (mouse) that results from cleavage downstream of the LCCL domain (Pfam:PF03815) by aggrecanases proteolytic activity. This form results from the deglycosylation of the N-terminal fragment p18. UniProtKB:Q62507, 26-134." [PMID:23684986, PRO:KRC]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000037262 |
cochlin p18 (mouse)
|
mCOCH/Clv:p18
|
"A cochlin, signal peptide removed form (mouse) that results from cleavage downstream of the LCCL domain (Pfam:PF03815), and includes at least one glycosylated residue. UniProtKB:Q62507, 26-134, MOD:00693." [PMID:23684986, PRO:KRC]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000037263 |
cochlin p40 (mouse)
|
mCOCH/Clv:p40
|
"A cochlin, signal peptide removed form (mouse) that results from further cleavage of the LCCL domain (Pfam:PF03815) after aggrecanases proteolytic activity. UniProtKB:Q62507, 135-552." [PMID:23684986, PRO:KRC]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000037271 |
transcriptional activator GLI3 proteolytic cleavage product
|
GLI3/ClvPrd
|
"A transcriptional activator GLI3 that has been processed by proteolytic cleavage." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000037268 |
transcriptional repressor GLI3R (mouse)
|
mGLI3/Clv:GLI3R
|
"A transcriptional activator GLI3 precursor (mouse) that has been processed by proteolytic cleavage, removing the C-terminal region. UniProtKB:Q61602, 1-?." [PMID:10693759, PRO:KRC]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000037806 |
a disintegrin and metalloproteinase with thrombospondin motifs 18 proteolytic cleavage product
|
ADAMTS18/ClvPrd
|
"An a disintegrin and metalloproteinase with thrombospondin motifs 18, signal peptide removed form that has been processed by proteolytic cleavage." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000037808 |
a disintegrin and metalloproteinase with thrombospondin motifs 18 C-terminal fragment (mouse)
|
mADAMTS18/Clv:Cter
|
"An a disintegrin and metalloproteinase with thrombospondin motifs 18 proteolytic cleavage product that is the C-terminal part after cleavage at the thrombin site in mouse. UniProtKB:Q4VC17, 776-1219." [PMID:22386991, PRO:KRC]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000044456 |
lentivirus-type protease
|
lentivir-protease
|
"A lentivirus-type gag-pol polyprotein that has been processed by proteolytic cleavage to yield the standalone protease domain. Example: UniProtKB:P04585, 489-587." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000045349 |
advanced glycosylation end product-specific receptor proteolytic cleavage product
|
AGER/ClvPrd
|
"An advanced glycosylation end product-specific receptor that has been processed by proteolytic cleavage." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000045350 |
RICD
|
AGER/Clv:intracellular
|
"An advanced glycosylation end product-specific receptor that is the C-terminal intracellular domain of the protein after gamma secretase activity." [PMID:18355449, PRO:KRC]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000045351 |
RICD (mouse)
|
mAGER/Clv:intracellular
|
"A RICD that is produced in mouse." [PMID:18355449, PRO:KRC]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000045352 |
RICD (rat)
|
rAGER/Clv:intracellular
|
"A RICD that is produced in rat." [PMID:18355449, PRO:KRC]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000045353 |
RICD (human)
|
hAGER/Clv:intracellular
|
"A RICD that is produced in human." [PMID:18355449, PRO:KRC]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
modification
|
|
PR:000045354 |
sRAGE proteolytic cleavage product
|
AGER/Clv:ecto
|
"An advanced glycosylation end product-specific receptor that represents the ectodomain of the protein generated by the proteolytic activity of ADAM10." [PMID:18355449, PRO:KRC]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000045355 |
sRAGE proteolytic cleavage product (mouse)
|
mAGER/Clv:ecto
|
"An sRAGE proteolytic cleavage product that is produced in mouse." [PMID:18355449, PRO:KRC]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000045356 |
sRAGE proteolytic cleavage product (human)
|
hAGER/Clv:ecto
|
"An sRAGE proteolytic cleavage product that is produced in human." [PMID:18355449, PRO:KRC]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000045364 |
sRAGE proteolytic cleavage product (rat)
|
rAGER/Clv:ecto
|
"An sRAGE proteolytic cleavage product in rat." [PMID:18355449, PRO:KRC]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000045366 |
advanced glycosylation end product-specific receptor isoform 1 cleaved 1 (mouse)
|
mAGER/iso:1/Clv:1
|
"An advanced glycosylation end product-specific receptor isoform 1 (mouse) that has had the signal peptide removed and has been subjected to proteolytic cleavage. UniProtKB:Q62151-1, 24-329." [PMID:15381690, PRO:KRC]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000045367 |
advanced glycosylation end product-specific receptor isoform 1 cleaved and N-glycosylated 1 (mouse)
|
mAGER/iso:1/ClvNGlycoPyrGlu:1
|
"An advanced glycosylation end product-specific receptor isoform 1 cleaved 1 (mouse) that has the N-terminal Gln converted into pyroglutamate, and has N-glycosylation on two Asn residues. UniProtKB:Q62151-1, 24-329, Gln-24, MOD:01048|Asn-25/Asn-80, MOD:00160." [PMID:15381690, PRO:KRC]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000050072 |
cytochrome b-c1 complex Rieske-derived subunit 9
|
UQCRFS1/Clv:1
|
"A cytochrome b-c1 complex subunit Rieske, mitochondrial that corresponds to the N-terminal portion after proteolytic cleavage by matrix processing peptidase. Example: UniProtKB:P47985, 1-78." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000050081 |
cytochrome b-c1 complex Rieske-derived subunit 9 (human)
|
hUQCRFS1/Clv:1
|
"A cytochrome b-c1 complex Rieske-derived subunit 9 in human. UniProtKB:P47985, 1-78." [PRO:DAN, UniProtKB:P47985]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000050155 |
ubiquitin-like protein FUBI
|
FAU/FUBI
|
"A ubiquitin-like FUBI-ribosomal protein eS30 fusion protein that has been processed by proteolytic cleavage to yield the N-terminal portion containing the Pfam:PF00240 (ubiquitin) domain. Example: UniProtKB:P62861, 1-74." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000050588 |
ubiquitin-like protein FUBI (human)
|
hFAU/FUBI
|
"A ubiquitin-like protein FUBI in human. UniProtKB:P62861, 1-74." [PRO:DAN, UniProtKB:P62861]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000064866 |
ubiquitin-like protein FUBI (mouse)
|
mFAU/FUBI
|
"A ubiquitin-like protein FUBI in mouse. UniProtKB:P62862, 1-74." [PRO:DAN, UniProtKB:P62862]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000050156 |
ribosomal protein eS30
|
FAU/RPS30
|
"A ubiquitin-like FUBI-ribosomal protein eS30 fusion protein that has been processed by proteolytic cleavage to yield the C-terminal portion containing the Pfam:PF04758 (Ribosomal protein S30) domain. Example: UniProtKB:P62861, 75-133." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000050589 |
ribosomal protein eS30 (human)
|
hFAU/RPS30
|
"A ribosomal protein eS30 in human. UniProtKB:P62861, 75-133." [PRO:DAN, UniProtKB:P62861]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
modification
|
|
PR:000060269 |
epidermal growth factor
|
EGF
|
"A pro-epidermal growth factor that has been cleaved to release an extracelluar 53aa segment proximal to the cell membrane. Example: UniProtKB:P01133, 971-1023." [PRO:DAN]
|
|
Yes |
|
|
|
|
| | | | |
| | | | | | | | | |
organism-modification
|
|
PR:000029994 |
cysteine desulfurase cleaved 1 (yeast)
|
yNFS1/Clv:1
|
"A proteolytic cleavage product that is derived from cysteine desulfurase, transit peptide removed form in yeast whereby three N-terminal amino acids have been removed by Icp55p. UniProtKB:P25374, 37-497." [PMID:19720832, PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
organism-modification
|
|
PR:000050267 |
spike protein S1 (SARS-CoV-2)
|
S1 (SARS2)
|
"A spike glycoprotein, signal peptide removed form (SARS-CoV-2) that has been processed by proteolytic cleavage to yield the N-terminal portion. UniProtKB:P0DTC2, 13-685." [PRO:DAN, UniProtKB:P0DTC2]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
organism-modification
|
|
PR:000050268 |
spike protein S2 (SARS-CoV-2)
|
S2 (SARS2)
|
"A spike glycoprotein, signal peptide removed form (SARS-CoV-2) that has been processed by proteolytic cleavage to yield the C-terminal portion. UniProtKB:P0DTC2, 686-1273." [PRO:DAN, UniProtKB:P0DTC2]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000050269 |
spike protein S2' (SARS-CoV-2)
|
S2' (SARS2)
|
"A spike protein S2 (SARS-CoV-2) that has been further processed by proteolytic cleavage to yield the C-terminal portion. UniProtKB:P0DTC2, 816-1273." [PRO:DAN, UniProtKB:P0DTC2]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
organism-modification
|
|
PR:000050281 |
rep gene proteolytic cleavage product (SARS-CoV-2)
|
rep/ClvPrd (SARS2)
|
"A rep gene translation product (SARS-CoV-2) that has been processed by proteolytic cleavage." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000050270 |
host translation inhibitor nsp1 (SARS-CoV-2)
|
rep/Clv:nsp1 (SARS2)
|
"A rep gene proteolytic cleavage product (SARS-CoV-2) that is the N-terminal portion produced by the enzymatic action of PL-PRO proteinase (nsp3) when it cleaves the precursor rep gene translation product (SARS-CoV-2) between residues 180-181." [GenPept:YP_009725297, PRO:DAN, UniProtKB:P0DTC1, UniProtKB:P0DTD1]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000050271 |
non-structural protein 2 (SARS-CoV-2)
|
rep/Clv:nsp2 (SARS2)
|
"A rep gene proteolytic cleavage product (SARS-CoV-2) that is the central portion produced by the enzymatic action of PL-PRO proteinase (nsp3) when it cleaves the precursor rep gene translation product (SARS-CoV-2) between residues 180-181 and 818-819." [GenPept:YP_009725298, PRO:DAN, UniProtKB:P0DTC1, UniProtKB:P0DTD1]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000050272 |
papain-like proteinase nsp3 (SARS-CoV-2)
|
rep/Clv:nsp3 (SARS2)
|
"A rep gene proteolytic cleavage product (SARS-CoV-2) that is the central portion produced by the autocatalytic action of PL-PRO proteinase (nsp3) when it cleaves the precursor rep gene translation product (SARS-CoV-2) between residues 818-819 and 2763-2764." [GenPept:YP_009725299, PRO:DAN, UniProtKB:P0DTC1, UniProtKB:P0DTD1]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000050273 |
non-structural protein 4 (SARS-CoV-2)
|
rep/Clv:nsp4 (SARS2)
|
"A rep gene proteolytic cleavage product (SARS-CoV-2) that is the central portion produced by the combined actions of PL-PRO proteinase (nsp3) when it cleaves the precursor rep gene translation product (SARS-CoV-2) between residues 2763-2764, and 3CL-PRO (nsp5) when it cleaves the precursor between residues 3263-3264." [GenPept:YP_009725300, PRO:DAN, UniProtKB:P0DTC1, UniProtKB:P0DTD1]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000050274 |
3C-like proteinase nsp5 (SARS-CoV-2)
|
rep/Clv:nsp5 (SARS2)
|
"A rep gene proteolytic cleavage product (SARS-CoV-2) that is the central portion produced by the autocatalytic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor rep gene translation product (SARS-CoV-2) between residues 3263-3264 and 3569-3570." [GenPept:YP_009725301, PRO:DAN, UniProtKB:P0DTC1, UniProtKB:P0DTD1]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000050275 |
non-structural protein 6 (SARS-CoV-2)
|
rep/Clv:nsp6 (SARS2)
|
"A rep gene proteolytic cleavage product (SARS-CoV-2) that is the central portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor rep gene translation product (SARS-CoV-2) between residues 3569-3570 and 3859-3860." [GenPept:YP_009725302, PRO:DAN, UniProtKB:P0DTC1, UniProtKB:P0DTD1]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000050276 |
non-structural protein 7 (SARS-CoV-2)
|
rep/Clv:nsp7 (SARS2)
|
"A rep gene proteolytic cleavage product (SARS-CoV-2) that is the central portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor rep gene translation product (SARS-CoV-2) between residues 3859-3860 and 3942-3943." [GenPept:YP_009725303, PRO:DAN, UniProtKB:P0DTC1, UniProtKB:P0DTD1]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000050277 |
non-structural protein 8 (SARS-CoV-2)
|
rep/Clv:nsp8 (SARS2)
|
"A rep gene proteolytic cleavage product (SARS-CoV-2) that is the central portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor rep gene translation product (SARS-CoV-2) between residues 3942-3943 and 4140-4141." [GenPept:YP_009725304, PRO:DAN, UniProtKB:P0DTC1, UniProtKB:P0DTD1]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000050278 |
non-structural protein 9 (SARS-CoV-2)
|
rep/Clv:nsp9 (SARS2)
|
"A rep gene proteolytic cleavage product (SARS-CoV-2) that is the central portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor rep gene translation product (SARS-CoV-2) between residues 4140-4141 and 4253-4254." [GenPept:YP_009725305, PRO:DAN, UniProtKB:P0DTC1, UniProtKB:P0DTD1]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000050279 |
non-structural protein 10 (SARS-CoV-2)
|
rep/Clv:nsp10 (SARS2)
|
"A rep gene proteolytic cleavage product (SARS-CoV-2) that is the central portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor rep gene translation product (SARS-CoV-2) between residues 4253-4254 and 4392-4393." [GenPept:YP_009725306, PRO:DAN, UniProtKB:P0DTC1, UniProtKB:P0DTD1]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000050282 |
ORF1a proteolytic cleavage product (SARS-CoV-2)
|
ORF1a/ClvPrd (SARS2)
|
"A replicase polyprotein 1a (SARS-CoV-2) that has been processed by proteolytic cleavage." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000050280 |
non-structural protein 11 (SARS-CoV-2)
|
rep/Clv:nsp11 (SARS2)
|
"An ORF1a proteolytic cleavage product (SARS-CoV-2) that is the C-terminal portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor replicase polyprotein 1a (SARS-CoV-2) between residues 4392-4393. UniProtKB:P0DTC1, 4393-4405." [GenPept:YP_009725312, PRO:DAN, UniProtKB:P0DTC1]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000050283 |
ORF1ab proteolytic cleavage product (SARS-CoV-2)
|
ORF1ab/ClvPrd (SARS2)
|
"A replicase polyprotein 1ab (SARS-CoV-2) that has been processed by proteolytic cleavage." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000050284 |
RNA-directed RNA polymerase nsp12 (SARS-CoV-2)
|
ORF1ab/Clv:nsp12 (SARS2)
|
"An ORF1ab proteolytic cleavage product (SARS-CoV-2) that is the central portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor replicase polyprotein 1ab (SARS-CoV-2) between residues 4392-4393 and 5324-5325. UniProtKB:P0DTD1, 4393-5324." [GenPept:YP_009725307, PRO:DAN, UniProtKB:P0DTD1]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000050285 |
helicase nsp13 (SARS-CoV-2)
|
ORF1ab/Clv:nsp13 (SARS2)
|
"An ORF1ab proteolytic cleavage product (SARS-CoV-2) that is the central portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor replicase polyprotein 1ab (SARS-CoV-2) between residues 5324-5325 and 5925-5926. UniProtKB:P0DTD1, 4393-5324." [GenPept:YP_009725308, PRO:DAN, UniProtKB:P0DTD1]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000050286 |
proofreading exoribonuclease nsp14 (SARS-CoV-2)
|
ORF1ab/Clv:nsp14 (SARS2)
|
"An ORF1ab proteolytic cleavage product (SARS-CoV-2) that is the central portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor replicase polyprotein 1ab (SARS-CoV-2) between residues 5925-5926 and 6452-6453. UniProtKB:P0DTD1, 4393-5324." [GenPept:YP_009725309, PRO:DAN, UniProtKB:P0DTD1]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000050287 |
uridylate-specific endoribonuclease nsp15 (SARS-CoV-2)
|
ORF1ab/Clv:nsp15 (SARS2)
|
"An ORF1ab proteolytic cleavage product (SARS-CoV-2) that is the central portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor replicase polyprotein 1ab (SARS-CoV-2) between residues 6452-6453 and 6798-6799. UniProtKB:P0DTD1, 6453-6798." [GenPept:YP_009725310, PRO:DAN, UniProtKB:P0DTD1]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | | |
organism-modification
|
|
PR:000050288 |
2'-O-methyltransferase nsp16 (SARS-CoV-2)
|
ORF1ab/Clv:nsp16 (SARS2)
|
"An ORF1ab proteolytic cleavage product (SARS-CoV-2) that is the C-terminal portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor replicase polyprotein 1ab (SARS-CoV-2) between residues 6798-6799. UniProtKB:P0DTD1, 6453-6798." [GenPept:YP_009725311, PRO:DAN, UniProtKB:P0DTD1]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | | |
organism-modification
|
|
PR:000050289 |
NSP2-3 intermediate (SARS-CoV-2)
|
rep/Clv:nsp2-3 (SARS2)
|
"A rep gene proteolytic cleavage product (SARS-CoV-2) that is the central portion produced by the enzymatic action of PL-PRO proteinase (nsp3) when it cleaves the precursor rep gene translation product (SARS-CoV-2) between residues 180-181 and 2763-2764." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
organism-modification
|
|
PR:000050382 |
cytokeratin-19 fragment 21-1 (human)
|
hCYFRA21-1
|
"A keratin, type I cytoskeletal 19 (human) that has been cleaved by caspase-3 or other protease to produce a C-terminal fragment. UniProtKB:P08727, 239-400." [PMID:11251967, PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
organism-modification
|
|
PR:000085744 |
gasdermin-C2 cleaved 1 (mouse)
|
mGsdmc2/Clv:1
|
"A gasdermin-C2 (mouse) that corresponds to the N-terminal portion after proteolytic cleavage. UniProtKB:Q2KHK6, 1-?." [PRO:DAN, UniProtKB:Q2KHK6]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
organism-modification
|
|
PR:000085747 |
processed XK-related protein 9 (mouse)
|
mXKR9/processed
|
"An XK-related protein 9 (mouse) that corresponds to the N-terminal portion after proteolytic cleavage by caspase-3, caspase-6, or caspase-7. UniProtKB:Q5GH62, 1-357." [PRO:DAN, UniProtKB:Q5GH62]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
organism-modification
|
|
PR:000085748 |
processed XK-related protein 4 (mouse)
|
mXKR4/processed
|
"An XK-related protein 4 (mouse) that corresponds to the N-terminal portion after proteolytic cleavage by caspase-3, caspase-6, or caspase-7. UniProtKB:Q5GH67, 1-564." [PRO:DAN, UniProtKB:Q5GH67]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
organism-modification
|
|
PR:000085749 |
asprosin (mouse)
|
mFBN1/asprosin
|
"A fibrillin-1, signal peptide removed form (mouse) that corresponds to the C-terminal portion after proteolytic cleavage by furin. UniProtKB:Q61554, 2734-2873." [PRO:DAN, UniProtKB:Q61554]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
organism-modification
|
|
PR:000085751 |
soluble secretory phospholipase A2 receptor (mouse)
|
mPLA2R1/soluble
|
"A secretory phospholipase A2 receptor, signal peptide removed form (mouse) that corresponds to the N-terminal portion after proteolytic cleavage. UniProtKB:Q62028, 27-?." [PRO:DAN, UniProtKB:Q62028]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
organism-modification
|
|
PR:000085752 |
processed XK-related protein 8 (mouse)
|
mXKR8/processed
|
"An XK-related protein 8 (mouse) that corresponds to the N-terminal portion after proteolytic cleavage by caspase-3. UniProtKB:Q8C0T0, 1-354." [PRO:DAN, UniProtKB:Q8C0T0]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
organism-modification
|
|
PR:000085754 |
gasdermin-D p13 (mouse)
|
mGSDMD/p13
|
"A gasdermin-D (mouse) that corresponds to the N-terminal portion after proteolytic cleavage by caspase-3 or caspase-7. UniProtKB:Q9D8T2, 1-88." [PRO:DAN, UniProtKB:Q9D8T2]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
organism-modification
|
|
PR:000085755 |
gasdermin-D p40 (mouse)
|
mGSDMD/p40
|
"A gasdermin-D (mouse) that corresponds to the N-terminal portion after proteolytic cleavage by a caspase-independent pathway. UniProtKB:Q9D8T2, 1-310." [PMID:35794369, PRO:DAN, UniProtKB:Q9D8T2]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
organism-modification
|
|
PR:000085756 |
gasdermin-C2 cleaved 2 (mouse)
|
mGsdmc2/Clv:2
|
"A gasdermin-C2 (mouse) that corresponds to the C-terminal portion after proteolytic cleavage. UniProtKB:Q2KHK6, ?-480." [PRO:DAN, UniProtKB:Q2KHK6]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | | |
organism-modification
|
|
PR:000085758 |
mature fibrillin-1 (mouse)
|
mFBN1/mature
|
"A fibrillin-1, signal peptide removed form (mouse) that corresponds to the N-terminal portion after proteolytic cleavage by furin (which also removes the propeptide). UniProtKB:Q61554, 45-2733." [PRO:DAN, UniProtKB:Q61554]
|
|
|
|
|
